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The development of complex musculoskeletal system requires essential 
interaction between muscles, bone, cartilage, soft connective tissue which 
includes tendons and ligaments and innervation of muscle by motor neurons. 
Tendon is a fibrous connective tissue that connects bone to muscle and bone to 
bone. Axial tendon progenitors arise from the syndetome in somites while limb 
tendons arise from lateral plate mesoderm. Scleraxis, a bHLH transcription 
factor is expressed in tendon cells.  
 
Meox2 has been shown to express in the limb mesoderm. In this study, we 
found that Meox2 is also necessary for the normal development of tendons and 
soft connective tissue. Meox2-/- neonatal mice had brittle, pale and thin tendons. 
Histological analysis showed mispatterned tendon tissue and reduced tendon 
mass. Using the Scleraxis-GFP reporter transgene, we found decreased 
expression of GFP in Meox2-/- in postnatal limb and tail tendons. In situ analysis 
of Scx RNA expression in Meox2-/- embryos confirmed the earliest tendon 
defects occurred at E12.5, preceding the defects observed in the Scx-/- mice.  
 
To elucidate the mechanism, Meox2+ cells were analysed by antibody staining 
and compared with ScxGFP+ cells from E12.5-14.5. At E12.5, when tendon 
cells organise between prospective muscle and bone in the developing limb and 
trunk, we found Meox2 expression adjacent to (limbs) or overlapping (somites) 
but not co-expressed with Scx-GFP. During tendon cell condensation and 
differentiation at E13.5, Meox2+ cells were found in the connective tissue of the 
autopod and in non-overlapping expression with Scx-GFP+ cells in the 
zeugopod. However, at E14.5, the stage when the initial formation of mature 
tendons is complete, Meox2+ cells were found in Scx-GFP+ autopod tendons, 
whereas in the zeugopod Meox2+ cells remained non-overlapping with Scx-
GFP+ cells revealing tendon diversity in the limb autopod and zeugopod. 
Analysis of a Meox2-nLacZ knock-in allele showed LacZ+ cells in tendons and 
connective tissue at E13.5, indicating that although these cells do not express 
endogenous Meox2 at that stage they are derived from Meox2-expressing 
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progenitors that have contributed to the tendon lineage. We also found 
reduction of LacZ+ cells in the limb soft connective tissue and tendons at E15.5.  
 
TGFβ signalling plays an essential role in the formation of muscle connective 
tissues and a severe tendon phenotype in TGFβ2/3 knockouts first manifest at 
E12.5 which coincides with the earliest tendon defect in Meox2 mutants. 
Dynamic expression of TGFβ2 in the majority of musculoskeletal tissues and, its 
involvement in the recruitment of tendon cells led us to hypothesise that the 
defect in Meox2 mutants may be due to the down regulation of TGFβ2 
signalling. Surprisingly, TGFβ2 RNA expression in Meox2-/- at E12.5 showed 
increased levels in the inter-limb somites and the expression domains were 
markedly expanded in zeugopod. Additionally, the overexpression of TGFβ2 in 
vitro showed differential expression of Meox2.  
 
Collectively, these data provide a model on the biphasic necessity of Meox2 
wherein it acts extrinsically during tendon induction and organisation while 
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1.1 Connective tissue- a component of 
musculoskeletal system  
 
The musculoskeletal system serves as a tool that provides all vertebrates 
locomotion, movements and maintaining body positions. The accumulated 
knowledge based upon molecular characterization showed that the functional 
musculoskeletal system has diverse group of tissues. It includes muscle, bones, 
dense connective tissue (tendons and ligaments) and loose connective tissue 
(muscle connective tissue and fascia). The innervations of nerves then takes 
place to receive neuronal signals and vascularization by blood vessels that 
provide nutrients and signal to the growing tissues takes place. In order to 
understand this multicomponent system, it is necessary to comprehend basic 
development, which includes specification, differentiation and maturation of 
these diverse cell groups. In addition, it is also important to understand how 
these different tissues undergo coordinated morphogenesis by extrinsically 
influencing molecular machinery and thereby achieve an integrated functional 
system.   
 
Furthermore, the musculoskeletal system acts as a great model of studying 
embryonic morphogenesis because it is composed of easily identifiable tissue 
types, which allow studying histology and patterning development. The 
development of a functioning musculoskeletal system is dependent on intricate 
signaling pathways along with the extrinsic and intrinsic gene regulation activity. 
During development these tissue must interact with high fidelity to give rise to a 
function musculoskeletal system (Figure 1.1). To date, much work has been 
focused on the muscle and bone development. However, several emerging 
studies provided insights on embryonic genesis of connective tissues and their 







Figure 1.1: Illustration of the limb musculoskeletal system. The embryonic 
development of this system depends on the molecular signals from muscles (red), 
bone (grey), muscle connective tissue (purple), tendon (green) and nerve innervations 
(yellow). R, radius; U, ulna; H, humerus  
 
1.2 Tendons- a dense connective tissue 
 
Tendons are dense, fibrous connective tissues and are embedded in 
extracellular matrix (ECM). Tendon connects muscle to skeletal elements, and 
via these connecting attachments, it then passively transfer force generated by 
muscle thereby contributing to the overall integrity of the musculoskeletal 
system (Birk et al., 1989). The precise attachment site ensure that the bones 
are connected to the appropriate muscles by their respective tendons, and that 
the integrity of the joints is held together by the ligaments, while the individual 
muscle bundles are embedded within the loose connective tissue i.e. muscle 
connective tissue (MCT). Therefore, the tissues in direct contact with the final 
muscle are the tendons that are classified under dense connective tissue. 
The mutual interactions between cells during embryonic development from 
somites lead to the formation of complex tissue, an example of which is the 
musculoskeletal system. Somites are the segmental blocks of mesoderm 
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present dorsally in the embryo and lie next to the neural tube and notochord. 
During the development, a naïve somite buds off as a columnar epithelial ball 
surrounding a central mesenchymal cavity from the presomitic mesoderm 
(PSM). The secreted signal from surrounding tissues results in epithelio- 
mesenchyme transition of the ventral part of somite. This event establishes the 
polarity in the somite along the dorsoventral and mediolateral axes. As a result, 
the somite derivatives are further subdivided into epaxial and hypaxial domains 
and these domains forms two separate compartments: sclerotome from the 
ventral mesenchyme and the dermomyotome from a dorsal epithelial layer. 
These distinct compartments in somites ultimately form muscles and dermis 
from dermomyotome, cartilage from sclerotome and tendons from syndetome, 
respectively (Brent et al., 2003; Kardon, 1998; Schweitzer et al., 2001; Tozer 
and Duprez, 2005). The dorso-medial dermomyotome expresses Myf5 and 
these cells contribute to the underlying epaxial myotome, where the cells start 
to express MyoD, this region gives rise to the axial muscles. The ventro-lateral 
region of the dermomyotome forms hypaxial myotome that also expresses 
MyoD. This region forms intercostal and abdominal wall muscles. Finally, the 
central region of the dermomyotome develops into dermatome and forms 
dermis in the skin of neck, back, lateral and ventral surfaces of the trunk. 
Additionally cells from the central dermomyotome provide progenitors of future 
satellite cells – skeletal muscle stem cells. The ventro-lateral dermomyotome 
also gives rise to precursors of limb and extrinsic tongue muscles. 
Delamination, migration, proliferation, and differentiation occur in response to 
the cues available from the adjacent mesoderm. The delamination and 
migration of myoblasts are dependent on c-met, a tyrosine kinase receptor and 
its ligand SF/HGF expressed by limb mesoderm (Dietrich et al., 1999). In the 
absence of c-met or HGF, limbs muscles are absent (Bladt et al., 1995; Schmidt 
et al., 1995). Moreover, transcription of c-met is dependent on Pax3 and in 
mutant mouse embryos that lack functional Pax3 gene, myoblasts fail to 
delaminate from hypaxial dermomyotome and thus show a limb muscle 
phenotype (Borycki et al., 1999; Daston et al., 1996). Interestingly, epaxial 
myogenesis remained unaffected in Pax3-/- mutants (Borycki et al., 1999). 
Furthermore, another transcription factor, Lbx1 is important for the migration but 
not delamination (Schafer and Braun, 1999). In Lbx1-/- mutant mice, the dorsal 
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limb muscle precursors followed their destined path whereas ventral limb 
myoblasts were disorientated (Brohmann et al., 2000; Gross et al., 2000; 
Schafer and Braun, 1999). Once delaminated, these cells express the receptors 
CXCR4 and EphA4 and respond to SDF1, the CXCR4 ligand, expressed in the 
limb mesoderm (Hunger et al., 2012; Vasyutina et al., 2005). Thereby, these 
regulators provide a defined path for the arrival of limb muscle precursors inside 
the limb mesoderm. In the absence of CXCR4 or SDF1, there is a reduction of 
Lbx1+ muscle progenitor cells in the dorsal distal limb domain (Vasyutina et al., 
2005). Finally, the migrated myoblasts in the limb then undergo differentiation 
and specification into dorsal and ventral muscle masses. Muscle patterning in 
the limb bud is perturbed in the absence of Meox2 and loss of function in mice 
showed normal migration of muscle progenitors but impaired muscle patterning 
and specification in the limb (Mankoo et al., 1999).  
Understanding normal mechanism of tendon development is important in order 
to generate functional and self-renewing tendon tissue. An optimal level of 
elasticity along with high mechanical strength and good flexibility makes tendon, 
unique connective tissues that have relatively few blood vessels and functions 
at low metabolic rate. Tendon injuries are common and affect a substantial 
portion of recreational and professional athletes and those in many occupations 
involving repetitive work (Brukner and Connell, 2016). This can be reasoned 
due to the classification of tendons amongst the heaviest loaded tissue type in 
the body (Harrison et al., 2010). Injuries in tendon clinically represent a serious 
and still unresolved problem since damaged tendon tissue heals very slowly 
and no surgical treatment can restore damaged tendon tissues to its normal 
structure integrity and mechanical strength (Sakabe and Sakai, 2011). Although 
events in the tendon healing are identical to most connective tissue, however, it 
occurs at a slower rate in tendon due to density of the tissue and 
hypocellularity. The total volume occupied by cells in tendon is only 5%. 
Tendinopathy, is characterised by activity related pain, focal tendon tenderness 
and decreased strength and movement of affected area. The acute traumatic 
flexor tendon injuries accounts for 25% of work related injuries and 75% of 
Achilles tendon injuries are reported in the individuals participating in sports 




1.2.1 Tendon structure  
The structure of tendons can be divided into six major compartments (Figure 
1.2). The smallest component of a tendon is a collagen fibril, which is made up 
of longitudinally arranged chains of tropocollagen. A collagen fibril is a group of 
interconnected collagen strands that are bound together and are secreted by 
fibroblasts. One-step up in the tendon structure is the collagen fibre. The 
collagen fibre is a group of collagen fibrils bound in a sheath of endotenon (a 
substance that helps to stabilize and binds the fibrils). Fibre bundles represent 
the next level in the tendon. Fibre bundles are a group of collagen fibres bound 
together in a sheath of endotenon. A secondary fibre bundle is a group of fibre 
bundles bound together in a sheath of endotenon. A fascicle is the second 
largest component of tendon structure. Moreover, the group of secondary fibre 
bundles are bound together by endotenon. The endotenon that surrounds the 
fascicles is crimped in areas that may come under high stress. The tendon itself 
is the largest structure and is composed of a group of fascicles that are bound 
together by an interior sheath of endotenon and an exterior sheath of 







Figure 1.2: Illustration of the tendon position and organisation. Identical structural 
formats can be seen in either flexor tendon of hand or foot Achilles tendon. Tenocytes 
(tendon cell type) produce and secretes trihelical tropocollagen proteins that form 
collagen bundles and are arranged in cross-striated parallel fibrils. These collagen 
fibrils are enveloped by endotenon, which in turn surrounded by an exterior sheath 
called epitenon.  
 
1.2.2 Composition of tendon  
Water is predominant component at 55-70% in tendons. The collagen proteins, 
predominantly type I and small amounts of type III and V (Silver et al., 2003) 
comprises 70-80% of the dry weight. In addition, elastin, proteoglycans, 
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glycosaminoglycans and glycoproteins (e.g. fibronectin, thrombospondin) are 
also present. Collagen protein, an essential building block of musculoskeletal 
system can be found in both fibril and non-fibril forms. Type I collagen molecule 
is rod-like with little flexibility and high mechanical strength (Engel, 1997). 
Moreover, all of the fibril forming collagens self-assembles into cross-striated 
fibrils with a characteristic 67 nm repeat. They all share a triple helical region 
that is roughly 1000 amino acid residues long with a length of about 300nm 
(Reviewed by Silver et al., 2003). These collagens are synthesized within cells 
in a precursor form termed procollagen that has amino and carboxy-terminal 
non-helical ends that are about 15 and 10 nm long, respectively.  
 
The cellular elements within tendons are known as tenocytes, which are type of 
fibroblasts, that synthesis, and secrete the collagen and all components of the 
extracellular matrix (ECM). These fibroblasts are termed “tenoblasts” when still 
immature. They are spindle-shaped. As they age, tenoblasts become elongated 
and transform into “tenocytes.” Together, tenocytes account for 90–95% of the 
cellular elements of tendons. The remaining 5–10% consists of chondrocytes at 
the bone attachment and insertion sites, synovial cells of the tendon sheath and 
vascular cells, including capillary endothelial cells and smooth muscle cells of 
arterioles (Reviewed by Hoffmann and Gross, 2007). Nonetheless, most of the 
mentioned molecules are not specific to tendons and virtually occurs throughout 
most ECM, and hence not considered as specific markers for tendon 
differentiation. However, there are extensive researches on the molecular 
architectural of tendon and its composition but not much in known about how 
this tissue is patterned and coordinated during development. Identification of 
early events in the tendon formation became possible with the gene, which 
encodes for a basic helix-loop-helix transcription factor Scleraxis (Scx). It is a 
distinctive marker of tendon cells since it is expressed by both tendon 
progenitor cells (TPC) and mature differentiated tenocytes (Schweitzer et al., 
2001). Recently stem cells have been discovered in tendon that show similar 
properties to tenoblast cells and are therefore specified but undifferentiated 
tendon progenitor cells. Tendon stem/progenitor cells (TSPCs) were isolated 
from adult tendons, and the stem cell niche of TSPCs is defined by the ECM of 
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tendons (Bi et al., 2007). These cells showed the characteristics of stem cells 
and also expressed combination of tendon cell markers, namely, Scx, TNMD, 
COMP and tenascin. TSPCs differ in their differentiation potential, morphology, 
proliferation and marker expression from tenocytes (Zhang and Wang, 2010); 
and TSPCs proliferate and increase collagen production in response to anabolic 
exercise, in a manner parallel to that shown by muscle stem cells (Zhang et al., 
2010). In fact, Zhang et al. confirmed that these TSPCs express the known 
stem cell markers such as Oct-4, SSEA-4 and nucleostemin. The primary role 
of adult stem cells is to maintain homeostasis and repair of tissues, this function 
has yet to be demonstrated for TSPCs.  
 
1.2.3 Embryonic morphogenesis of tendons 
 
Comprehensive work has identified mechanisms, which regulates all stages of 
embryonic genesis of tendons. Still there are only few molecular factors shown 
to be crucial for tendon development when compared to those found in the 
genesis of muscles and skeleton. The tendon morphogenesis is a well-
organised process. During the 10th day of mouse development, tendon specific 
cells labelled by Scx gene, begin to induce in the limb mesoderm and in 
syndetome of somites. The cranial tendons are specified from neural crest cells 
(Schweitzer et al., 2010) Both compartments give rise to different group of 
tendons found in the appendicle and axial structure. These so-called “tendon 
progenitor cells” (TPC’s) that are specified to express tendon specific gene, 
Scx, exhibit three distinctive stages during the course of morphogenesis 
namely, (a) induction (E10.5-11.5), (b) alignment and organisation (E12.5), (c) 
maturation and differentiation (E13.5 onwards) as shown in figure 1.3 for limb 





Figure 1.3: Diagram of the mouse limb tendon development. Induction of initial 
Scx-expressing tendon precursors occurs within the limb mesenchyme between E10.5-
E11.5. During organisation and alignment of tendon progenitor cells between E12.0-
E12.5, the cells are positioned at the presumptive functional site and a second wave of 
the recruitment of tendon cells occurs. Moreover, the intrinsic and extrinsic regulators 
are maintaining the tenoblastic identity. Eventually, from E13.5 onwards, mature 
tendons are formed due to combined activity of the extrinsic signals from the adjacent 
muscle and cartilage cells. In addition, Scx intrinsically favours the aggregation and 
differentiation of tendon cells to form the mature distinct tendon.  
 
From the neonatal stage, the tendon tissues lose their ability to differentiate, 
instead, synthesize and secrete extra-cellular matrix (ECM) proteins that acts as 
scaffolding proteins for collagen fibril assembly. Moreover, an increase in 
collagen fibril diameter and changes in the morphology of fibroblast cells occur 
(Diamant et al., 1972). 
 
The cellular dynamics and interactions of musculoskeletal components that 
regulate tendon development differ in the axial skeleton versus limb, and 
between autopod versus zeugopod. For example, the specification of TPC are 
autonomous in the limb mesoderm, however, for the proper organisation and 
maturation, signals from myogenic cell are crucial (Huang et al., 2015a; Kardon, 
1998). In contrast, Scx-positive tendon cells in the somites are induced under 
the influence of FGF signalling emanating from adjacent myotome. A more 
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elaborated description on axial versus limb tendon development stages is 
discussed in the next section.  
  
1.2.4 Inductive cues for axial versus limb tendon 
progenitor cells 
 
Earlier chick-quail grafting orthotopic and heterotrophic transplantations showed 
that the non-myogenic components of the intricate musculoskeletal system of 
the limb, such as bones, cartilage, tendons, ligaments and connective tissue, 
are created de novo and are derived from the lateral plate or somatopleural limb 
mesenchyme (Wachtler et al., 1981). Radio-destruction of the somitic 
mesoderm showed that the absence of a given muscle results in the absence of 
corresponding tendons (Chevallier et al., 1977), providing the first evidence of a 
developmental relationships between these two distinct precursor populations. 
However, most of the subsequent analyses of tendon development 
concentrated on the distal autopod tendons. In a similar experiment, Kieny and 
Chevallier (1977) showed that despite the induced absence of flexor and 
extensor muscles, differentiation of the distal manus tendons still occurred. 
Although they were transient structures, it demonstrates an early autonomy of 
the tendons from the muscles. A requirement for subsequent interactions 
between the two tissues from maintenance and further development of the 
tendons was observed.  
An axial tendon connects the muscles that are located near the spinal column to 
the vertebrae. As a result, this complex tissue helps in the stability of the spine 
and transfers force generated by muscles to the axial skeleton and assists in 
the extension, rotation, and flexion of the trunk. The progenitors for the axial 
tendons arise from the somites, unlike limb tendon progenitors that are derived 
from limb mesenchyme (Brent et al., 2003). However, current advances on 
proper steps in the trunk tendon development is limited due to the multiple 
complexities associated with the interaction between diverse tissues in the 




Trunk tendons: The axial tendon progenitors originate from syndetome that is 
a fourth compartment in somite and is located at the junction between two 
neighbouring myotomes and the sclerotome (Fig 1.4). Despite differences in the 
origin of muscle, cartilage, and tendon in somite compartments, their 
development is coordinated and interdependent. The bHLH transcription factor, 
Scx is an exclusive marker for both tendon progenitor cells and mature 
tenocytes. The double in situ hybridisation on mouse embryo at E10.5 for a 
myogenic marker MyoD and a tendon marker Scx revealed that indeed Scx-
expressing cells are located in syndetome which is next to the myotome (Brent 
et al., 2003). Same study also showed that in the quail-chick chimera system 
the tendon progenitors are expressed between the myotome and sclerotome. In 
this experimental approach, the grafting of sclerotome from quail to chick 
resulted in the formation of sclerotome cells and Scx-expressing tendon 
precursors from the grafted quail. On the other hand, the surgical implantation 
of quail dermomyotome into the chick formed only dermomyotome and 




Figure1.4: Illustration of axial tendon development in mouse A depiction of the 
longitudinal trunk sections from the somite showing sclerotome (Pax1+), myotome 
(MyoD+), syndetome (Scx+) and neural tube (NT). The whole mount in Scx in situ 
hybridisation is shown for the stages E12.0 (tendon organisation) and E13.5 (tendon 
condensation). The black line shows the level of longitudinal sections from the 
embryos. Myotome signals induce Scx+ at anterior region of sclerotome that is known 
as syndetome from E12.0. Mature condensed tendons are then acting as connectors of 
the vertebrae and muscle cells from E13.5 onwards.     
 
 
Myotomal fibroblast growth factors (FGFs) play a critical role in the induction of 
Scleraxis expressing tendon progenitors. FGF4 and FGF6 in mouse embryo 
while FGF4 and FGF8 in chick embryo have been shown to induce Scleraxis 
(Brent et al., 2005; Brent and Tabin, 2004; Tozer and Duprez, 2005). Brent and 
her colleagues further demonstrated the role of FGF signalling in Scx induction 
in 2003, where the expression of Scx was lost due to inhibition of FGF signalling 
in trunk culture of mouse embryo. FGFs activate Ets transcription factors, Pea3 
and Erm, which regulates directly or indirectly Scx transcription (Brent and 
Tabin, 2004) (Fig. 1.5). Another study also suggests that expression of Scx is 
also stimulated by FGF signalling via the mitogen activated ERK and MAPK 
kinase activity (Brent and Tabin, 2004; Smith et al., 2005). In chick embryos, the 
antibodies against active phosphorylated MAPK/ERK1 and MAPK/ERK2 
detected active MAPK/ERK throughout dermomyotome, dorsal sclerotome, 
myotome and strong expression seen in adjacent sclerotome where Scx is 
expressed (Brent and Tabin, 2004).  
In addition, the early development of tendons in somites is coordinated and 
interdependent on surrounding tissue i.e. muscle and cartilage. The muscle 
precursor region of somite is essential for tendon development since in MyoD 
and Myf5 double mutant mice where no muscles are formed, the Scx 
expression in the somite was completely abolished in syndetome (Brent et al., 
2005). In the same study, it was revealed that in Sox5-/-; Sox6-/- mutant embryos 
the loss of chondrocyte differentiation results in an expanded Scx+ tendon 















Figure1.5: Model of genes involved in axial tendon development- Myotomal signal 
FGF8 activates Scx via Pea2 and Erm to induce tendon precursor cells in syndetome. 
Both Scx and Mkx can promote tendon differentiation factors e.g. tenomodulin (Tnmd). 
Pax1 and Sox5, which are sclerotomal factors, inhibit Scx expression and promote 
development of cartilage in sclerotome. Myotome in pink, syndetome in green and 
sclerotome in brown. NT, neural tube; No, notochord.  
 
Limb tendons: Limb tendons originate from lateral plate mesoderm. Once 
induced, the tendon progenitors are reorganised in the sub-ectodermal regions 
of ventral and dorsal areas of the limb (Schweitzer et al., 2001). Ectodermal 
signals have been shown to be involved in tendon progenitor induction for limb 
tendon precurssors. Removal of dorsal limb ectoderm in chick embryos results 
in loss of Scleraxis induction in limb mesenchyme (Schweitzer et al., 2001). The 
obvious signals from ectoderm are FGFs but to date no definitive evidence are 
available to show the involvement of FGF signalling in limb tendon 
development. Absence of Fgf8 in proximal regions of limb makes it unlikely that 
it regulates induction of Scx in proximal mesenchyme of limbs (Schweitzer et 
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al., 2001). The induction of Scleraxis was found also in the absence of muscle 
cell, which expresse Fgf4 (Edom-Vovard et al., 2002). However, in muscleless 
wings in chick embryos, Scx expression was eventually lost demonstrating 
muscle-dependent phase of tendon development. Hence, the molecular factor 
that leads to Scleraxis induction in limbs remains to be investigated. 
Furthermore, chondrogenesis was favoured in the absence of FGF signalling 
(Schweitzer et al., 2001). 
Bone morphogenetic proteins (BMP) have negative influence on appendicular 
tendon development. The facilitation of chondrogenesis over tendon 
morphogenesis by BMP2 in developing limbs was shown in chick embryos 
(Edom-Vovard and Duprez, 2004; Edom-Vovard et al., 2002; Schweitzer et al., 
2001). The application of endogenous BMP signalling inhibitor, Noggin up 
regulates Scleraxis expression in limb bud. 
Interestingly, the dynamics of limb tendon development and patterning in 
contrast to axial tendons is independent of muscle and cartilage. As seen in Fig. 
1.6, cartilage cell condensation is in the centre and in contrast to the somite 
(Fig. 1.5) where the tendon and muscle progenitors are well compartmented, 







Figure1.6: Schematic of vertebrate tendon morphogenesis in the limbs. (A) 
Induction of initial Scx-expressing tendon precursors occurs under influence of Wnt 
signalling. (B) Organisation of tendon progenitors depends on TGFβ signalling which 
recruits a second wave of tendon cells and maintains tenoblastic identity. (C) Scx 
favours aggregation and differentiation of tendon progenitors to form mature distinct 
tendon occurs by E13.5. The positive and negative regulators are highlighted at the 
bottom of the stages of limb depiction.  
                                          
Unlike axial tendons, which require myotome signals, Scx expressing tendon 
cells are clearly detected in muscle-less limbs of Myf5/MyoD mutant mice 
(Edom-Vovard et al., 2002; Kardon, 1998; Murchison et al., 2007; Schweitzer et 
al., 2001). In chick embryos, Scleraxis expression was seen in limbs even after 
the surgical removal of developing muscles (Edom-Vovard and Duprez, 2004; 
Schweitzer et al., 2001). Moreover, normal Scx expression was also found in 
Splotch embryos that have a defect in Pax3 gene and failure in the migration of 
limb muscle progenitors from somite (Huang et al., 2015b). Altogether, these 
studies suggest that limb tendon induction does not require signals from 
myogenic cell population. However, for the continuous expression of Scleraxis 
signals from muscles is essential. It was discovered that in continued absence 
of myogenic cells, Scx expression was not maintained in chick embryos (Edom-
Vovard et al., 2002). This clarified the role of muscles in limb tendon 
development where the initial establishment of Scx is independent on myogenic 
cells but they are essential at subsequent stages (Edom-Vovard et al., 2002; 
Kardon, 1998).  
 
Recently, it was shown that the expression of transcription factor Pea3, a known 
effector molecule of FGF signalling is expressed by tendon cells at the site 
where myotendinous junction is present. When analysed in Pax3 mutant mice 
limbs, there was complete loss of Pea3 expression at E12.5 from defined 
tendon cells present at the close proximity to muscle cells (Eloy-Trinquet et al., 
2009). This study has now further enhanced our understanding of muscle-
dependent phase of tendon formation.  
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Based on the known molecular regulators for limb tendon development, a model 
is shown in Figure 1.7. Altogether, several sources of evidence are now 
available which show there are significant differences in limb tendon 
development when compared to axial tendons. Furthermore, in same study it 
was found that TGFβ signalling also helps in recruiting the additional Scleraxis 
expressing tendon progenitors at the site of condensation and might be involved 
in interaction between tendon precursors, adjacent muscle, and cartilage. 
Furthermore, the limb mesenchyme acts as a host for multipotent cells that can 
give rise to cartilage cells and connective tissues, which can be grouped into 
two categories, i.e. dense connective tissue (tendons and ligaments) and loose 
connective tissue (muscle connective tissue).  
Recently, the modularity in the limb tendon development was established 
(Huang et al., 2015b). While the induction and proliferation of autopod tendons 
requires cues from cartilage, the zeugopod tendon development is dependent 
on muscle cells. 
 
Figure1.7: Illustration of limb tendon induction and organisation. Induction of Scx 
expression in the limbs takes place in response to FGF and Wnt signalling. BMP 
signalling has negative effect on Scx while TGFβs promote tendon development by 
maintaining and recruitment of tendon precursor cells at the site of condensation. Other 
unknown positive regulator from muscle cells and MCT’s extrinsically regulates Scx 
whereas Sox9 from cartilage cells restricts Scx expression domains. Other transcription 




Other important factors in regulation of tendon development in limbs include the 
transforming growth factor β (TGFβ) superfamily. The application of TGFβ2 -
containing beads to mouse limbs in organ culture showed induction of Scleraxis 
at stages from E10.5 to E13.5 (Pryce et al., 2009). Additionally, surgical grafting 
of TGFβ2- loaded beads in somites of E10.5 embryos caused robust induction 
of Scx. In the absence of TGFβ signalling i.e. in Tgfβ2-/-; Tgfβ3-/- mutant mice 
and TgfβRII mutant where deletion of the receptor blocked all TGFβ signalling, 
the initial induction of Scx remains unaffected but is subsequently lost, 
suggesting additional regulators are involved in induction of Scleraxis. In 
TGFβ2/3 double mutant mice, all limb tendon progenitors were lost at E12.5 
(Fig.1.8). It was also found in cross sections, all long tendons of tail were 
missing but the intrinsic muscles and tendons  persisted in Tgfβ2-/-; Tgfβ3-/- 
mutant mice when observed at E15.5 (Pryce et al., 2009). Interestingly, this 
double ligand mutant of TGFβ displayed modularity in limb tendon phenotype 
whereby in E14.5 embryos, the digit tendons appeared normal but zeugopod 
tendons were abnormal. Moreover, the authors also detected TGFβ2 
expression in differentiating cartilage and muscle cells that could explain 
severity of phenotype in zeugopod than autopod.  
The same study also showed a role for TGFβ signalling in regulation of Scx in 
vitro. The mesenchymal-like cell line C3H10T1/2 expresses Scx at moderate 
level. By semi-quantitative RT-PCR it was observed that the mRNA level of Scx 





Figure 1.8 Whole-mount ISH for Scx on E12.5 The endogenous expression of Scx in 
the whole embryos and dorsal and ventral forelimbs in wild-type (D,G,J), Tgfb2-/- 
(E,H,K) and Tgfb2-/- and Tgfb3-/-  embryos showed a severe phenotype in Tgfb2-/-  and 
complete loss in compound mutants (Adapted from Pryce et al., 2009).  
 
1.2.5 Organisation and differentiation of tendon cells 
Murchison and his colleagues in 2007 provided the first evidence for the pivotal 
role of Scleraxis in tenocyte differentiation from E13.5 onwards. In Scx mutant 
mice, movement of paws was highly restricted and tail movement was 
completely lost. In addition, the long force-transmitting tendons and 
intermuscular tendons were the severely affected. However, the distribution of 
ScxGFP–positive cells in short range anchoring tendons such as intercostal 
tendon layer and ligaments were not affected in the mutant mice. The earliest 
defects were observed at E13.5 suggesting failure of condensation and 
aggregation of the tenocytes. This has been observed by loosely organised 
mesenchyme of tendon progenitors in the forelimbs (Fig. 1.9).  
Moreover, flexor tendons were affected more in the absence of Scx than 
extensor tendons. Further analysis showed no significant changes in the 
apoptosis or cell proliferation events in the mutants. Additionally, the matrix 
organisation was significantly disrupted in the absence of Scx and it was also 
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shown that Scx directly regulates the expression of Col1a1 and Tenomodulin at 
tendon differentiation stages. In the absence of Scx function, by E18.5, the 
cellular components (tenocytes) of mature tendons were affected along with 
disorganised tendon sheath.  
 
Figure 1.9 ScxGFP detected by in situ hybridization in wild type (I) and Scx-/- (L) 
forelimbs at E13.5. The tendon phenotype was first detected at E13.5 in mutant mice. 
(J,M) Sections through wild-type (J) and Scx-/- (M) forelimbs at E13.5 at a proximal 
metacarpal level (level 4 in A) (Adapted from Murchison et al., 2007).  
 
Furthermore, Scx positively regulates the type I collagen through the tendon-
specific element 2 of the procollagen, type1, alpha 1 (Col1a1) promoter (Lejard 
et al., 2007). Other genes shown to be positively regulated by Scx are 
tenomodulin and collagen XIV (Espira et al., 2009; Shukunami et al., 2006). 
Tenomodulin (Tnmd) is another important factor in tendon differentiation. It is 
type II transmembrane glycoprotein and is expressed by tendons and ligaments 
(Shukunami et al., 2001). A decrease in tenocyte proliferation and density was 
seen in targeted Tnmd mice. TNMD is required for maintaining proper network 
of collagen proteins in tendon.  
Recently, it was discovered that another atypical homeobox gene Mohawk 
(Mkx) is expressed by tendon progenitors. It plays a critical role in tendon 
maturation (Anderson et al., 2006; Ito et al., 2010). Mohawk-/- mice show 
hypoplastic tendons at postnatal stages and reduction in type I collagen. 
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Interestingly, in Mkx null mice the tendon cell numbers remain unaffected even 
though there is a reduction in tendon mass.  
Moreover, early growth response transcription factors EGR1 and EGR2 are now 
shown to increase collagen expression during vertebrate tendon differentiation 
(Lejard et al., 2011). In chick limbs, FGF4 signals positively regulate Egr gene 
expression. This was shown by bead experiments where ectopic Egr1 and Egr2 
transcripts could be detected after FGF4 bead implantation in dorsal chick 
wings. Moreover, Egr gene can induces tendon markers Scx, and the tendon 
collagen Col1a1. Egr1 and Egr2 double mutant mice at embryonic stage (E) 
18.5 displayed decreased level of Col1a1 transcripts and reduced collagen 
fibrils in embryonic tendons. When analysed by performing ChIP, the regulation 
of Col1a1 by Egr1 and Egr2 were found by binding of Egr1 to proximal 3.2kb 
segment, which also contains two tendon specific elements TSE1 and TSE2. 
These elements were shown to be essential for binding of Scx to regulate 
Col1a1 expression (Lejard et al., 2007). In addition, the expression levels of the 
two DNA-binding factors, Scx and Mkx were also reduced in Egr1−/− mutant 
mice. Fibin2 is a recently dicovered tendon marker strongly expressed in 
mature tendons (Liu et al., 2010). The expression analyses of Fibin 2 have 
shown a strong expression in the syndetome and continue to express through 
out the development in tendon cells. Thus, it can be considered as an additional 
marker for tendon specific cells for future investigations.  
 
1.2.6 Tendon growth and maturation 
 
The morphological events of tendon differentiation, growth, and maturation 
occur from E14.5 onwards until birth. During this phase, the correct connections 
between muscle-tendon (also called as myotendinous junctions) and tendon-
bone attachment takes place. For this proper connections, ECM proteins acts 
as “glue” to join both cell types via integrin receptors found on cell membranes 
and are associated with cytoskeletal actin filaments present inside myocytes 
and tenocytes (Docheva et al., 2014; Mayer et al., 1997; Pan et al., 2013; 
Welser et al., 2009). The next segment in this chapter will discuss the several 
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ECM factors, which are coupled in spatio-temporal manner to mediate the force 
transmission at the myotendinous junction.  
Moreover, tendon differentiation, maturation, and growth require muscle only in 
the zeugopod. For instance, in Splotch mouse embryos with a defect in 
migration of myogenic cells due to mutation of the Pax3 locus showed down 
regulation of Scx and Tnc in zeugopod (Bonnin et al., 2005; Eloy-Trinquet et al., 
2009; Huang et al., 2015b). The modularity in tendon development at this stage 
led to complete degeneration of differentiated tendons in the zeugopod segment 
(Kardon, 1998; Schweitzer et al., 2001). Recently, Huang and co-workers 
(2015) showed that in Splotch embryos, the autopod tendons are not only 
induced and differentiated but also survived throughout embryogenesis. Similar 
observations were also reported in chick embryos (Kardon, 1998). Therefore, 
we have now conclusive evidence that maintenance of zeugopod tendons 
requires physical interactions with muscles, and mechanical load applied by 
muscles also plays a pivotal role in overall growth and maturation of zeugopod 
tendons.  
The tendons in digit segments are established in the regions where no muscle 
cells are normally found. The essential muscle-dependent signal for the tendon 
differentiation is replaced by cartilage-derived cues (Huang et al., 2015b). In 
Sox9Prx1Cre embryos, which contain the conditional deletion of Sox9 gene from 
limb mesenchyme showed loss of Scx expression in the autopod at E13.5 
whereas in Gli3Xt/Xt embryos, tendons were found in all the extra digits. Gli3 is 
an important regulator of the digit formation and mutation of this gene in Gli3Xt/Xt 
embryos caused development of an extra digit (Vortkamp et al., 1992). 
Collectively, the tendon differentiation and maturation is dependent on skeletal 
condensation in the autopod whereas in zeugopod, myogenic cells help in the 






1.3 Myotendinous junction  
 
The transmission of force generated by muscles into skeletal elements takes 
place at myotendinous junctions (MTJ). Electron microscope analysis revealed 
that the establishment of MTJ occurs when cytoskeletal proteins of muscle cells 
and tendon ECM interact (Tidball, 1994; Tidball and Lin, 1989). These ECM 
proteins (e.g. collagens, laminins, thrombospondins) are accumulated between 
interacting myoblasts and fibroblasts (Figure 1.10) (Kuhl et al., 1986; Sanderson 
et al., 1996).  
 
 
Figure 1.10 Schematic of myotendinous junction The extracellular matrices of 
muscle fibres (in red) and tendon cells (in green) interact at a sparse layer of ECM 
called myotendinous junction (MTJ). Distinguish molecular markers of muscle and 
tendon ECM are shown in red and green, respectively. Muscle ECM is composed of 
laminin trimers and fibronectin whereas tendon ECM contains collagen trimers and 
thrombospondin proteins.  
 
 
While studies have shown that ECM proteins may enhance proliferation and 
growth of myogenic tissue (Lan et al., 2005; Langen et al., 2003; Stern et al., 
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2009), they also modulate tendon maturation stage during development. The 
study that generate Scx-/- mutant mice, showed the disruption of tendon ECM at 
later stages of tendon morphogenesis (Murchison et al., 2007). The same study 
has further shown a severe down regulation of the expression of structural 
collagen proteins, Col1a1, Col1a2, Col3a1 and Col14a1 in Scx-/- mutant mice. 
Moreover, Scx is a direct regulator of Col1a1 and Col1a2 transcription (Espira 
et al., 2009; Lejard et al., 2007). 
 
Likewise, Mkx also promotes expression of Col1a1 and Col1a2 and thus Scx 
and Mkx act as transcriptional activators of these collagen genes. Interestingly, 
in Mkx-/- that exhibit normal embryonic tendon formation, later showed a thinner 
collagen fibrils and reduction of fibromodulin (Fmod), decorin (Dcn), 
tenomodulin (Tnmd) (Ito et al., 2010; Liu et al., 2010). Moreover, the evidence 
suggests that the influence of Scx and Mkx on ECM proteins occurs via Smad 
mediated TGFβ signaling (Berthet et al., 2013; Hosokawa et al., 2010). 
Specifically, Berthet et al (2013) reported that the loss of Smad3 function 
resulted in reduction of Scx, Tnc, Mkx and matrix proteins such as Col1a1, 
Col1a2. Moreover, the authors showed that Smad3 physically interacting with 
Scx and Mkx. Furthermore, in Wnt1-Cre;Tgfbr2 flox/flox mice in which the 
derivatives of cranial neural crest cells were marked by Wnt1-Cre and Tgfbr2 
conditional inactivation in these migratory cells was established by using 
Tgfbr2flox/+ mice (Hosokawa et al., 2010). This conditional inactivation of 
Tgfbr2 resulted in loss of Scx expression from the tendons of tongue muscles 
that are derived from neural crest cells. Moreover, tongue explant assay 
demonstrated Scx induction in response to TGFb2 soaked bead. Therefore, it 
was concluded that TGFβ signalling regulates Scx expression and controls 
cranial neural crest derived cells.   
 
Extensive research been carried out to understand the development of MTJ. 
Upon completion of muscle differentiation, ECM proteins direct myofibres to the 
attachment sites in MTJ (Kjaer, 2004). This site than undergoes maturation and 
imparts mechanical forces to maintain the function of mature tendon cells 
(Schwartz et al., 2013). The MTJ develops in two stages and with respect to 
tendon cell requirement; the stages are classified as tendon independent and 
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tendon dependent stages. First, induced tenoblasts secrete fibrilliar ECM 
components near the periphery of migrated myoblasts. The integrins on muscle 
cell membranes recognize signals emanating from tenocytes e.g. 
Thrombospondin (Tsp), laminins (Lama) (Gotwals et al., 1994; Martin-Bermudo, 
2000; Subramanian et al., 2007). Additionally, muscle cells secrete Tiggrin that 
interacts with integrin receptors present on its surface membrane (Bokal and 
Brown, 2002; Fogerty et al., 1994).  
 
Second, fusion of myoblast results in the formation of myotubes, which are then 
followed by extensive scaffolding of ECM proteins that produce basement 
membrane. There are a diverse set of extracellular proteins present in the 
basement membrane that includes laminins, perlecan, collagen IV, nidogen 
(Yao et al., 1996; Koch et al., 1999; Fox et al., 1991; Mayer et al., 1995; Hudson 
et al., 1993; Kuhn, 1994; Kruegel and Miosge, 2010). Last, a mechanical cross 
talk takes place between muscle and tendon cells. For the efficient delivery of 
mechanical load, the various groups of proteins are necessary at this stage. 
These are divided into three sub-groups: (a) collagen proteins secreted by 
tenocytes (Col1a1, Col1a2, Col2a1 and Col3a1); (b) proteins that can form 
scaffolds (e.g. Lama2, Comp, Tsp4) and (c) cross-linking proteins (e.g. Col6a1, 
Col12a1, decorin, Fmod, lumican, biglycan, alpha-dystroglycan and beta-
dystroglycan). These altogether help in reducing frictions between fibers of 
ECM and disseminate the force appropriately (Wang et al., 2012; Dunkman et 
al., 2013). Interestingly, various studies have shown that misexpression of the 
gene coding for the cross-linking proteins produced an adverse outcome on 
tendon structure (Chakravarti, 2002; Corsi et al., 2002; Zhang et al., 2006). On 
a bigger scale, the ECM is critical for MTJ organization and plays a pivotal role 
by providing structural support and function. 
 
1.4 Enthesis: Tendon-bone attachment  
An enthesis is the site on the other end of a tendon where it attaches to the 
bone or cartilage. Starting at the tendon side, the first zone exhibits tendon 
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properties, including aligned type I collagen fibers and the proteoglycan decorin. 
The second zone comprises fibrocartilage that contains type II collagen, with 
only small amounts of type I collagen. The ECM of zone 2 contains, in addition, 
type III collagen, aggrecan and decorin. Next, zone 3 contains mineralized 
fibrocartilage that includes type II and type X collagens as well as aggrecan. 
Finally, zone 4 is bony and composed mostly of mineralized type I collagen 
(Reviewed by Schweitzer et al.,2010). Emerging studies have shown a close 
relationship between Scx expressing tenocytes and Sox9 positive chondrocytes 
in formation of enthesis (Soeda et al., 2010; Sugimoto et al., 2013a; Sugimoto 
et al., 2013b). Interestingly, Scx-/- mice lack entheses and its function was 
shown to be necessary for bone ridge initation (Blitz et al., 2013; Murchison et 
al., 2007). Moreover, BMP signalling and TGFb superfamily play key role in 
chondrocyte development (Blitz et al., 2009; Yoon et al., 2006).   
Collectively, the summary of factors involved in the tendon development and the 
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Scx null mice 
• First tendon phenotype at E13.5 
• Severe disruption of force-transmitting 
tendons but no defects in ligament and short-
range anchoring tendons 
• Disorganised tendon matrix 
• Decrease of Tnmd, Col14a1, Col1a1 from 
E16.5 
 
Mkx null mice 
• First tendon phenotype at E16.5 
• Decrease of Tnmd, Col1a1, Col1a2, Tnmd, 
Fmod, Dcn from E16.5 
 
Egr null mice 
• First tendon phenotype at E18.5 
• Decrease in Scx, Tnmd, collagen levels  
 
Sox9f/f; Prx1Cre 
Complete loss of Scx expression in autopod but 
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Complete loss of Scx expression in autopod but 
not in zeugopod at E12.5.  
 
TGFβ2/TGFβ3 double mutant 
• Complete loss of tendons from E12.5. 
•  TGFβ2 ectopic expression in mouse limbs 
and in vitro 10T1/2 cells upregulated Scx 
expression 
 
Mstn null mice 
• Postnatal tendon phenotype. 
• Abnormal mechanical properties and 
decrease in Scx, Mkx, collagen (Col1a2), 
Tnmd 
 
Gdf5 null mice 
Limb shortening, joint dislocation and abnormal 
tendons 
 
Smad3 null mice 
• Postnatal tendon phenotype 
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Tnmd null mice  
• Loss of tenocyte proliferation and reduced 
tendon density 
• Postnatal defects in collagen fibrils 
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Col1a1 null mice 
Postnatal decrease in collagen fibril diameter  
 
Disordered collagen fibril 
 
Short limb dwarfism and onset of osteoarthritis  
 
Irregular collagen fibril  
 
Abnormal collagen fibrillogenesis in tendons  
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1.5 Post-natal arrangement of limb tendons 
The post-natal stage of tendon maturation involves assembly of monomeric 
units of collagen and fusion of collagen fibrils for fibril growth (Zhang et al., 
2005). The unsheathing of the cell layers to form epitenon and paratenon takes 
place at birth (Benjamin and Ralphs, 1997, 1998; Birk et al., 1989). The 
organisation of major forelimb tendons at postembryonic stage was determined 
by Pryce and co-worker in 2007 using a ScxGFP transgene. The robust 
formation of the appropriate flexor and extensor tendon trajectories along the 
proximal-distal axis of the forelimb has been determined and the precise 
assemblage in the forelimb into a functional musculoskeletal system is achieved 
using ScxGFP (Watson et al., 2009). A major flexor tendon, the flexor digitorum 
profundus (FDP), trails down from the individual FDP muscle in the forearm as 
an elongated entity and reaches the carpal tunnel near the wrist and then splits 
into individual units on the palmar side of the phalanges (Figure 1.11). Within 
phalanx, each FDP tendon subunits insert into the distal interphalangeal joint, 
thereby, assisting in the movement of each fingers.  
Moreover, inside the fingers, another superficial tendon is present above the 
FDP, known as, the flexor digitorum superficialis (FDS). At the interphalangeal 
joints of the digits, FDP tendons become volar whereas FDS tendon units are 
present at the bottom. In the mid-part of the forearm, FDS tendons are present 
as four bundles that split into two segments enclosing each FDP tendon cluster. 
Inside the wrist, each FDS tendons along with FDP travels through the carpal 
tunnel and reach the prospective FDS muscles that extends distally towards its 




                         
Figure 1.11: An illustration of the major flexor and extensor tendons in the 
forearm. Green represents ScxGFP expressing tendon cells of flexor digitorum 
profundus tendon (FDP); pink is tendon cells of flexor digitorium sublimis tendon (FDS); 
lumbrical muscles are shown in red; ligaments are shown in blue; ECRB, extensor 
carpi radialis brevis; EPL, extensor pollicis longus; EDC, extensor digitorum communis; 
EDM, extensor digiti minimi  
 
In addition, the flexing of MCP joints are then achieved by interosseous and 
lumbrical muscles. Interosseous muscles arise from their metacarpal bone and 
present on both sides of the bone. On the other hand, lumbrical muscles reside 
within the palm and originate from FDP tendon, which is in contrast to the most 
muscles that originate from skeletal elements. Lumbricals pass through dorsally 
and laterally around each digit (Figure 1.11). The movement of thumb and little 
digit are due to the superficial thenar and hypothenar muscles. The thenar 
muscles are located at the base of thumb and produce a bulge. While, 
hypothenar muscles are muscular protrusions on the medial side of the palm, at 
the base of little finger. Lastly, transverse carpal ligament, a fibrous band acts 




Furthermore, a prominent extensor tendon, the extensor digitorum communis 
(EDC) is position on the dorsal side of the forearm and is the key tendon on the 
backside of the palm. As individual bands, each EDC tendon subunits fans out 
from the digits and passes through the compartment formed by the extensor 
retinaculum and radius, after which they reach the origins at the lateral 
epicondyle of the humerus. Additionally, extensor digiti minimi after crossing 
over the wrist splits into two separate tendons called digiti quarti and digiti 
quinti. The extensor carpi ulnaris are located on the proximal side of the little 
finger near the meta-carpophalangeal joints and thereby helps in the extension 
of the little finger (Figure 1.11). 
 
While a thorough knowledge is available on the forelimb tendon development, 
however, little is known about the hindlimb and axial tendon development. For 
instance, only recently the precise development and assemblage of flexor 
digitorum brevis (FDB) muscle-tendon unit inside the foot was established 
(Huang et al., 2013). Their study showed that in the hindlimb, three muscles 
gives rise to the FDB tendons at the metatarsophalangeal joint that then covers 
the flexor digitorum longus (FDL) tendon and eventually intercalate into the 
interphalangeal joint of the toes. Thereby, authors concluded a serial homology 
between the structure and formation of the FDS tendon in the forelimb with that 
of FDB tendons in the hindlimb.  
 
Another prominent tendon in the foot is the Achilles tendon and is considered as 
the strongest and thickest tendon among all hindlimb tendon groups. The 
Achilles tendons has musculotendinous portion at the proximal side and insert 
into the bone on the distal end (Del Buono et al., 2013). However, the 
information available for the foot tendon development is still considered as 
generic and therefore, further research is required to dissect out the precise 
developmental pathways of hindlimb tendons.  
 
Evidence has shown that FDS and FDB tendons share similar anatomical 
features based upon their positions the limbs, the only difference pertain in 
tendon patterning events (Huang et al., 2013). FDS tendon extends from distal 
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to proximal axis in the forelimb, and then translocation occurs into the zeugopod 
where they finally reside. No further studies has been conducted to provide 
genetic model for FDB tendon formation and at this point, we still lack the 
knowledge of FDB tendon formation in Scx-/- mutant mice.  
 
1.6 Muscle connective tissue 
 
Vertebrate muscle fibers are surrounded by muscle connective tissue (MCT) 
that is made up of fibroblasts and produce ECM. The studies have shown a 
pivotal role of MCT to partake in the muscle patterning and regulate their 
growth, type specification and differentiation (Chevallier and Kieny, 1982; 
Chevallier et al., 1977; Hasson et al., 2010; Kardon et al., 2003; Mathew et al., 
2011; Stern et al., 2009; Swinehart et al., 2013; Wachtler et al., 1981). This is 
supported by the fact that muscle progenitors do not have a pre-determined fate 
as determined by quail-to-chick grafting where quail-derived muscle cells were 
able to develop in the chick limb-bud, suggesting that they receive 
environmental cues for muscle patterning which might implicate signals from the 
surrounding connective tissue (Chevallier et al., 1977). In this experimental 
strategy, the heterotopic transplantations in which the somite from chick wing 
level was replaced by quail neck level somite.  There was a deep penetration of 
of cells from the quail graft into the distal limb level of chick and the proper limb 
muscle fiber was formed. Interestingly, this is very different from Drosophila, 
where the information pertaining muscle cell fate is intrinsic (see Abmayr and 
Pavlath, 2012). 
 
Various molecular factors that are widely expressed by connective tissue have 
shown to regulate the events of muscle patterning. One such example is the 
protein Tcf4, from the TCF/LEF family (Kardon et al., 2003). Tcf4 is expressed 
in the lateral plate-derived limb mesoderm and tendons, and is a marker for 
muscle connective tissue important in generating a template for muscle 
49	  
	  
pattering (Kardon et al., 2003). Tcf4 acts downstream of the "canonical" β-
catenin-dependent Wnt signaling pathway, determined to up regulate the 
myogenic commitment markers Myf5 when Myf5 activation was observed in 
mice embryos overexpressing an activated form of β-catenin (Borello et al., 
2006; Daugherty and Gottardi, 2007; Kardon et al., 2003). Tcf4-/- mutants show 
reduced limb mobility and muscle mispatterning suggesting that Tcf4 
expression generates a template for forming limb muscles. Tcf4 expression is 
maintained in the tissues that eventually form the endomysium, perimysium and 
epimysium surrounding the muscle fibres. Tcf4 also regulates myofibre type 
maturation and switch from foetal to adult muscles as evidenced by Tcf4 
deletion or MCT ablation. This can be considered as first evidence of a cell 
autonomous and non-autonomous regulation of myosin heavy chain towards 
the end of neonatal stage and continue in the adults. BMP2 and BMP4 have 
been shown to repress Tcf4 expression showing that these three signalling 
molecules are important for the positioning of the premuscular masses. 
However, at some regions Scx that serve as a tendon marker (Schweitzer et al., 
2001) also accompanied Tcf4 expressions (Kardon et al., 2003). 
 
T box transcription factors Tbx4 and Tbx5 are expressed in the forelimb- and 
hindlimb-generating regions respectively at the time of limb bud formation (Ahn 
et al., 2002; Chapman et al., 1996; Rallis et al., 2003). They are expressed in 
the limb mesenchyme post limb bud formation until late development (Hasson 
et al., 2010; Rallis et al., 2003). As development progresses, Tbx5 expression 
becomes restricted to a subpopulation of MCT, some skeletal elements and 
tendons. Tbx4 and Tbx5 knockouts show limb muscle and tendon mis-
patterning, myogenic differentiation and fusion proceeds, but the muscles 
demonstrate abnormal size, shape, splitting and localization; in Tbx5-only 
deletions, there is disorganized MCT and limb tendon patterning, with abnormal 
Scx expression. The muscle mis-patterning is accompanied by the reduced 
expression of N-cadherin and β-catenin as shown in figure 1.12 (Brand-Saberi 







Figure 1.12: A schematic representation of regulation of MCT and muscle fibres 
by Tbx4/Tbx5. In the MCT (orange) of normal limbs, Tbx4/Tbx5 expression regulates 
the activity of N-cadherin and b-catenin in cell autonomous fashion as shown in G. In 
contrast, the deletion of Tbx4 or Tbx5 resulted in loss of N-cadherin and b-catenin due 
to which a mispatterning of the associated muscles and disruption of MCT occurred. 
(Adapted from Hasson et al., 2010)  
 
 
However, Tbx4 and Tbx5 do not act upon the Tcf4-dependent β-catenin-
mediated Wnt signalling as no changes in Tcf4 transcripts and protein were 
detected and β-catenin deletion results in a decrease in N-Cadherin expression 
in a Wnt-independent manner and implies that Tbx4 and Tbx5 function via a 
parallel Wnt-independent β-catenin pathway (Hasson et al., 2010).  
 
More recently, Hox11 expression was also found in the MCT of developing 
zeugopod of the forelimb (Swinehart et al., 2013). Despite the co-expression of 
Hox11 and Tcf4 in MCT, still Hox11 loss-of-function mutation resulted in normal 
Tcf4 expressions in the forelimb zeugopod. Interestingly, the regional loss of 
Hox11 gene from MCT led to disrupted muscle patterning that was restricted 
only to zeugopod segment. Hence, it emphasises the diversity found within the 
muscle connective tissue and further investigation will reveal the mechanisms 






1.7 Myogenesis in the mouse embryo 
 
Mice embryonic myogenesis occurs in two stages. In primary myogenesis, 
primary myofibres result from the fusion of embryonic myoblasts (see Biressi et 
al., 2007). Secondary myogenesis follows with the fusion of fetal myoblasts, 
which develop from related progenitors and differ in proliferation and fusion 
capabilities, to form secondary myofibres in close proximity to primary myofibres 
(Duxson et al., 1989; Hutcheson et al., 2009). Differential expression in 
myofibres of myosin heavy chain isoforms for fast- and slow-contracting muscle 
takes place during secondary myogenesis (see Abmayr and Pavlath, 2012). In 
later development, satellite cells take their place between the basal lamina and 
myofibre cell membrane (Lepper and Fan, 2010). 
 
Sine oculis-related homeobox factors Six1 and Six4 sit on the apex of the 
regulatory network driving myogenic differentiation, regulating early 
specification by targeting genes such as Pax3 and basic helix-loop-helix (bHLH) 
genes such as MyoD, MRF4 and myogenin (Grifone et al., 2005). Paired-
homeobox transcription factors Pax3 and Pax7 are influential for the 
undifferentiated state of precursor cells, Pax3 being expressed in long-range 
migrating cells essential for limb development (Tremblay et al., 1998). Key 
myogenic regulatory factors (MRFs) that mediate myogenesis via DNA binding 
are Myf5, MyoD, myogenin and MRF4 (see Massari and Murre, 2000). MyoD 
and Myf-5, commit myoblast traits into progenitor cells and have been observed 
to be individually redundant but cooperatively essential for myogenic 
determination (Braun et al., 1992). Myogenin and MRF4 are downstream MRFs 
that control terminal differentiation; myogenin is essential for the expression of 
myotube-specific genes such as myosin heavy-chain and MRF4 (Hasty et al., 
1993). 
  
Initiation of migration of precursors is fundamentally controlled by the c-Met 
receptor and its ligand hepatocyte growth factor/scatter factor (HGF/SF) (Brand-
Saberi et al., 1996). Finally, different signalling mechanisms such as Wnt 
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signalling and Notch signalling, accompanied by the molecular activities of 
factors such as Sonic hedgehog and bone morphogenic proteins, also play a 
part in the self-renewal or differentiation of progenitor cells involved in muscle 




Following successful invasion of migratory precursor cells into the limb bud 
dorsal and ventral premuscular masses are formed. These premuscular masses 
subdivide in a proximal to distal gradient and each muscle mass eventually 
splits to individual muscles. 
 
The premuscular masses consist of two layers. The superficial layer of 
proliferating muscle precursor cells express Pax3 and myf5 and the second 
deeper layer of differentiating myoblasts expressing MyoD and muscle proteins 
(Patel, Christ & Stockdale 2002). Quail premuscular masses grafted into chick 
limb buds show chick muscle patterning and because quail and chick patterning 
is different this suggests that muscle patterning is specified by somatopleural 
mesoderm of the limb bud and is not prespecified in the migratory cells from the 
dermomyotome (Grim, Wachtler 1991). FGFs, IGF-1, BMPs and follistatin have 
shown increased muscle size brought on by increased rate of proliferation 
suggesting their role in inducing proliferation. For example, using mouse model, 
the hypertrophy of muscle mass was observed when IGF-1 was overexpressed 
using a muscle-specific promoter (Musaro et al., 2001). Moreover, when 
injections of FGF2 were introduced into the anterior tibial muscles, it resulted in 
the increase in muscle weight (Iwata et al., 2006). Notch and SF/HGF have 
been implicated in the inhibition of muscle differentiation. Noggin, an antagonist 
of BMP signalling, reduces muscle mass (Amthor et al. 2002, Barton-Davis et 
al. 1998, Hannon et al. 1996). The MRF genes, MyoD, Myf5, Myogenin and 
MRF4 are essential for the determination and differentiation of the myoblasts 
because they encode bHLH transcription factors. Evidence includes 
overexpression of MyoD and Myf5 converting different cell types to the 
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myogenic fate. Previously, it was shown that the complete loss of function of 
MyoD and Myf5 resulted in the lack of skeletal muscle cells (Rudnicki 1993). 
However, using a range of Myf5 mutant alleles, Kassar-Duchossoy and 
colleagues (Kassar-Duchossoy et al. 2004) showed that the skeletal muscle 
cells were only affected in the absence of MyoD and Myf5 when the expression 
of Mrf4 gene was compromised. They generated a series of three allelic Myf5 
knockout mice i.e. Myf5nLacZ, Myf5GF-P and Myf5loxp. The Myf5nLacZ  allele has an 
insertion of lacZ into the exon 1 that disrupts Mrf4 expression. The Myf5GFP-P 
contain targeted insertion of GFP into exon 1 which resulted in the deletion of 
bHLH domain of Myf5. The Myf5loxp mutant had a loxP site inserted into exon 1 
that deleted bHLH domain and lacked amino-terminal domain required for 
transactivation. Both Myf5GFP-P and Myf5loxp mutants showed normal Mrf4 
expression. Myf5nLacZ; MyoD double mutants showed the same phenotype as 
those described by Rudnicki et al.(1993) , namely a lack of skeletal muscle 
development. When the Myf5GFP-P and Myf5loxp alleles were crossed with MyoD 
mutants, Mrf4 expression was undisturbed and embryonic myogenesis occurred 
normally; however, these muscles are degenerated during the foetal stage of 
development and the mutant mice born without the skeletal muscles. Therefore, 
the phenotype of the original Myf5;MyoD (Rudnicki 1993) and the Myf5nLacZ; 
MyoD double mutants (Kassar-Duchossoy et al., 2004)-  was effectively a triple 
null of Myf5:Mrf4:MyoD where mutation of Myf5 affected the expression of the 
neighbouring Mrf4 gene in cis. Hence, it was concluded that Myf5 and Mrf4 both 
function upstream of MyoD to drive the embryonic multipotent cells into 
myogenic lineages (Kassar-Duchossoy et al., 2004).  
 
Primary muscle fibres are formed by the fusion of myoblasts expressing MyoD. 
These fibres traversing the muscle anlage from tendon to tendon allow 
secondary fibre insertion near sites of innervation. The secondary fibres 
increase rapidly in number and nucleation and eventually separate from the 
primary fibres (Duxson, Sheard 1995). Fusion of the myoblasts requires N-
CAM, N-cadherin and M-cadherin molecules (Arnold, Braun 1999).  
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1.8 Meox2 transcription factor  
 
1.8.1 Meox2 in limb myogenesis  
 
The Meox genes, Meox1 and Meox2 (also known as Mox1 and Mox2), are 
members of a homeobox gene subfamily first characterised in the early mouse 
embryo during somitogenesis. They play distinctive role in somite 
regionalisation, patterning, and differentiation due to the differential localisation 
and characteristic expression in the somites and paraxial mesoderm during 
vertebrate development (Mankoo et al., 1999). The chromosomal localisation 
revealed that Meox2 is not linked to any of the Hox clusters. The expression of 
Meox2 was first detected around 8th day after gestation and after half a day it is 
known to express throughout the entire epithelium of the somite. Meox1 and 
Meox2 showed highly overlapping patterns of transcript expression in the early 
epithelial somite, and Meox1 was also expressed in the pre-somitic mesoderm 
posterior to the earliest somite. Following differentiation of the somites, Meox2 
expression appeared to be localised in the sclerotome labelling sclerotome 
derived cells, e.g. vertebral precursors from E10.5 onwards and Meox1 in both 
the sclerotome and dermomyotome (Candia et al., 1992). However, Meox2 
protein levels detectable by immunostaining are only found in differentiated 
somites up to E11.5 and in the limb bud thereafter (but not Meox1) (Candia and 
Wright, 1996). These studies provided initial clues into their respective roles 
during skeletomuscular development. Conversely, during limb bud 
development, Meox2 is expressed in the cells residing in the limb mesoderm 
(Figure. 1.12) along with the migrating myoblast that arrive into limb territory 
from lateral edge of the dermomyotome (Mankoo et al., 1999).  This was further 
established by the expression of Meox2 in limb mesoderm at E10.5 in Splotch 
embryos that lacks muscle cells in the limb due to point mutation in Pax3 gene.   
 
Previous work described that Meox2 transcription factor is essential for the 
regulation of myogenic commitment and differentiation (Mankoo et al., 1999). 
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Indeed, mice homozygous for a null mutation of Meox2 exhibit obvious defects 
in limb musculature, characterised by overall decrease of muscle mass and 
absence of specific muscles but have normal skeletal morphologies, 
highlighting the role of Meox2 in controlling limb muscle development (Mankoo 
et al., 1999). Moreover, Meox2-/- mutant embryos at E10.5 show down 
regulation of genes Pax3 and Myf5, although MyoD expression was normal and 
collectively expressed by migrating muscle precursors from somites into the 
limb mesoderm. This finding places Meox2 upstream of Pax3 and Myf5 in the 
genetic hierarchy regulating limb muscle development. Recently, it was shown 
that Meox2 directly binds to 145-bp core element in the Myf5 limb enhancer and 
thereby modulate the expression of Myf5 during myogenesis (Daubas et al., 
2015) 
On the other hand, mice homozygous for a null mutation of Meox1 show 
abnormality in the axial skeleton, especially at the cranio-cervical joints, but 
have normal muscle development (Skuntz et al., 2009). Meox1 mutants also 
show altered expression of Bapx1, Uncx and Tbx18, genes important for 
maintenance of somite polarity (Skuntz et al., 2009), supporting a previous in 
vitro finding that Meox1 directly activates Bapx1 expression in the sclerotome 
by binding to a homeobox-binding domain in Bapx1's promoter (Rodrigo et al., 
2004). 
 
While studies involving Meox1 or Meox2 homozygote mutants alone highlight 
their non-redundant roles in skeletal and muscular development, respectively, 
Meox1;Meox2 double homozygous mutants display phenotypes characteristic 
of defective somitogenesis and patterning, lacking both normal axial skeleton 
and skeletal muscles(Mankoo et al., 2003). These double mutants exhibit loss 
of Pax1 and Twist expression in the paraxial mesoderm as well as severe 
downregulation of Pax9 expression. Pax1 and Pax9 are important for axial 
skeleton development while Twist is known to be involved in myogenic and 
chondrogenic differentiation (Mankoo et al., 2003). Putting it all together, these 
findings show that while Meox1 can compensate for loss of Meox2 in the 
sclerotome (but not in the myotome) and vice versa in differentiated somites, 
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both Meox genes are crucial upstream players in the genetic regulatory network 




Figure 1.12: Whole mount Meox2 in situ hybridisation on E10.5 mouse forelimb 
bud  
Image showing Meox2 mRNA expression in E10.5 mouse control (k) and Splotch homozygous 
(l) embryos. Arrows show Meox2 expression in the distal domain of control and mutant embryos 
i.e. in limb mesoderm. Arrowhead shows Meox2 mRNA expression in proximal domain i.e. in 
migrated myogenic cells (Adapted from Mankoo et al., 1999).  
 
Further analysis of Meox2 expression analysis in the Splotch embryos that have 
Pax3 mutation, which resulted in the absence of muscle revealed that Meox2 
expression from the proximal limb is lost, but the distal domain from the limb 
mesoderm remained unaffected (Mankoo et al., 1999). The aforementioned 
Meox2 is a potential candidate for MCT regulation of limb formation. While its 
mechanism, which was determined to be essential for limb muscle 
development, may be restricted within myoblasts and mediated via Pax3 and 
Myf5, it could also have a role in the MCT where its expression may affect 
connective tissue development and can be speculated to have a downstream 
effect on the surrounding muscle (Mankoo et al., 1999). 
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1.8.2 Meox2 transcription factor and TGFβ signalling  
 
The Meox2 transcription factor is a direct target of transforming growth factor β1 
(TGFβ1) in epithelial cell growth (Valcourt et al., 2007). Interestingly, regulation 
by TGFβ1 is in biphasic manner where initial weak repression is then followed 
by strong robust induction of Meox2 mRNA expression in normal mammary 
epithelial NMuMG cells and in normal immortalized HaCaT keratinocytes. 
Moreover, the regulation of Meox2 expression by TGFβ is via Smad proteins. In 
HaCaT cells, when dominant negative mutants of Smad3 and Smad4 were 
used to block endogenous Smad signalling, the expression of Meox2 was 
completely abrogated even after stimulation with TGF- β1. Collectively, Meox2 
is involved in epithelial cell biology under the control of the morphogenetic 
cytokine TGF-β and Meox2 play critical role along with Smad proteins to 
execute TGFβ’s role in inhibition of epithelial cell growth.  
Interestingly, Meox2 has been shown to counteract the effects of TGFβ1 in 
adventitial fibroblasts by up regulating p15, p16 and p21 (Zhang et al., 2008). 
These results suggest Meox2 may act as a direct target to provide negative 





Ablation of Meox2 by targeted gene disruption in mice gives rise to a 
hypotrophic phenotype in the musculature of the limbs of neonates; the 
morphogenesis of these mutant limbs is further complicated by abnormal 
patterning of specific muscles, revealed by aberrant and failure of cleavage and 
invasion of tendon space by ectopic muscle. These muscle defects are 
embryonic in origin and in the absence of Meox, the earliest stages of myogenic 
differentiation are affected in the limb. Meox2 is expressed both in migratory 
muscle precursors delaminating into the limb bud, and more distally in the 
somatopleural limb mesoderm in the first stage of the forelimb bud development 
at E10.5.  
 
As described in the previous sections, growing evidence shown the influence of 
tendons and muscle connective tissue on the series of the events involved in 
muscle patterning of the limb during development. Indeed the expression of 
Meox2 in limb mesoderm that hosts the progenitors for tendons and MCT 
indicate that Meox2 plays a role in differentiation of these tissues and thereby 
influence the various aspects of myogenic differentiation. Little is known about 
the implication of Meox2 mutation on limb mesenchyme derivatives. Preliminary 
observations showed thinner and extremely fragile limb and tail tendons in the 
Meox2-/- mutant animals and hence it opened up doorways to investigate 
Meox2 functions during tendon morphogenesis.  
 
1.10 Thesis hypothesis  
 
We hypothesized that Meox2 is necessary for normal axial and appendicular 
tendon development. Furthermore, we postulated that the role of Meox2 could 
be intrinsic or extrinsic to regulate tendon progenitors. Finally, as TGFβ2 signals 
are important for tendon progenitor cells, we proposed an interaction between 
Meox2 and TGFb2 during tendon development.  
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1.11 Project objectives  
 
Therefore, this thesis has three research objectives: 
 
1. To characterise the phenotype in Meox2 mutant neonates in axial and 
appendicular tendons, using haematoxylin and eosin staining and ScxGFP 
expression analysis.  
 
2. To identify whether the tendon defects are foetal or embryonic, and 
determine when the tendon phenotype first manifests,  by Scx whole mount in 
situ hybridisation at E11.5-13.5 and ScxGFP expression analysis at E14.5 
 
3. To determine whether Meox2 has an intrinsic or extrinsic role in tendon 
progenitors, and to elucidate the molecular mechanisms by which Meox2 fulfils 
this role. For this, Meox2 expression was compared to Scx expression in limb 
and axial tendons. Additionally, Meox2 derived cells were traced using Meox2-


























All animal work in the thesis was carried out in accordance with the Animals 
(Scientific Procedures) Act 1986; project license PPL70/7341.  
2.1 TRANSGENIC MICE, MATINGS AND HARVESTING 
EMBRYOS 
 
2.1.1 MEOX2KO (-/-) MICE 
 
The knockout for the Meox2 locus was described by Mankoo et al., (1999). The 
same transgenic line was maintained on a mixed129/SV and C57/BL6 
background and was used in this study. The generation of mutant mice was by 
targeted disruption of the Meox2 transcription and translation initiation sites, the 
first exon and part of the first intron, with PGK-neo-polyA cassette (fig 2.1). The 
Meox2 heterozygous animals i.e. Meox2+/- were used as controls.  
2.1.2 MEOX2nLacZ  MICE 
 
Generation of the Meox2nLacZ allele was achieved by knockin of nLacZ into the 
exon1 whereas most of the 3’ end of exon1 remained intact in nLacZ locus. The 
Meox2nLacZ mice were generated by removing the loxP flanked PGK-neo 
cassette from the original Meox2nLacZ-neo line generated on a 129/SV and 
C57/BL6 background and was produced by Dr. Mankoo. This was achieved by 
crossing the original Meox2nLacZ-neo females with Protamine-Cre males. The 
latter mice express this recombinase transgene in the male germline, and 
homologous recombination to excise the PGK-neo cassette occurs upon 
fertilization (O’Gorman et al., 1997). The resulting recombinant mice have the 
nLacZ insert followed by an adjacent loxP site, disrupting exon 1 and resulting 
in the same null phenotype as the original Meox2-/- mice (fig 2.1). Therefore, the 
Meox2nLacZ allele employed throughout this thesis corresponds to the 





2.1.3 SCLERAXIS-GFP MICE 
 
Scx is a unique marker expressed by tendon cells throughout tendon 
development (Brent et al., 2003; Schweitzer et al., 2001). The ScleraxisGFP 
(ScxGFP) transgenic mice were provided by Dr. Ronen Schweitzer (Oregon 
Health and Science University). The ScxGFP mice have GFP expression under 
the control of regulatory elements of Scx gene. After initiation sequence ATG for 
Scx gene, the open reading frame of GFP was cloned into the first exon of Scx 
gene and thereby removing most but not all of the first exon (Pryce et al., 2007). 
The retention of exon 2 in Scx gene locus along with first exon of splice donor 
sequence led to replicate an endogenous expression of Scx transcript. Because 
this transgene recapitulates endogenous Scx expression, all tendons appear 
green under fluorescence microscope. They were maintained by crossing with 
Meox2KO and Meox2nLacZ lines. 
 
2.1.3 SPLOTCH2H MICE 
 
The splotch-delayed mice (Splotch2H) mice were a gift from Prof.Andy Copp 
(Institute of Child Health), and this had been previously described in the 
literature (Franz et al., 1993). The genetic background of this line was unknown, 
and they were maintained by crossing with Meox2KO line. The Splotch2H mice 
have mutations in the Pax3 gene and interfere with the limb muscle 
development. The homozygous splotch-delayed mice have spina bifida and are 
thus phenotypically distinguishable from heterozygous controls at embryonic 
stages.   
 
2.1.5 TIMED MATINGS AND STAGING EMBRYOS 
 
Mice were mated and vaginal plugs were monitored for five days. Noon on the 
day of vaginal plug observation was taken as 0.5 embryonic day of 
development. A neck dislocation method and carbon dioxide inhalation was 
used as per Home Office guidelines to cull pregnant females. All embryos were 
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staged according to The Atlas of Mouse Development (Kaufman, London 
1992).For all experiments, at least three sets of embryos were used to produce 
the final results. Counting of the somites from the tail to the hindlimb and by 
comparing limb and head shape and size. 
 
2.2 GENOTYPING OF TRANSGENIC MICE 
 
2.2.1 GENOMIC DNA PURIFICATION 
Tail clips of 0.2-0.4 cm were obtained from mice between 2 and 4 weeks of age 
and portions of yolk sac of embryos for genotyping. The amount of Tail Buffer 
added was 250 µl for tail and 500 µl for yolk sac. 5 µl proteinase K (20 mg/ml) 
was used for tails and yolk sac. Samples were then incubated at 50oC 
overnight. Pellets of undigested hair from tails were obtained by centrifuging at 
13000 rpm for 10 minutes. The supernatant was transferred into the fresh 
microfuge tubes and precipitated with an equal volume of isopropanol by mixing 
and then centrifuging for 10 minutes. The DNA pellet was washed with 200 µl 
70% ethanol and spun for 3 minutes. The DNA pellet was air dried for 30 
minutes and redissolved in 50 µl TE. DNA was then stored at -20 oC. 
 
2.2.2 PCR FOR GENOTYPING TAIL AND EMBRYO 
 
PCR reaction was done in a 30 µl sample volume consisting of 10X Hotstar 
buffer (Qiagen), 25 mM MgCl2, 10 mM dNTPs, 6 µl of Q buffer, 1 unit of Hotstar 
polymerase, 100 ng/µl forward and reverse primer and 1 µl of extracted 
genomic DNA. The programme for Techne genius thermal cycle used was 94oC 
5 minutes, 3 cycles of 94oC, 58oC 60 seconds and 72oC 60 seconds, followed 
by 35 cycles of 94oC 60 seconds, 51oC 60 seconds and 72oC 60 seconds and 
lastly, one cycle for 5 minutes at 72oC. The PCR products were analysed by 
1.3% agarose gel electrophoresis/TAE and the absence or presence of a 





MEOX2 ALLELES PCR PRIMERS (See figure 2.1 for relative locations of the 
primers). 
Table 2.1: Primer sequence used for genotyping 

































2.3 GENERATION OF TEMPLATE cDNA FOR RNA SYNTHESIS  
 
2.3.1 PREPARATION OF cDNA  
 
Meox2 full-length cDNA was generated by B. Mankoo. Scleraxis was a gift from 
R. Schweitzer; Sox9 was a gift from P. Koopman and Tgfβ2 was an IMAGE 
clone (ID 4009682) obtained from Invitrogen. 
2.3.2 BACTERIAL TRANSFORMATION OF PLASMID DNA 
 
In order to obtain large amounts of cDNA for the synthesis of RNA probes, 50 µl 
of chemically competent E.coli DH10B (Invitrogen) cells were transformed with 
10 ng plasmid DNA diluted in 20 µl of water. The cells were incubated on ice for 
10-30 minutes. A heat shock was applied by transferring the cells directly to a 
42°C heat block for 2 minutes. Cells were briefly incubated on ice and 
supplemented with 1 ml LB medium, without selection. The transformed cells 
were incubated at 37°C for 1 hour then plated onto LB-agar containing 100 
ng/µl ampicillin to isolate ampicillin resistant single transformed colonies after 
overnight culture at 37°C. 
2.3.3. PURIFICATION OF PLASMID DNA BY ZIPPY METHOD  
 
Single bacterial clones were picked from the plates and grown in 5 ml cultures 
of LB medium containing 100 ng/µl ampicillin overnight in a shaking incubator at 
370C. Next day, cultures were spun in a centrifuge for 10 minutes at 4000 rpm. 
The bacterial cell pellet was then resuspended in 0.7 ml of zippy buffer and 50 
µl of 10 mg/ml lysozyme and transferred to microcentrifuge tubes. The tubes 
were heated at 90-120 sec at 950C in preheated heating block and then 
centrifuged for 10 minutes at maximum speed. A wooden toothpick was used to 
remove the gelatinous precipitate and to the remaining supernatant, an equal 
volume of 0.7 ml isopropanol was added. After vigorous shaking, DNA in pellet 
was obtained after centrifugation for 10 minutes. A DNA pellet was washed with 
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70% ethanol and centrifuged again for 3 minutes. Finally, DNA pellets were air-
dried for 20 min at room temperature and then resuspended in 50 µl of TE and 
3 µl of 100 ng/µl heat-treated RNase A. DNA was then stored at -20 oC. 
 
2.3.4 ANALYSIS OF PURIFIED PLASMID DNA.  
 
The production of correct DNA was verified by restriction digestions cleaving the 
individual insert from the vector, and analysed by 1.2% gel electrophoresis. The 
sizes of the fragments were determined using the λ DNA/BstEII fragments as a 
ladder (New England Biolabs). DNA concentration was estimated qualitatively 
by comparison with individual determined concentrations of ladder fragments 
and quantitatively by nanodrop spectrophotometer.   
 
2.3.5 RESTRICTION ENZYME DIGESTION OF PLASMID DNA  
All plasmid DNA were linearized to enable anti-sense RNA transcription from 
the promoter situated at the 3’ end of all cDNAs. 20 µg of template cDNA was 
digested in a total volume of 200 µl with appropriate restriction enzymes, as 
summarised in table 2.2 and verified by 1% gel electrophoresis.  
 
2.3.6. PURIFICATION OF LINEARISED cDNA  
 
200 µl of linearized plasmid was purified by phenol-chloroform extraction. 120 µl 
of phenol-chloroform was added, and the tube was then mixed and centrifuged 
at 13000 rpm for 3 minutes; the DNA in aqueous phase was transferred to a 
fresh centrifuge tube and 120 µl of chloroform was added. This was mixed and 
centrifuged for 5 minutes. To this supernatant, 10% volume of 3M sodium 
acetate and 100% ethanol (2.5x DNA volume) were added. The tube was 
incubated at -20oC for an hour and then centrifuged for 20 minutes to precipitate 
the DNA. The DNA pellet was washed with 70% ethanol, centrifuged for 3 
minutes. The pellet was air dried and re-suspended in 20 µl of RNase-free 
water. Final concentration and purity of linearized template cDNA was 




2.3.7 DIG LABELLED RNA PROBE SYNTHESIS  
Labelling reaction: RNA synthesis reaction of 20 µl final volume comprised of 
1µL of 1 µg/µl of linearized plasmid DNA in autoclaved ELGA water, 2 µl of 10X 
DIG-RNA labelling mix, 2 µl of RNA polymerase (Table 2.2) and 0.5 µl of RNase 
inhibitor (RNasin Roche).. The reaction was incubated at 37oC for 2 hours and 
RNA synthesis was confirmed by analysis of 1 µl of reaction on 1% TAE 
agarose gel. Plasmid DNA was digested by adding 1 µl DNase1 (RNase free, 
Roche) was added and incubated for 1 hour at 37oC. The activity of DNase1 
was stopped by adding 1 µl of 0.5M EDTA.  
Purification of RNA: To the above labelling reaction 2.5 µl 4M LiCl and 75 µl 
prechilled 100% ethanol were added and mixed. The samples were incubated 
at -80oC for 30 min and centrifuged 13000 rpm for 20 minutes at 4oC. RNA 
pellets were washed with using 50 µl chilled 70% ethanol. After air-drying for 20 
min, riboprobes were dissolved in 50 µl sterile RNAse-free water and stored at -
800C. Riboprobes were analysed using 1 µl on agarose-gel and concentration 
was determined using nanodrop spectrophotometer.  
 







MEOX2 XbaI T3 1400 nt 
SCLERAXIS SalI T3 900 nt 
TGF-β2 EcoRI T7 1200 nt 






2.4 WHOLE MOUNT IN SITU HYBRIDIZATION  
 
2.4.1 EMBRYO COLLECTION  
 
Embryos of the required stage were collected as described in section 2.1.5 and 
fixed overnight in 4% paraformaldehyde at 40C. Washing with ice cold PBST for 
5 minutes was carried out. Fixed embryos were then de-hydrated with gentle 
rocking in ascending concentration of methanol/PBST (25%, 50%, 75% and 
100%) at room temperature until embryos sink at the bottom and finally stored 
in 100% methanol at -200C. 
 
 
2.4.2 PRE-TREATMENTS AND HYBRIDISATION  
 
Rehydration of embryo was performed on a rocker in 75%, 50% and 25% 
methanol/PBST mixture at room temperature and they were bleached with 6% 
H2O2 in PBT for 60 minutes. Proteinase K (10 µg/ml) made up in PBST was 
added for 50 minutes. The proteinase K activity was then stopped by adding 2 
mg/ml glycine in PBST for 10 minutes. The bleached and porous embryos were 
washed twice in PBST for 5 minutes and post fixed for 20 minutes in 4% 
paraformaldehyde and 0.1% glutaraldehyde. Embryos were then rinsed with 1:1 
PBST/hybridisation mixture and then with 1ml pre-warmed hybridisation mix. 
The tubes were then incubated horizontally in 1ml pre-warmed hybridisation mix 
for 1 hour at 700C. 0.2 µg/ml of DIG-labelled RNA probe in pre-warmed 
hybridisation mix was added to the tubes and incubated horizontally overnight 
on a rocker at 70oC. 
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2.4.3 POST-HYBRIDISATION WASHES  
 
After 15 hours of incubation, embryos were washed twice with pre-warmed 
hybridisation mix for 30 min each at 70oC followed by 1:1 hybridisation 
mix/TBST for 20 minutes. Embryos were then rinsed and washed twice with 
TBST at room temperature. The tubes were then rinsed twice with MABT. 
Afterwards, embryos were pre-incubated with MABT plus 10% filtered heat-
treated sheep serum for an hour. Subsequently, a 1/2000 dilution of anti-DIG 
antibody (Roche) in MABT plus 10% filtered heat-treated sheep serum was 
added and tubes were incubated at 4oC overnight on a rocker.  
 
2.4.4 POST-ANTIBODY WASHING  
 
Next day, embryos were washed three times with MABT and then six times for 
1 hour each with 2 ml MABT on a rocker. Tubes were incubated at room 
temperature overnight in MABT on a rocker. 
 
2.4.5 COLOUR DEVELOPMENT  
 
On Day 4, embryos were washed twice for 10 min with NTMT, and then 
incubated with 1.5 ml NTMT and 200µl NBT/BCIP mix (Roche) until colour 
developed to the desired extent. The colour reaction was then stopped by 
washing three times with PBT.  
 
2.4.6 IMAGING  
 
Images were taken with the digital camera (Leica) on the Leica MZ125 








2.5 IN SITU HYBRIDIZATION ON CRYOSECTIONS  
 
All the reagents used in this method were pre-treated with 0.1% 
diethylpyrocarbonate (DEPC) overnight at room temperature followed by 
autoclaving. 
 
2.5.1 EMBRYO COLLECTION AND CRYOSECTIONING  
Fresh collected embryos were fixed in 4% paraformaldehyde at 40C for 2 hour. 
Embryos were then washed in ice-cold PBS and incubated overnight in 5% 
sucrose/PBS at 40C with gentle rocking. Next day, 15% sucrose/PBS was 
added for 2 hours at 40C and then embryos were transferred to 30% 
sucrose/PBS for 2 hours at at 40C. The embedding of embryos was done in 
OCT (Sakura) on dry ice at the appropriate orientation and they were stored at -
800C. Transverse sections of 20 µm were obtained using the Leica CM1950 
cryostat on the day of hybridization. The sections were collected on poly-lysine 
coated slides and air-dried for 3 hours at room temperature. GFP positive tissue 
sections were dried in the dark.  
 
2.5.2 TISSUE PREHYBRIDIZATION AND HYBRIDIZATION  
 
Slides were rinsed twice with PBST for 15 minutes. Also it was important to 
keep tissues wet all the time and therefore not allowed to dry out. Tissue 
sections were then washed with DEPC-treated 1:1 PBT/Hybridization mix (used 
in the section 2.4.2). The slides were then prehybridized in the hybridization mix 
for 1 hour at 650C in a moist atmosphere using 65oC Wash Buffer to maintain 
humidity. Then, DIG-labelled RNA probe (0.1 µg/ml; 500 µl per slide) was 
added onto sections and slides were covered with RNase-free coverslip 
(Invitrogen, Catalog no. 10625983). Sections were left overnight at 65oC in a 






2.5.3 POST-HYBRIDIZATION WASHES  
 
The following day the slides were dipped into 65oC Wash Buffer for the removal 
of the cover slips. Sections were then rinsed once and washed twice for 30 
minutes at 65oC with Wash Buffer. The slides were rinsed twice with MABT for 
5 minutes followed by incubation of the slides in MABT and 10% filtered heat-
treated sheep serum for 1 hour at room temperature. Subsequently, 200 µl of 
1/2000 dilution of anti-DIG antibody (Roche) in MABT plus 10% filtered heat-
treated sheep serum was added and slides were kept at 4oC overnight in a 
humidified chamber using MABT.  
 
2.5.4 POST-ANTIBODY WASHING AND COLOUR DEVELOPMENT  
 
Slides were briefly rinsed three times and then washed six times for 5 minutes 
each with 2 ml MABT at room temprature. Sections were then washed twice for 
10 minutes each with NTMT. The colour development on the sections was 
obtained by incubating with 1.5 ml NTMT and 200 µl NBT/BCIP mix (Roche) 
until the desired extent. The colour reaction was then stopped by washing three 
times with PBT. The slides were finally mounted with propyl gallate mounting 
medium containing DAPI (10 mg/ml). 
 
2.5.6 IMAGING  
 
Images were taken using the digital camera (Leica) on a Zeiss Axiovert 200M 
fluorescence microscope and processed by Adobe Photoshop CS5.1. 
 
2.6 β-GALACTOSIDASE ANALYSIS  
2.6.1 EMBRYO PROCESSING  
 
The collection of appropriate staged embryos was done in ice-cold PBS 
followed by fixation in 4% paraformaldehyde at 40C for 2 hours. Embryos were 
then washed in ice-cold PBS and incubated overnight in ice-cold 5% 
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sucrose/PBS. Next day, 15% sucrose/PBS was added for 2 hours at 40C and 
then embryos were transferred to 30% sucrose/PBS for 2 hours at 40C. The 
embedding of embryos was done in OCT on dry ice at the required orientation 
and they were stored at -800C.  
 
2.6.2 CRYOSECTIONING  
 
Transverse sections of 20 µm were obtained using the Leica cryostat on the day 
of staining. The sections were collected on poly-lysine coated slides and were 
air-dried for 3 hours at room temperature. GFP positive tissue sections were 
dried in the dark.  
 
2.6.3 X-GAL and S-GAL STAINING 
 
Air dried slides of cryosections were washed thrice with LacZ wash buffer 
without X-gal or S-gal for 15 minutes at room temperature. LacZ staining 
solution was added for 20 minutes. Slides were then washed in PBS for 5 
minutes and then submerged in LacZ staining solution containing 0.5ml of 
40mg/ml X-gal (dissolved in dimethyl formamide) (Thermofischer) or 0.1mg/ml 
S-gal (6-chloro-3-indolyl- β-D-galactopyranoside, Apollo Labs) overnight at 
370C. Subsequently, sections were washed in PBS and rinsed in water for 5 
minutes. S-gal, a β-gal substrate produces pink-colour precipitate when 
hydrolysed by β-galactosidase and was preferred, as S-gal precipitates do not 
quench DAPI unlike X-gal that gives blue colour precipitate and therefore 
interferes with the DAPI signal.  
 
2.7 HAEMATOXYLIN AND EOSIN STAINING  
Tissue histology at post-natal stages was studied using haematoxylin and eosin 
staining. Air-dried cryosections (section 2.6.2) were stained for 3 minutes with 
haematoxylin stain and then rinsed with distilled water. In order to lessen the 
background colour, slides were washed in tap water for 5 minutes. Destaining 
was then performed using an acid rinse (2% glacial acetic acid in distilled water) 
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by fast dipping for 8-12 times. The slides were rinsed with tap water and then 
with distilled water for 2 minutes. After that, eosin staining was performed on the 
same slides. Eosin stain (0.1% eosin in 95% ethanol) was added for 30 
seconds. The slides were then dehydrated in 95% ethanol and 100% ethanol 
for 3 minutes each. Subsequently, slides were air dried for 30 minutes. Finally, 
the slides were mounted with propyl gallate mounting medium containing DAPI 
(10 mg/ml). 
 
2.8 GENERAL IMMUNOFLUROSCENCE  
20 µm cryosections were processed as mentioned in 2.6.2. The cryosections 
were rinsed thrice in PBS at room temperature followed by blocking with PBST 
and 10% goat serum for 2 hours. The primary antibody diluted in 5% goat 
serum/PBST was then applied on sections and incubated overnight at 4oC in an 
atmosphere humidified with PBS. Next day, the sections were washed thrice for 
5 minutes in PBST. Secondary antibody diluted in 5% goat serum/PBST was 
then added onto the sections for 2 hours at room temperature. The slides were 
then rinsed thrice for 5 min in PBST. The slides were finally mounted with propyl 
gallate mounting medium containing DAPI and examined with a Zeiss Axiovert 
200M fluorescence microscope. Adobe Photoshop CS5.1 was used for image 
processing. The above described immunofluorescence method was used for all 
antibodies except the listed Meox2 antibodies (discussed in next section). 
Primary and secondary antibody details are tabulated in Table 2.3 and Table 
2.4.  
2.9 MEOX2 IMMUNOFLUORESCENCE   
The optimisation of Meox2 antibody protocol was required for this project, as 
the general immunofluorescence method described did not produced any signal 
for this antibody.   
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2.9.1 EMBRYO PROCESSING  
 
Mouse embryos of E12.5-E14.5 were fixed in ice-cold solution 1 containing 
0.2% paraformaldehyde overnight at 4oC. On day 2, the embryos were washed 
twice in cold PBS then incubated in solution 1 without 0.2% paraformaldehyde 
overnight at 4oC. After 24 hours, the embryos were washed in cold PBS and 
incubated in solution 2 overnight at 4oC. Finally, on day 4, the embryos were 
rotated in solution 3 for 1 hour at 37oC, followed by embedding in OCT with 
appropriate orientation and stored at -800C  
 
2.9.2 CRYOSECTIONING  
 
As described in section 2.6.2.  
 
2.9.3 Meox2 ANTIBODY STAINING  
 
The sections were fixed in pre-cooled 100% methanol at -200C for 5 minutes. 
The slides were then rinsed twice with PBSX for 5 minutes. The 
permeabilization was then performed using PBSX for 20 minutes. The sections 
were then blocked in PBSX plus 10% sheep serum for 1 hour. Meox2 antibody 
(table 2.3) diluted in PBSX and 10% sheep serum was added onto the sections 
for overnight incubation at 40C in moist atmosphere using PBS. Next day, the 
sections were washed at least 5 times for 5 minutes with PBSX at room 
temperature. Secondary antibody diluted in PBSX plus 10% sheep serum was 
added for 2 hours at room temperature. After washing with PBSX for 5 minutes, 
slides were air-dried and were finally mounted with propyl gallate mounting 
medium containing DAPI. 
 
2.9.4 IMMUNODETECTION  
 
The stained sections were documented using a Zeiss Axiovert 200M 
fluorescence microscope and a Zeiss LSM Exciter confocal microscope. (S 
Hughes lab). Adobe Photoshop CS5.1 was used for image processing as 
shown in Fig 2.2.  
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Table 2.3: Primary antibodies 
Name  Supplier Catalogue no. Species Dilution 










559565 Rabbit 1:300 
Anti-GFP Abcam ab13970 Chicken 1:2000 
Anti-Ki67 Abcam ab15580 Rabbit 1:200 
Rabbit pre-
immune IgG 
GenWay Custom-made Rabbit 1:100 
 
Table 2.4: Secondary antibodies  





























2.10 IN VITRO ANALYSIS  
2.10.1 C3HT101/2 CULTURE 
 
A murine cell line considered to represent a mesenchymal progenitor state 
C3HT101/2 was used in this project (Pinney and Emerson, 1989). The stock was 
kindly provided by Hughes lab and was stored in liquid nitrogen. The cells were 
stored in liquid nitrogen and in freezing media containing 10% FCS, 1% PS, 
herewith, referred as growth medium (DMEM+FCS+PS) with 10% 
dimethylsulfoxide, DMSO. The cryovial containing the cells was thawed quickly 
and the cells transferred to 5 ml of growth medium in a 15 ml conical falcon 
tube. This was then centrifuged for 5 min at 1000 rpm. The supernatant was 
removed and the cell pellet was resuspended in 1 ml growth medium. The cells 
were then re-plated as indicated by the storage instructions. Routinely, 
C3HT101/2 cells were frozen in aliquots equivalent to 1/6th of a T75 flask and 
replated onto a T75 flask. 
 
2.10.2 CELL SPLITTING  
 
When necessary (>80% confluency for C3HT101/2  cells) the cells were split by 
first removing the medium and washing the cells twice with sterile PBS. The 
cells were detached from the bottom of the flask using 2 ml of 1x Trypsin-EDTA, 
incubated for 3-5 minutes. Cells were further dislodged by hitting hard on the 
sides of the flask and checked under a microscope for roundness. 2 ml of sterile 
PBS was added and used to detach the cells from plastic and dispersed into a 
single cell suspension. 8 ml DMEM+FCS+PS was added to quench the Trypsin-
EDTA and the cell suspension was transferred to a 15 ml sterile Falcon tube. 
Cells were pelleted by centrifuging for 5 minutes at 1000 rpm and the 
supernatant was discarded. The cell pellet was then resuspended in a fresh 




2.10.3 CELL PLATING FOR IN VITRO ANALYSIS 
 
C3H10T1/2 were seeded in a 24-well plate at a cell density of 1X105 cells/well in 
growth medium. After 24 hours, the medium was supplemented with a freshly 
thawed aliquot of 20 ng/ml TGFβ2 (Peprotech, Catalog no. 100-35B) or 25 
ng/ml FGF4 (Peprotech, Catalog no. 100-31) and 1 ng/µl BSA. The cells were 
incubated for 1 hour, 4 hours, 8 hours and 24 hours. Subsequently, cell lysates 
were collected after each time point and processed for RNA purifications. 
 
2.10.4 RNA PURIFICATION BY TRIZOL METHOD  
 
After the desired time point, cells were washed with PBS and 0.25 ml of Trizol 
reagent was added to obtain cell lysates. The adherent cells were collected by 
using a cell scraper (BD Falcon) and transferred into the sterile eppendorf 
tubes. 0.25 ml chloroform was added and 15 sec of vigorous shaking was 
performed. The tubes were then incubated at room temperature for 3 minutes 
and spun at 13000 rpm for 15 minutes at 4oC. RNA in supernatant was 
collected in an eppendorf tube and 0.125 ml isopropanol was added. The 
mixture was incubated for 10 minutes at room temperature. The tubes were 
spun at 13000 rpm for 15 minutes at 4oC. The RNA pellets were washed with 1 
ml of 70% ethanol and mixed properly. After centrifugation for 5 minutes at 40C, 
RNA pellets were collected and air dried for 15-20 minutes. Finally, RNA was 
dissolved in 50 µl of RNase-free water and the concentration was measured at 





2.10.5 PREPARATION OF cDNA  
Reverse transcription of purified RNA was performed as per the manufacturer’s 
standard protocol using the QuantiTect Reverse Transcription kit (Qiagen). 
Briefly, the template RNA and Quantiscript reverse transcriptase was thawed on 
ice. The gDNA wipeout buffer, Quantiscript reverse transcription buffer, reverse 
transcription primer-mix were thawed at room temperature. The genomic DNA 
elimination reaction was then prepared in an eppendorf using  2 µl gNDA wipe 
out buffer,  1 µg of template RNA and then the volume of the mixture was 
levelled for 14 µl using RNase free water. The tubes were incubated for 2 
minutes at 42oC and then placed on ice immediately. Following this, the reverse 
transcriptase master mix on ice was prepared. In a fresh eppendorf tube, 14 µl 
of genomic DNA elimination reaction was added along with 1 µl of Quantiscript 
reverse transcriptase, 4 µl of 5X Quantiscript reverse transcription buffer and 1 
µl reverse transcription primer-mix was added. The tubes were mixed properly 
and incubated at 42oC for 15 minutes. The tubes were then incubated at 95oC 
for 3 minutes to inactivate Quantiscript reverse transcriptase. Finally, 1 µl 
sample was added for semi-quantitative PCR reaction and rest of the sample 
was stored at -80 oC.  
 
2.10.6 SEMI-QUANTITATIVE PCR  
 
The PCR reaction was done in 30 µl sample volume consisting of 10XHotstar 
buffer (Qiagen), 25 mM MgCl2, 10 mM dNTPs, 6 µl of Q buffer, 1 unit of Hotstar 
polymerase, 5 µM forward and reverse primer and 1 µl of cDNA. The 
programme for thermal cycle used was 95oC for 5 minutes, 3 cycles of 94oC for 
50 seconds, 60.2 oC for 30 seconds and 72oC 40 seconds, followed by 35 
cycles of 94oC 50 seconds, 57oC 30 seconds and 72oC for 40 seconds and, 
lastly, one cycle for 5 minutes at 72oC. The PCR products were analysed on 






PCR primers were: 
a) Scleraxis forward  5’CTTCCACAGCGGTCGTGCGGC3’ 
b) Scleraxis reverse  5’AGCGTGCTCTTGGGGACCTGCGCT3’ 
c) Meox2 forward  5’GCGACAGCTCAGATTCCCAGG3’ 





Unless otherwise stated, all solutions were made with autoclaved MilliQ double 
distilled H20. 
CaCl2 1M 14.7 g CaCl2.2H2O in 100 ml of H2O. 
Deoxynucleotide triphosphates (dNTPs) 10mM 2.5 mM each of dDNTP, 
dCTP, 
dGTP, and dTTP (Omega). Stored at 20°C. 
DEPC-H2O MilliQ water treated overnight with 0.1% (v/v) diethyl dicarbonate 
(diethylpyrocarbonate) then autoclaved. 
EDTA stock 500mM EDTA, adjusted to pH 8.0 with NaOH. 
Freezing media DMEM (Dulbecco’s Modifies Eagle Medium) and glutamax 
(Invitrogen), Stored at 4°C. 
FGF4 recombinant protein (25 µg/ml) 5 µg dissolved in 200 µl 1 mg/ml BSA. 
20 µl Aliquots stored at -20°C. 
Growth medium DMEM+FCS+PS i.e. DMEM containing 10%FCS and 
1%PenStrep. Prepared under sterile hood. Stored at 4°C. 
Hybridization mixture 50% formamide, 1.3X SSC pH 5, 5mM EDTA, 50 µg/ml 
Yeast RNA, 0.2% Tween-20, 1% SDS, 100 µg/ml Heparin in water. Stored at -
20°C. 
LB 85mM NaCl, 0.5% (w/v) yeast extract, 1% (w/v) bacto-tryptone. Autoclaved 
and stored at 4°C. 
LB+AMP LB supplemented with 1x ampicillin. 
LB-agar LB supplemented with 1.5% (w/v) agar. Cast into 10 cm petriplates. 
Stored at 4°C. 




LacZ wash buffer PBS, 0.02% Nonidet P-40 
LacZ stain PBS, 0.02% Nonidet P-40, 2mM MgCl2, 0.01% 
Sodiumdeoxycholate, 40mg potassium-ferrocyanide, 30mg potassium-
ferricyanide. 
MABT 100mM Maleic acid, 150mM NaCl pH7.5, 1%Tween-20 
Na2HPO4 0.2M 28.4 g Na2HPO4 in 1000 ml of ddH2O. 
NaH2PO4 0.2M.H2O 27.6 g NaH2PO4.H2O in 1000 ml of ddH2O. 
NBT stock 50mg/ml NBT in 70% (v/v) DMF. Stored at -20°C. 
NTMT 100mM Tris-HCl pH9.0, 100mM NaCl, 50mM MgCl2, 0.1% (v/v) Tween-
20 in sterile water.  
Optimal Cutting Temperature (OCT) Sakura, Catalog no.4583. 
10x HotStar PCR Buffer Proprietary formula (Qiagen). 
PBS (5x) 137mM NaCl, 2.7mMKCl, 10mM Na2HPO4, 1.76mM KH2PO4, pH 
7.4. Prepared with 5 tablets (Oxoid) per 100ml MilliQ H20 and autoclaved. 
PBST 1xPBS with 0.1% (v/v) Tween-20. 
PBSX 1xPBS plus 0.1% (v/v) Triton X-100 
Phosphate buffer stock solution 0.24M, pH 7.2 6.4 gm NaH2PO4.H2O + 27 
gm Na2HPO4 in 1000ml ddH2O. Autoclaved.  
Propyl gallate mounting medium 2.5 g (Sigma P3130) dissolved in 35 ml 
glycerol overnight at room temperature on a roller and 1 µl of DAPI was added 
next day. Aliquotes stored at -20°C. 
Paraformaldehyde (4%PFA) 4 gm PFA powder (stored at 4°C) in 1x PBS. 
Poly-lysine coated slides (Thermo-scientific, Catalog no.J2800AMNZ) 
QuantiTect Reverse Transcription kit (Catalog no. 205310 Qiagen) 
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Sodium Saline Citrate (SSC, 20X) 3 M NaCl, 0.3 M Na citrate, pH 5. 
Autoclaved. 
Solution 1 (Meox2 antibody staining) 8 gm Sucrose, 0.12mM of 1M CaCl2, 
0.2M Na2HPO4, 0.2M NaH2PO4.H2O. Adjusted the pH 7.4 and aliquotes stored 
at -20°C. 
Solution 2 (Meox2 antibody staining) 0.12M phosphate buffer pH 7.2/15% 
sucrose. Aliquots stored at -20°C. 
Solution 3(Meox2 antibody staining) 0.12M phosphate buffer/15% 
sucrose/7.5% gelatin. Dissolved at 37ºC and aliquotes stored at -20°C.  
TAE 40mM Tris-HCl pH 8.0, 20mM acetic acid, 1mM EDTA. 
Tail Buffer 100mM Tris-HCl pH 8.0, 5mM EDTA, 200mM NaCl, 0.2%SDS. 
10x TBS 1.37M NaCl, 27mM KCl, 0.25M Tris-HCl pH 7.5. Autoclaved. 
TBST 1xTBS with 1% (v/v) Tween-20. Freshly made from 10x TBS on the day 
of requirement.  
Tris-EDTA buffer (TE) 10mM Tris-HCl, 1mM EDTA. Prepared at pH 7.5 and 
pH 8.0. 
Tris stock 1M Trizma-HCl at pHs of 6.5, 7.0, 7.5, 8.0, 8.5, 9.0, 9.5 in ddH2O . 
Autoclaved and stored at RT. 
Triton buffer 0.25% Triton 100, 10mM Tris pH 8.0, 10mM EDTA, 0.5mM 
EGTA. 
2.5% Trypsin-EDTA (10x) 146.55mM NaCl, 1.05mM Trypsin (Invitrogen). 
TGFβ2 recombinant protein (20 µg/ml) 1 µg dissolved in 50 µl 1 mg/ml BSA. 
Aliquots stored at -20°C. 
Wash buffer 50% formamide, 1X SSC pH 5 and 0.1% Tween 20 used at 65°C. 
Zippy buffer 8 % sucrose, 0.5% Triton X-100, 0.5 M EDTA, 1M Tris pH 8.0 in 
autoclaved distilled water. Autoclaved.  
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All restriction endonucleases were obtained from New England Biolabs. Majority 
of the  chemicals were obtained from Sigma-Aldrich unless otherwise stated. 
Integrated DNA Technologies synthesized all oligonucleotides. Solutions were 
stored at room temperature (RT) unless otherwise stated. Where applicable, 
reagents have been named in accordance with the naming conventions of the 
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Figure 2.2 Optimization of the Meox2 antibody staining: The transverse 
cryosection of the limb was immunostained with rabbit pre-immune IgG as a 
control (A and B) whereas Meox2 antibody was added to the equivalent limb 
section (C and D). The sections were observed under a Zeiss Axiovert 200M 












Phenotypic analysis of the 












3.1 Introduction  
 
The requirement of Meox2 during limb muscle patterning has been reported 
before. Muscle abnormalities included overall reduction in skeletal muscle mass 
of the limb and mutant animals displayed normal axial and appendicular 
skeleton (Mankoo et al., 1999). Meox2-/- embryos at E10.5 show down 
regulation of genes previously known to be expressed in myogenic precursors 
that eventually populate the limb mesenchyme Pax3 and Myf5, although MyoD 
expression was normal (Mankoo et al., 1999). This finding places Meox2 
upstream of Pax3 and Myf5 in the genetic hierarchy regulating limb muscle 
development. Interestingly, during the limb bud development, distal Meox2 
expression was found to be normal in Splotch2H embryos in which all limb 
muscles are lost due to a point mutation in the Pax3 gene resulting in the failure 
in migration of muscle progenitor cells into the limb buds. It was suggested that 
the Meox2 expressing cells from the limb mesenchyme might cause the muscle 
patterning defects in Meox2-/- animals.  
 
Several studies have shown that the interactions between muscle and tendon 
tissues are mandatory for their patterning and development (Chevallier et al., 
1977; Kardon, 1998). The initial stages of tendon and muscle progenitor cells 
induction are autonomous; however, the patterning, growth and maintenance of 
both tissues require the local extrinsic cues within the limb bud. For instance, in 
the chick, when the tendons were surgically altered in the limb, the migration of 
muscle cells were found normal and likewise, tendon precursors were 
originated in the muscle-less limbs (Kardon, 1998). However, in the absence of 
myotendinous interactions, muscles and tendon cells failed to develop and 
hence, degeneration of both tissue occurred. This observation found similar 
results with a classical quail-chick chimera study (Chevallier et al., 1977) that 





The interdependency of both tissues during embryogenesis led us to 
hypothesize that the muscle defects in Meox2-/- could be the result of loss of 
Meox2 expression in the limb tendons. The bone and cartilage were normal in 
these mutants suggesting normal cartilage development, however, tendons 
were thinner, fragile and hypoplastic. Thus, we characterised the tendon tissue 
defects in Meox2-/- neonates.  
 
 
3.2 Aims  
 
Our aim was to describe the tendon distribution along the proximal-distal axis of 
the forearm in the heterozygous animal and homozygous neonates and this 
analysis was carried out using ScxGFP transgene to identify tendon fibres. 
Tendon histology was performed on transverse sections of paraffin-embedded 
limbs that were obtained from a control and mutant new born animals and 
counterstained with Haematoxylin and eosin stain. Due to the complexity of the 
stylopod segment of the limb, the focus of this analysis has been restricted to 
the autopod and zeugopod. Tendon nomenclature is tabulated in Table 1 and 












3.3.1 REDUCED SCXGFP IN TENDON CELLS IN MEOX2 
NULL MUTANTS   
 
The ScxGFP transgenic reporter was shown to recapitulate the endogenous 
Scx expression domains in the tendon cells (Pryce et al., 2007). Thus, to 
visualize whole tendons, the ScxGFP transgene was used to compare tendons 
in controls and mutants. Mice heterozygous for the Meox2 mutation (Meox+/-) 
and crossed to the ScxGFP transgene displayed no tendon abnormalities (Fig. 
3.3.1A,C). When intercrossed, the homozygous mutant animals (Meox2-/-; 
ScxGFP) were born with the expected Mendelian transmission rate of these 
alleles. Newborn Meox2-/-; ScxGFP litters showed severe limb tendon defects 
and extremely thin tendon trajectories were evident. In forelimbs of the mutants, 
the GFP expression was dramatically reduced from the extensor digitorium 
communis (EDC) on the dorsal side but only partially reduced on the ventral 
side (T3, Fig. 3.3.1B,C). Interestingly, EDC tendon was completely missing at 
the wrist level on the ventral side that could probably explain the abnormal 
extension and abduction of the wrist and paw in the absence of Meox2. 
Additionally, other extensor tendons i.e. carpi radialis longus and carpi radialis 
brevis remained completely invisible (T7 and T8, Fig. 3.3.1B,C). Moreover, only 
the trails of the extensor digiti quarti/quinti tendons were present in the mutants 
(T9a and T9b, Fig. 3.3.1A,B,C,D). In addition, extensor pollicis (T5) and 
extensor carpi ulnaris tendon (T6) were detectable but thin and reduced in the 
size. In conclusion, the various levels of complexity in tendon defects could be 
responsible for the locked dorsal flexur in the forelimb. 
 
Together, the ScxGFP expression in Meox2 mutants demonstrated the major 
structural defects in the forelimb tendons whereby flexor tendons were more 
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affected than extensor tendons and hence the degree of severity in the tendon 
phenotype was concluded.  
 
3.3.2 REDUCED SCXGFP SIGNAL FROM THE HINDLIMB 
TENDONS 
 
The hindlimb tendons undergo similar tissue developmen and patterning 
compare to the forelimbs (Popesko et al., 2003). The serial homology between 
forelimb and hindlimb tendon tissue was recently uncovered and it was shown 
that the FDS tendon development in forelimb and the flexor digitorium brevis 
(FDB) tendons were developmentally delayed compared to the other tendon 
groups (Huang et al., 2013). Therefore, the absence of the FDS tendon from the 
forelimb in Meox2 mutants prompted us to investigate FDB tendons. For this, 
hindlimb tendons were once again visualised using the ScxGFP marker. As 
predicted in the mutants, the FDB tendon was completely disrupted on the 
dorsal side as observed by loss of ScxGFP (Fig. 3.3.2A,B). 
 
In control hindlimbs, the Achilles tendon, one of the major tendons of the 
hindlimb, exhibited bright ScxGFP fluorescence both dorsally and ventrally. 
However, the mutant mice exhibited greatly diminished GFP fluorescence from 
Achilles tendon and revealed that it was thinner (Fig. 3.3.2A,B,C and D). In fact, 
to acquire the images for comparing control and mutant tendons, we had to 
increase the exposure by four times for the mutant limbs. Additionally, the 
extensor digitorium longus (EDL) tendon was also completely missing (Fig. 
3.3.2A,B,C and D).  
 
Therefore, hindlimb tendons also showed reduced ScxGFP expression in the 







3.3.3 DISRUPTION OF AXIAL AND TAIL TENDONS  
 
Tendons progenitor cells of the epaxial and hypaxial muscles are derived from 
the syndetome that are found in between two adjacent somites. Therefore, 
ScxGFP fluorescence was used to visualize tendons of axial musculature in this 
study.   
 
The distinctive structure of epaxial tendon in a skinned Meox2 heterozygous 
animal showed normal ScxGFP expression and fine long fibres of tendons were 
evident. However, the mutant counterparts displayed severe disruption of GFP 
fluorescence from trunk tendon cells (Fig. 3.3.3A and B, white arrows). 
Moreover, the loss of ScxGFP expression indicated intercostal tendons were 
completely lost (Fig. 3.3.3A and B, red arrowheads). Despite sharing a common 
origin with tendons of axial musculature in syndetome, the dramatic loss of tail 
tendons was evident in the absence of Meox2 gene while the control littermates 
showed complete dorsal and ventral sides of long tail tendons (Fig. 3.3.6C and 
D). In contrast, annulus fibrosus ligament in the tail was recognised (Fig. 
3.3.6C) and remained unaffected in the mutant tails (Fig. 3.3.6D).  
 
In summary, the limb tendons as well as axial tendons at postnatal stage were 
had severe abnormalities in ScxGFP expression. Since, ScxGFP faithfully 
replicates the endogenous Scx expression from tendon cells; our data indicate 
defects in tendon development in Meox2-/- animals. The intercostal and tail 
tendons were completely lost. Meox2 mutants did not exhibit any change in the 
cartilage and ligaments. This suggests a role of Meox2 in tendon development 
independent of cartilage condensation both in the limbs and in trunk. 
 
3.3.4 SEVERE FORELIMB AUTOPOD TENDON 
DEFECTS  
 
Although ScxGFP is a useful tool to visualize whole tendon, still it fails to impart 
the important information associated with the morphology of the tendon tissue. 
92	  
	  
Therefore, we decided to analyse the tendon structure using haematoxylin and 
eosin staining of the forelimb sections at P0. The evaluation of morphology was 
carried out in the distal autopod (digit tendons) and proximal autopod 
(metacarpal tendons), which has revealed significant tendon differences 
between controls and mutants tendon tissues (Fig. 3.3.4A’-D’). The FDS tendon 
was completely lost in the Meox2 mutants along the proximal-distal axis of the 
forearm (T2 in Fig. 3.3.4A,A’,B,B’). In contrast, only a remnant of the FDP was 
found (T1 in Fig. 3.3.4A,A’,B,B’). The primary extensor tendon, EDC remained 
unaffected in the absence of Meox2 (T3 in Fig. 3.3.4A,A’,B,B’). Moreover, the 
proximal segment of the paw showed a more profound tendon phenotype in the 
Meox2 mutants. The reduced mass of the other extensor tendons was also 
found, namely, extensor carpi radialis longus and extensor carpi radialis brevis 
(T7 and T8 in Fig. 3.3.4C,C’,D,D’). Another two groups of extensor tendons, 
namely, extensor digiti quarti/quinti were reduced in size (T9a and T9b Fig 
3.3.4B,B’,C,C’).  
 
Furthermore, the flexor carpi radialis tendon was present as loose extensions in 
contrast to the compact round bundle in the heterozygous controls (T10Fig. 
3.3.4C,C’). Notably, the fusion of interosseous muscle and lumbricals muscle 
occurred in the absence of Meox2 (Fig.3.3.4B,B’, blue arrowheads, blue 
arrows). There was also a significant disruption of the superficial paw muscles 
i.e. thenar muscles and hypothenar muscles (Fig.3.3.4D,D’, yellow arrowheads, 
yellow arrows). However, the collateral ligament metacarphophalangeal joint 
(MCP) and transverse carpal ligament were unaffected in the mutants 
(Fig.3.3.4A,A’,D,D’, pink arrowheads).  
 
Collectively, it is apparent from the autopod histology that in Meox2-/- animals, 
flexor digitorum superficialis (FDS) tendon in the forelimb was lost and other 
tendons that were present showed abnormal histology. In addition, the muscles 






3.3.5 DEFECTIVE FORELIMB ZEUGOPOD TENDONS 
 
Depiction of the major zeugopod tendons in the histological examination along 
the proximo-distal axis revealed significant differences in the heterozygous 
control and homozygous mutant forearm (Fig.3.3.5A-D and A’-D’). The forelimb 
bones, radius and ulna remained unaffected in the zeugopod. The FDS tendon 
(T2 Fig.3.3.5A-D and A’-D’) was not present throughout the zeugopod in 
mutants indicating complete failure of the FDS tendon morphogenesis in the 
absence of Meox2. Furthermore, only the remnants of FDP tendon mass was 
present in the mutants (T1 in Fig.3.3.5A-D and A’-D’). In controls, a major 
extensor tendon, EDC crosses over the entire length of the zeugopod as four 
tendon bundles and they travel along with another tendon called extensor 
indicis proprius (T3, T4 in Fig.3.3.5A-D) within a common sheath. Conversely, in 
Meox2-/- forelimb zeugopod, the fusion of EDC tendon bundles was evident 
throughout the sets of the sections and a considerable loss of extensor indicis 
proprius was observed (T3, T4 Fig.3.3.5A’-D’). We found the abnormal muscle 
fibres replacing the regions of EDC and indicis proprius tendon tissues in the 
mutant sections (Fig.3.3.5C,C’,D,D’). The majority of the other extensor 
tendons, namely, carpi ulnaris (T6) and pollicis (T5) were also small and 
disorganised. Furthermore, significant reduction in the tendons mass and fusion 
of two separate but closely associated extensor tendons i.e. carpi radialis 
longus and carpi radialis brevis (T7 and T8 in Fig.3.3.5A-D and A’-D’) was 
clearly observed. While, the extensor digiti quarti/quinti remained as two 
separate tendon bundles in the control, in the mutants both tendons were fused 
into one small tissue mass (T9a and T9b in Fig.3.3.5A-D and A’-D’). 
Interestingly, the dislocation of palmaris longus tendon was found in the 
mutants (T12 Fig.3.3.5C, C’, D and D’). For instance, in controls palmaris 
longus tendon was located between flexor carpi radialis and flexor carpi ulnaris 
(T10, T12, T11 Fig.3.3.5C,D). While the equivalent mutant zeugopod section 
showed presence of a small palmaris longus tendon tissue at a different 
location (T10, T12 Fig.3.3.5C’,D’). Noticeably, the flexor carpi radialis tendon 
showed loosely organised tendon fibres in the mutants in contrast to the tight 
compaction found in controls (T10 Fig.3.3.5A-D and A’-D’). Finally, flexor carpi 
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ulnaris (T11) which is adjacent to the palmaris longus (T12) in controls was 
missing in the absence of Meox2 in (Fig.3.3.5A-D and A’-D’).  
 
In conclusion, the tendon phenotype in zeugopod was more dramatic than 
autopod with almost all tendon groups (flexors and extensors) severely affected. 
This suggests that Meox2 contribute to the normal zeugopod tendon formation 
and or maintenance of tendon cells during embryonic genesis of tendons.   
 
3.3.6 IRREGULAR FASCIA IN THE PROXIMAL 
FORELIMB ZEUGOPOD  
 
Fascia is a form of the connective tissues that are derived from undifferentiated 
mesenchymal cells. They form a layer of fibrous tissue which envelopes and 
separates different muscle groups (Benjamin and Ralphs, 1998). The fascia in 
the proximal sections of the forelimb zeugopod in heterozygous controls and 
homozygous mutants showed multiple differences. The well-defined separation 
of individual muscle groups into the compartments by fascia was evident in the 
controls, whereas, the intermixing of abnormal muscles resulted and the 
defective fascia in the mutants was observed (Fig.3.3.6A-C’). For example, the 
fascia of FDP tendon was present as thick sheets separating FDP and FDS 
muscles in the controls (Fig.3.3.6A,B,C, black arrowhead). On the contrary, the 
fascia in the mutants were severely redundant resulting in intermingling of 
loosely organised muscle fibres (Fig.3.3.6A’, B’ and C’). In Meox2 mutants, 
tendon tissues were replaced by abnormal muscle fibres (Fig.3.3.6A, A’). The 
individuated tendon bundles of EDC was present in controls whereas only 
residues were found in the mutants (T3 Fig.3.3.6A, B, A’,B’). Other extensor 
tendons i.e. pollicis, carpi radialis longus and carpi radialis brevis (T5, T7 and 
T8 in Fig.3.3.6A, B, A’ and B’) were abnormal and more compact in the more 
proximal zeugopod.  
 
Therefore, it can be proposed that Meox2 is required for the proper formation of 
fascia. At post-natal stage, more proximally, the failure of fascia development in 
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the absence of Meox2 could be responsible for the muscle and tendon 
abnormality.  
 
3.3.7 DEFECTIVE HINDLIMB AUTOPOD TENDONS  
 
To understand the tendon defects inside the hindlimb autopod, we obtained the 
serial cross sections from the paw region and counter stained for studying 
tissue histology of major hindlimb tendons. We found major morphological 
modifications of the hindlimb tendons in the absence of Meox2 similar to those 
in the forelimbs. In controls, the cup-like structure of FDB tissue surrounding 
another tendon group called flexor digitorium longus (FDL) was present (T14 
and T18 in Fig 3.3.7A,C,E). Conversely, the disappearance of a major flexor 
tendon known as flexor digitorium brevis (FDB) due to Meox2 mutation was 
obvious (T14 in Fig 3.3.7 A-F). In addition to the complete loss of FDB, there 
was reduction in the FDL tendon mass due to the Meox2 mutation (T18 
Fig.3.3.7B,D,F). Another flexor tendon known as flexor hallucis longus was 
highly reduced in size compared to the controls neonates (Fig.3.3.7A-F, black 
arrowhead). Interestingly, the extensor digitorium longus (EDL) tendon 
remained unaffected in the mutants (Fig.3.3.7A-F black arrows). Moreover, the 
lumbrical muscle defects in the hindlimb showed defective muscle patterning 
similar to that in the forelimb (Fig.3.3.7A-F yellow arrowheads). 
 
Taken together, it is evident that Meox2-/- mutant animals show remarkable 
degrees of abnormalities in limb tendons. The ScxGFP and histology data 
demonstrated the complete loss FDB tendon tissue and suggesting an 
important requirement of Meox2 in the normal patterning and growth.  
 
3.3.8 DISRUPTED ACHILLES TENDON AND FASCIA IN 
THE ZEUGOPOD OF HINDLIMB  
 
The histological analysis further confirmed the tendon defects in the zeugopod 
segment of the hindlimb. A sharp decrease in the size of Achilles tendon was 
identified in the mutant that corresponds to the highly reduced ScxGFP 
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fluorescence from this tendon cells (T13 in Fig 3.3.8 A,B). Moreover, only a 
fragment of flexor digitorium longus was found in the mutants in comparison to 
the thick tendon mass in controls (T18 in Fig.3.3.8 A,B). The extensor hallucis 
longus tendon was also found to be severely reduced in size (T17 in Fig.3.3.8 
A,B). In addition, defects in the fascia were evident in the more proximal section 
(Fig.3.3.8 C,D, black arrows).  
 
Therefore, similar to the forelimbs, overall defects in the hindlimb tendon 
resulted in Meox2-/- animals. Interestingly, in both appendicular musculatures, 
cells of fascia were disorganised.  
 
3.3.9 INTERCOSTAL MUSCLES ARE NORMAL IN 
MEOX2-/- NEONATES 
 
Using tissue histology for muscles, we found normal epaxial and hypaxial 
muscles in the absence of Meox2 gene function. These muscle groups were 
examined on the thin sections obtained from trunk of control and mutants 
embryos (Fig. 3.3.9 A and B). The muscle morphology and fiber arrangement 
remained unaltered in all muscles on the sections.  
 
Hence, the overall hypaxial muscles in the trunk that includes intercostal and 
abdominal wall along with epaxial muscles that encompasses right serratus 
anterior muscles were normal.    
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3.4. Discussion  
 
Our detailed analysis on the role of Meox2 in tendon morphogenesis provided a 
new insight in understanding genetic control of tendon development. Although 
Meox2-/- animals are viable, the severe tendon defects were found in addition to 
the reported muscle defects. A detailed investigation of the phenotype was 
performed at a neo-natal stage. The histological analysis of all tendon tissues in 
the limb from post-natal mice revealed that these tissues were abnormal and 
disorganised. ScxGFP expression from the tendon cells showed Meox2 mutant 
mice display an overall impaired tendon structure including failure in the 
formation of correct shape and size. Altogether, the axial and limb tendon 
defects in our mutant mice model, once again, featured the structural and 
molecular divergence in the relatively unexplored complex tissue like tendons.  
 
 
Gross appendicular tendon defect in the absence of 
Meox2  
 
In order to visualize the whole limb tendons in the Meox2 null mice, we utilized 
the ScxGFP transgene. The fluorescent signals from this transgene revealed 
thinner tendons at all levels in the mutant limb. In agreement with the 
histological analysis, some subsets of tendons were completely missing e.g. 
extensor digiti quarti/quinti and an extensive loss of GFP signal from EDC 
tendon on the dorsoventral aspects of the forelimb. Furthermore, the ScxGFP 
analysis in the hindlimb showed complete loss of FDB tendon and only small 
tissue mass of Achilles tendon.  
 
We further investigated this profound limb tendon malformation by histological 
examination in Meox2-/- mice. The most dramatic aspect of this mutation was a 
complete loss of tendons, FDS in the forelimb and FDB in the hindlimb. The 
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developmental pathway of this tendon groups are unique compare to other limb 
tendons. The data from previous studies has shown that while the pattern and 
position of all other tendons was established by E14.5, the induction of FDS and 
FDB tendon cells initiates at this stage and mature form is only acquired at 
E16.5. (Huang et al., 2013; Pryce et al., 2009). Our data indicate complete 
failure of FDS and FDB tendon formation suggesting a role of Meox2 during late 
induction and maturation of these tendon groups in the forelimb and hindlimb. 
Moreover, Huang and co-workers show that FDS and FDB tendons share 
similar anatomical features based upon their position in the limbs, the only 
difference in tendon patterning steps is  FDS tendon extends from distal to 
proximal axis in the forelimb, and then translocation occurs into the zeugopod 
that acts as the final location. In contrast, FDB tendon cells originate and 
differentiate within the hindlimb autopod. In agreement with this, our data 
conclude that the failure in formation of FDS and FDB confirm the requirement 
of Meox2 transcription factor in the developmental machinery for both tendon 
groups. In Scx-/- mutants, FDS tendons was absent in the digits and metacarpal 
level indicating an exclusive requirement of the Scx gene in the FDS tendon 
formation (Huang et al., 2013; Murchison et al., 2007). Despite sharing 
anatomical homology between FDS and FDB, in Scx-/- mutants, there is no 
analysis available on developmental effects Scx mutation on FDB tendons. 
Therefore, to date in our knowledge, Meox2 is the only known transcription 
factor that is critical for FDB tendon formation in hindlimb. We can conclude that 
in addition to Scx, Meox2 is also an important molecular regulator of FDS 
tendon development.   
 
Another major flexor tendon in forelimbs i.e. FDP, though present, was 
rudimentary. This observation is consistent with Scx-/- mutants, in which FDP 
tendons were smaller (Murchison et al., 2007). A recent lineage tracing analysis 
using Six2CreERT2 deleter along with Rosa-TdTomato Cre reporter showed the 
co-expression of Six2+ and ScxGFP+ cells in the autopod FDP tendons (Huang 
et al., 2015b). However, the zeugopod segment for FDP only expressed 
ScxGFP. Thereby, separate groups of progenitor cells in the autopod and 
zeugopod to form FDP was concluded. Interestingly, in the absence of Meox2, 
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both of these FDP tendon progenitors in the autopod and zeugopod are 
affected.  
 
Huang et al. (2015) have also shown that the cartilage is necessary and 
sufficient for the formation of normal FDS tendons in the autopod. The distal 
formation of FDS tendon in the autopod is dependent on the cues from the 
metacarpophalangeal (MCP) joint whereas the proximal development in the 
zeugopod is dependent on the FDS muscles. Notably, Meox2-/- mutants showed 
the regular bilateral symmetry of the MCP joint despite the loss of FDS digit 
tendon. The normal chondrocyte differentiation due to Meox2 mutation could 
not explain the complete loss of FDS tendons in distal segments of the digit. 
This indicates that in addition to the cartilage, a distinct but concurrent signal 
dependent on Meox2 is also required for normal FDS tendon formation.  
 
Moreover, the proximal stretch of FDS tendon anlage was also absent. During 
late development of FDS muscles, the shifting of differentiated muscle fibres 
from the autopod towards zeugopod takes place by retraction at distal end that 
is attached to FDS tendon and proximal elongation once inside the zeugopod 
(Huang et al., 2013). The same study showed that in Scx-/- mutant embryos, 
there was a complete loss of distal retraction and restricted proximal elongation 
of FDS muscle. Conversely, Mdg embryos in which muscle paralysis occurred 
due to a mutation in voltage-gated calcium channels, there was a defective FDS 
muscle retraction and translocation along the proximodistal axis. Thereby, 
authors concluded that a coordinated response from the FDS tendon at distal 
end is necessary for the FDS muscle contractility. Previously, it was shown that 
Meox2-/- mice exhibit disrupted FDS muscle in the proximal zeugopod (Mankoo 
et al., 1999). Our data on the complete loss of FDS tendon explain the 
disruption FDS muscles and thereby indicates a crucial role of Meox2 in the 
formation of FDS muscle-tendon unit.  
 
Closer examination of histology sections demonstrated that the EDC tendon 
was present in the autopod but reduced in size and like controls, were found as 
individual units on the top of each digit. Conversely, the EDC tendons inside the 
zeugopod showed a dramatic phenotype. The anatomical position of EDC 
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tendon tissue is known to present on the dorsal side of the forearm and is the 
key tendon on the dorsal aspect of the paw. As individual bands, each EDC 
tendon subunit fans out from the digits and passes through the compartment 
formed by the extensor retinaculum and radius, after which they reach the 
origins at the lateral epicondyle of the humerus. Other subsets of extensor 
tendon groups along the proximodistal axis i.e. extensor digiti quarti/quinti were 
fused into a highly reduced tendon tissue in Meox2-/- animals. Moreover, the 
dislocation and fusion of the flexor carpi radialis longus tendon occurred in 
these animals with another extensor tendon groups i.e. carpi radialis longus and 
carpi radialis brevis within the zeugopod region. Recently, analogous 
observations were made where the fusion of tendon groups namely, EDC, 
extensor longus/brevis and extensor digiti quarti/quinti occurred due to muscle 
inactivity in the zeugopod (Huang et al., 2015b). Due to inactivation of Pax3 
gene, in Splotch embryos myoblast migration was disrupted. In these embryos, 
the autopod tendons were found normal, whereas, at the wrist level of 
zeugopod segment showed coalescence of the fused extensor tendons.  
 
Similarly, the fusion of EDC tendon bundles and other extensor tendon groups, 
carpi radialis longus/brevis and digiti quarti/quinti was also found in the 
Muscular dysgenesis (Mdg) embryos at E16.5. The embryos of Mdg contains a 
mutation in voltage-gated calcium channels resulting in the paralysis of all 
muscles, although, the muscle patterning remained unaffected (Chaudhari, 
1992; Huang et al., 2015b; Huang et al., 2013). Therefore, it could be reasoned 
that the zeugopod tendon phenotype in Meox2 mutants is due to an extrinsic 
role of Meox2 gene from the muscle cells onto the zeugopod tendon 
morphogenesis. In addition, Meox2 gene is critical for the modular development 
of extensor tendons at the wrist level. However, the exact mechanism to 
address this issue is described in the subsequent results chapter. A summary of 
comparison of the development of major flexor and extensor tendons in the 
absence of Meox2-/- mutants with the Scx-/-, Spd, Mdg and Sox5-/-; Sox6-/- 
mutants are listed in table 3.3 and 3.4. For instance, in the absence of Meox2 
and Scx, FDP tendon cells showed similar defective phenotype in the digits 
whereas the paralysis of muscle in Mdg embryos or loss of cartilage in Sox5-/-; 
Sox6-/- mutants does not affect FDP tendon development in digit autopod. 
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Conversely, the metacarpal location of FDP tendon cells showed severe 
abnormality in Meox2-/- and Spd but normal morphology was reported in Scx-/- 
and Sox5-/-; Sox6-/- mutants. Moreover, the most remarkable tendon phenotype 
for FDS tissue was a complete loss throughout the proximodistal axis of the 
forearm due to loss of the Meox2 gene. In contrast, rudiments of FDS tendon 
was present Scx-/- and Spd mutants. Majority of the extensor tendons showed 
tissue fusion in the transgenic mice with defective expression of Meox2, Scx, 
and Pax3 or muscle inactivity. However, no defects of extensor tendons were 
observed in the proximal segment of the forearm in Sox5-/-; Sox6-/- mutants.  
 
Furthermore, previous work that evaluated the developmental requirement of 
Meox2 by muscle cells also established disrupted forelimb flexor muscles 
namely, flexor digitorium profundus, flexor carpi ulnaris and flexor carpi radialis 
(Mankoo et al., 1999). Consistently, the data reported here, revealed the fusion 
of the interosseous and lumbricals muscles in the autopod of mutants. 
Additionally, the superficial paw muscles i.e. thenar and hypothenar were 
disarranged.  
 
It has been shown that the cartilage cells express Sox9 gene and are derived 
from limb mesenchyme (Suzuki and Kuroiwa, 2002). Recent studies revealed 
the presence of a unique population in the early mesenchyme that express both 
Scx and Sox9 (Blitz et al., 2013; Sugimoto et al., 2013a). The divergent fates of 
generation of either cartilage primordia or tendon primordia are due to the 
extrinsic signals received by these early progenitors during subsequent 
differentiation and maturation stage of development in the limb (Schweitzer et 
al., 2001). The inductive factors for tendon progenitors could be either TGFβ 
signalling emanated from nearby cartilage or ectoderm derived Wnt signalling 
and repressed by BMP signalling from surrounding limb mesenchyme cells 
(Pryce et al., 2009; Yamamoto-Shiraishi and Kuroiwa, 2013;(Schweitzer et al., 
2001). Meox2 is expressed in the early limb mesenchyme at E10.5 where 
multipotent chondro-tendo progenitor population exists expressing both Scx and 
Sox9, therefore it would be useful to analyse the Sox9 expression (cartilage 
marker) in Meox2-/- mutants during embryonic stages. Analysis of this proposed 
experiment could provide a better understanding of the specific role of Meox2 
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only on Scx+/Sox9 and not Scx+/Sox9+ progenitor cells. Extrapolation of the 
results would direct us to explain the normal cartilage but defective tendon 
formation in Meox2-/- animals at birth.  Together, we conclude that Meox2 plays 
a significant and dual role in the tendon and muscle development.  
 
Meox2 is necessary for the intercostal and tail tendon 
at P0 
 
A pioneer study in chick using Scleraxis as a marker for tendon cells exposed 
details of axial and tail tendon development (Schweitzer et al., 2001). In both 
groups of tissue, the progenitors are derived from the compartment of somite 
called syndetome as opposed to the limb tendons whose developmental origins 
are limb bud mesenchyme. The robustness of ScxGFP fluorescence from all 
tendon cells offered a tool to characterise the morphological consequences of 
the Meox2 mutation on the axial and tail tendons. Similar to our limb analysis, 
the whole mount ScxGFP expression in the Meox2 deficient mice showed an 
extensive loss of axial tendon. We could not able to detect any ScxGFP 
expression from the intercostal tendons in the Meox2 mutants. This tendon 
connects the adjacent ribs and assists in joining the intercostal muscles to the 
ribs. In Scx-/- mutant embryos, the intercostal tendon layer remained unaffected, 
however, all force-transmitting and intermuscular tendons connecting two 
muscles throughout the body were abnormal (Murchison et al., 2007). To our 
knowledge, the data presented in this thesis provide the first evidence for a 
requirement of specific transcription factor for the intercostal tendon 
development. Interestingly, our histological analysis showed normal intercostal 
muscles in the mutants that could explain the viability of these animals despite 
absence of tendon layer in the thorax.  
 
The substantial loss of tail tendons in Meox2 mutants was evident due to the 
absence of ScxGFP signal from long tendons in the tails. However, the highly 
organised ligament of tail tendon, annulus fibrosus, remained unaffected due to 
Meox2 mutation. The role of this ligament is to connect the adjacent vertebrae. 
The cells in the annulus fibrosus contain collagen fibres that are arranged 
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perpendicularly to the tendons and display criss-cross pattern. This observation 
is similar to the tail tendon phenotype of Scx-/- mutants (Murchison et al., 2007). 
It is not yet clear how exactly the Meox2 dependent cues in these anatomical 
similar tissues (axial and tail tendons) led to discrete outcome and hence, 
elucidating the exact mechanism needs further investigation. Meox2 and Scx 
genes might be functioning independently or in a complementary manner for the 
proper formation of tail tendons. Evidence from data shown in this study 
suggests that the Meox2 dependent signals are necessary for the post-natal 
tendon growth and maintenance. Interestingly, TGFβ2 mutant mice also show 
loss of all axial and tail tendons due to failure in the maintenance and 
recruitment of tendon progenitors by TGFβ signalling during embryonic stages 
(Pryce et al., 2009). Additionally, an analogous phenotype was reported in Scx-/- 
mice that showed severe disruption of the force-transmitting from the trunk 
(Murchison et al., 2007). A plausible explanation of the comparable phenotype 
in all these mutants could be the requirement of a cross talk of these molecular 
regulators during normal tendon development. For instance, complete loss of 
ScxGFP expression from trunk tendons in TGFβ2-/-; TGFβ3-/- mutant mice was 
reported. Additionally, TGFβ signalling acts as a potent inducer of Scx in both 
cell culture and organ culture. Besides, this study showed that TGFβ signalling 
regulates Scx expression during key stages of tendon morphogenesis (Pryce et 
al., 2009). Likewise, in future, it would be interesting to observe if Meox2 could 
directly regulate Scx and or regulating TGFβ signalling pathway to execute its 
function for the normal tendon development.  
 
Furthermore, changes in the collagen fibril growth and extracellular matrix 
(ECM) deposition towards the end of embryogenesis are the hallmark of post-
natal tendon growth. It includes further accumulation of the collagen matrix and 
maturation of collagen proteins. Recently, the Mohawk gene was shown to be 
involved in the tendon cell differentiation and maturation stage in addition to the 
Scx (Anderson et al., 2006; Ito et al., 2010; Liu et al., 2010). While the defects in 
collagen matrix in the absence of Mkx-/- mice is appeared only after birth, the 
embryonic genesis of tendon is normal, highlighting the differences in the 
embryonic and post-natal tendon morphogenesis (Liu et al., 2010). Interestingly, 
Scx-/- mice show a less and disorganised collagen matrix towards the end of 
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embryogenesis (Murchison et al., 2007). A unique role of Scx in regulating 
cardiac fibroblast was shown via its DNA-binding mechanism in promoting 
collagen 1α2 expression (Espira et al., 2009). This suggests an important 
function of Scx in regulating ECM proteins. Moreover, in situ analysis show Mkx 
expression in tendons and surrounding cells and therefore authors concluded 
that Scx could be considered as the key embryonic regulator of collagen 
proteins whereas Mkx determines the postnatal maturation and growth of these 
matrix proteins (Liu et al., 2010; Ito et al., 2010).  
 
Furthermore, the reduction in overall tendon size and defective collagen matrix 
is also observed in a transgenic mice deficient of the Egr1 transcription factor 
(Guerquin et al., 2013). Although Scx expression along with collagen protein 
expression is relatively normal in the absence of Egr1, fragile tendons are 
evident after birth and mutant mice show a modest tendon phenotype. The 
importance of Egr gene in tendon biology is emphasised due to its capacity to 
convert the mesenchymal stem cells into tenogenic cells in vitro (Liu et al., 
2015). Moreover, GDF6/BMP13 and GDF5/ BMP14 deficiencies in mice are 
associated with altered compositional, ultrastructural, and mechanical 
properties of tendons (Mikic et al., 2009).  
 
Prior to the discovery of Scx, a type II transmembrane glycoprotein, 
Tenomodulin (Tnmd) served as faithful marker for the tendon cells (Shukunami 
et al., 2001). Tnmd-/- mutant mice show no tendon defects during embryonic 
stages and only a small reduction in tenocyte proliferation and tenocyte density 
was observed in tendon cells after birth (Docheva et al., 2005). However, it can 
still be considered, as an ideal marker for later stages of tendon development 
due to exclusive expression and is known to be positively regulated by Scx 
(Shukunami et al., 2006). Myostatin/GDF8 knockout mice show defects in 
muscle integrity and performance, and evidence indicates this is exacerbated 
by increased tendon stiffness (Mendias et al., 2008). The spatiotemporal 
expression of Myostatin during development, in conjunction with the observation 
that tendon fibroblasts continue to express both the Myostatin and receptors 
into adulthood and that Scx is a direct downstream target of Myostatin 
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signalling, strongly suggest that Myostatin plays a role in both the prenatal and 
postnatal development and regulation of tendons.  
 
A hallmark of tendon differentiation after birth include expression of several 
proteins in the collagen matrix of tendon fibres, namely, type I collagen, 
biglycan, decorin, fibromodulin, fibrillin 2, lumican and tenomodulin (Ansorge et 
al., 2009; Birk and Mayne, 1997; Birk et al., 1989; Boregowda et al., 2008; 
Elliott and Crawford, 1965; Trelstad et al., 1983). Evidence suggests that these 
proteins have key role in tendon differentiation, however, tendon induction and 
maturation remained normal in the absence of any of these proteins. For 
instance, mice double deficient for the Small Leucine Rich Proteoglycans 
(SLRPs) Biglycan and Fibromodulin show disruption in disturbed collagen fibril 
structures of tendons, with reduced stiffness (Young et al., 2002). Similarly, 
Lumican and Fibromoulin double mutants have defects in tendon integrity 
(Jepsen et al., 2002). Loss of Biglycan and Fibromodulin also impairs tendon 
formation in vivo by disrupting BMP signalling in the stem cell niche of TSPCs 
(Bi et al., 2007). So far, this is the only knockout model where a defect in tendon 
integrity has been linked to abnormalities in tendon stem cell function. Fibrillin2 
is located in the pericellular matrix of interior tenocytes, and knockout mice have 
decreased collagen cross-linking of tendons (Boregowda et al., 2008). 
Mutations in Fibrillin2 result in muscle weakness and regenerative myopathy, a 
likely consequence of connective tissue abnormalities (Miller et al., 2010). 
 
3.5. Conclusion  
 
We finally conclude that our evidence represents the first demonstration of a 
requirement of Meox2 for normal tendon genesis in axial and appendicular 
tissue. The summary of the phenotype is tabulated in table 3.1 and 3.2 for the 
forelimbs and hindlimbs respectively. This provide, to our knowledge, the first 
direct evidence of a role Meox2 in the important and often neglected complex 
tissue i.e. tendon. Moreover, the detailed characterization reported for all 
individual tendons could provide a direction for the future studies to understand 
a diverse role of Meox2 in tendon morphogenesis. However, further 
106	  
	  
investigation is needed to understand whether the failure of tendon formation is 
an outcome of deteriorated tendon morphogenesis during the embryonic 
stages. Therefore, the experimental observations in next chapter focus 
embryonic stages of tendon development. 
 
Meox2 is an important regulator of tendon development in axial and 
appendicular tissue. The tendon phenotype in zeugopod was more profound 
than the autopod segment demonstrating a unique regional role of Meox2 in the 
modular limb tendon morphogenesis. Furthermore, our analyses from mutant 
mice highlighted the loss of FDS in the forelimb and FDB tendons from the 
hindlimb and hence, an exclusive role of Meox2 in these anatomically similar 
tendons can be concluded. Interestingly, there was no discernible defect in 
cartilage and ligaments of Meox2-/- null mice. Together, Meox2 is a key 
component of the cellular mechanisms that govern growth and maturation of 












LOST ABNORMAL  
 Flexors   
Autopod Flexor digitorum profundus 
(FDP) T1 
 ü  
Reduced size 
Autopod Flexor digitorum 
superficialis (FDS) T2 
ü   
Zeugopod  Flexor carpi radialis T10  ü  
Reduced size 
Zeugopod Flexor carpi ulnaris T11 ü   
Zeugopod Palmaris longus T12  ü  
Dislocated 




communis (EDC) T3 
 ü  
a)Normal in autopod  
 
b) Fusion of individual 
bundles and reduced 
size in zeugopod 
Zeugopod Extensor Indicis Proprius T4 ü   
Zeugopod Extensor pollicis T5  ü  
Dislocation and fusion 
with carpi radialis 
longus/brevis  tendons 
Zeugopod Extensor carpi ulnaris T6 ü   
Zeugopod Extensor carpi radialis 
longus T7 
 ü   
Fusion with carpi radialis 
longus/brevis  tendons 
Zeugopod Extensor carpi radialis 
brevis T8 
 ü   
Fusion with carpi radialis 
longus/brevis  tendons 
Zeugopod Extensor digiti quarti/quinti   
T9a/T9b   
 ü  
Fusion of both tendon 









TENDON CLASSIFICATION  LOST ABNORMAL  
Flexors   
Flexor digitorum brevis (FDB) T14 ü   
Flexor digitorum longus(FDL) T18  ü  
Reduced size 
Extensors  ü  
Extensor digitorum longus (EDL) T16  ü  
Reduced size 
Extensor hallucis longus tendon T17  ü  
Reduced size 



















Table 3.3: Summary of the flexor tendon phenotype in the 
various mouse models (Huang et al., 2015)  
 
























































































Table 3.4: Summary of the extensor tendon phenotype in the 
various mouse models (Huang et al.,2015)  
 

















































Zeugopod Fused Fused Fused Fused ? 
Extensor 
digiti 
quarti/quinti     

















Nomenclature of tendons in Meox2+/- and Meox2-/- 












No. Tendon classification 
T1 Flexor digitorum profundus (FDP) 
T2 Flexor digitorum superficialis (FDS) 
T3 Extensor digitorum communis (EDC) 
T4 Extensor Indicis Proprius  
T5 Extensor pollicis  
T6 Extensor carpi ulnaris  
T7 Extensor carpi radialis longus  
T8 Extensor carpi radialis brevis  
T9a Extensor digiti quarti    
T9b Extensor digiti quinti                                                                                        
T10 Flexor carpi radialis  
T11 Flexor carpi ulnaris  
T12 Palmaris longus 
T13 Achillies tendon 
T14 Flexor digitorum brevis (FDB) 
T15 Peroneous longus brevis 
T16 Extensor digitorum longus 
T17 Extensor hallucis longus tendon 
T18 Flexor digitorum longus(FDL) 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Fig 3.3.1 Decreased ScleraxisGFP expression from the forelimb 
tendons in Meox2 null neonates 
The heterozygous and homozygous alleles for Meox2 were maintained on a 
ScxGFP transgenic background. Whole-mount view of ScleraxisGFP in the 
heterozygous and homozygous forelimb dorsal (A and B) and ventral (C and D) 
confirmed the limb tendon abnormality. Numerical tendon assignments are 
tabulated in Table 2. Marked decrease in the GFP levels can be seen in mutant 
forelimbs and absence of extensor digiti quarti/quanti subsets of tendons (T9a 




















Fig 3.3.2 Absence of major hindlimb tendons in Meox2 null 
neonates  
The heterozygous and homozygous alleles for Meox2 were maintained on a 
ScxGFP transgenic background. Whole-mount view of ScleraxisGFP was 
compared in the dorsal and ventral aspects of heterozygous (A, C) and 
homozygous (A and B) and ventral (C and D). The tendon names are as follow:; 
(EDL) , (EHL), (PLB) and achilles tendon (AT). The apparent reduction in an 












Fig 3.3.3 Axial and tail tendons showed diminished ScxGFP 
expression in the absence of Meox2 at neonatal stage 
Axial and limb tendons of Meox2 heterozygous and homozygous littermates are 
directly visualized in skinned tissue using ScxGFP transgenic reporter. Axial 
tendons (A and B) showed significant reduction in GFP levels. The intercostal 
tendons were completely lost as shown by red arrowheads. In contrast, all tail 
tendons (C and D) are lost in mutants as shown by white arrows. White 















Fig 3.3.4 Forelimb autopod of Meox2-/- neonates showed tendon 
deformities 
Sequential transverse sections of a forelimb autopod stained for Haematoxylin 
& eosin from a heterozygous control (A, B, C and D) and Meox2 homozygous 
(A’, B’, C’ and D’). Tendon classifications are shown with black numerals except 
Flexor digitorium superficialis (FDS, T2) in red for its absence in the mutants. 
The nomenclature is described in Table 1. Majority of other tendons are 
reduced in size in mutants e.g. Flexor digitorium profundus (T1), extensor digiti 
quarti/quanti subsets of tendons (T9a and T9b). Red arrowheads indicate FDS 
tendon, Pink arrowheads indicate collateral ligament metacarphophalangeal 
joint (MCP), blue arrows head indicate interosseous muscle , blue arrows 
indicate lumbricals muscle, yellow arrowhead show thenar muscle , yellow 
arrow show hypothenar muscle and white arrow indicates transverse carpal 















Fig 3.3.5 Reduction of zeugopod tendon mass in Meox2-/- 
postnatal mice 
Transverse sections through the zeugopod of heterozygous control (A, B, C and 
D) and Meox2 mutant (A’, B’, C’ and D’) at P0. Haematoxylin & eosin staining 
show abnormality in tendon histology in Meox2 mutants including severe 
reduction in tendon mass and tendon fusion. Tendon classifications are shown 
with black numerals. Notice the absence of FDs tendons (T2 in red) the mutant 
zeugopod. Tendon classification as shown with black numerals is named in 










Fig 3.3.6 Irregular fascia in the forelimb zeugopod of Meox2 
mutants  
Transverse sections through the forearm of the heterozygous control (A, B, C 
and D) and Meox2 mutant (A’, B’, C’ and D’) at P0. Haematoxylin & eosin 
staining show drastic reduction of the thick fascia at the wrist level which 
includes several extensor and flexor tendons. Blue arrow shows m. flexor 
digitorium profundus; blue arrowheads show m. flexor digitorium sublimis and 
red arrowheads indicate t. flexor digitorium sublimis. Notably, in the absence of 
Meox2, defective fascia was observed in the majority of tendon-muscle 













Fig 3.3.7 Hindlimb autopod showed severe tendon defects  
Sequential transverse sections of a hindlimb autopod stained for Haematoxylin 
& eosin from a heterozygous control (A, C, E) and Meox2 homozygous (B, D, 
F). Tendons are shown by arrow and classifications are as follow: red 
arrowhead indicate flexor digitorum brevis (FDB), blue arrowhead show flexor 
digitorum longus (FDL), black arrow head indicate flexor hallucis longus tendon 
and black arrows assign extensor digitorum longus tendons. The meta-tarsal 
joint is shown by yellow arrowhead and lumbricals muscle indicated by yellow 
arrowhead. FDB tendons, a serial homologues of FDS tendon in the forelimb 










Fig 3.3.8 Abnormal zeugopod tendon mass and defective fascia 
in the hindlimb 
Transverse sections through the zeugopod of heterozygous control (A, C) and 
Meox2 mutant (B, D) at P0. Haematoxylin & eosin staining show abnormality in 
the tendon histology including severe reduction in tendon mass and loss of 
fascia. The zeugopod bones are t, tibia and f, fibula. Individual tendon and 
muscles indicated by numbers:; 5, m, extensor digitorum longus; 6, m. biceps 
femoris; 7, m. soleus. Black arrowheads indicate fascia separating the muscle 
compartments in the proximal end of zeugopod. Considerable loss of thick 



















Fig 3.3.9 Normal intercostal muscles in the Meox2 null 
neonates  
Transverse sections through the trunk of heterozygous control (A) and Meox2 
mutant (B) at P0. Haematoxylin & eosin staining show normal epaxial muscle 
i.e. right serratus anterior muscles shown by yellow arrows and hypaxial 
muscles i.e. intercostal muscle (external and internal layers) shown by black 
arrows. The brown fact overlying the shoulder muscles were also normal as 












Embryonic tendon defects in 













4.1 Introduction  
 
Vertebrate tendon development is multistep processes that include three stages 
in modular fashion: a) induction of tendon progenitors b) recruitment and 
organisation c) aggregation and differentiation of these tendon precursors. In 
mouse, the initial induction of committed tendon progenitor cells occurs in 
somite and limb mesenchyme between E10.5-11.5 and in somites that is 
associated with FGF signalling (Edom-Vovard et al., 2002; Eloy-Trinquet et al., 
2009). At this stage, the limb bud progression occurs from the proximal to the 
distal axis and Scx expression is found in dorsal and ventral sub-ectoderm 
patches (Murchison et al., 2007; Schweitzer et al., 2001). By E12.5, a loose 
cellular organisation of tendon progenitors and muscle connective tissue occurs 
throughout the body between differentiating muscles and cartilage tissue. This 
phase of limb tendon development is dependent on TGFβ signals emanating 
from the skeletal elements and muscles, which contributes towards recruiting 
more tendon progenitors at the site of condensation. Additionally, TGFβ signals 
emitted from the induced tendon progenitors are involved to maintain the 
tenoblastic identity of the committed progenitors and are recruiting more 
committed precursors to undergo tendon cell fate at E12.5 (Pryce et al., 2009). 
Finally, in some tendon groups, the differentiation and aggregation from E13.5 
depends on the presence of muscles (Bonnin et al., 2005; Edom-Vovard and 
Duprez, 2004; Eloy-Trinquet et al., 2009; Kardon, 1998; Schweitzer et al., 
2001). Scx, which is expressed in all tendon progenitors, plays an essential role 
as molecular regulator for tendon cell differentiation in force-transmitting 
tendons (Murchison et al., 2007). 
 
Tendon progenitor cells from E14.5 onwards are also known as tenocytes and 
are fibroblast-like characteristics that form the mature tendons. These tenocytes 
are capable of synthesizing the extra-cellular matrix including the assembly of 
early collagen fibres, which acts as fundamental units of a mature tendon. From 
E14.5, onwards tendon growth occurs and is a tightly regulated balance 
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between collagen fibrillogenesis and cellular processes that package the 
collagen fibrils into a higher order structure forms.  
Recent evidence indicates that tendon development in the autopod and 
zeugopod is modular (Huang et al., 2015b), whereby the autopod progenitors 
are induced and organised in the developing digits (Schweitzer et al., 2001). 
Interestingly, the zeugopod tendon cells are induced near the presumptive wrist 
and then extend proximally to form various tendon groups (Huang et al., 
2015b). While the axial tendon progenitor induction occurs in the somite under 
the influence of FGF signalling, the subsequent stages are then assumed 
similar to the limb tendon development. (Brent et al., 2003; Brent and Tabin, 
2002; Schweitzer et al., 2001; Schweitzer et al., 2010).  
 
In the previous chapter, we established that Meox2 mutant mice display a 
neonatal tendon phenotype. This indicated a primary defect in embryonic or 
foetal stages of tendon development, which could be in induction (E11.5), 
organisation (E12.0-12.5), maturation (E13.5), or maintenance (E14.5 
onwards). To identify when the primary defect occurs, we closely monitored the 
entire embryonic stages that are relevant to axial and appendicular tendon 
development. We performed analysis starting from E11.5 (induction of tendon 
progenitors) until E14.5 (mature tendon formation) in Meox2-/- embryos. From 
this, we also aimed to suggest if Meox2 has a role in the developmental 
modularity by comparing defects in the autopod and zeugopod segments in our 
mutant model.  
  
 
4.2 Aim  
 
The tendon progenitor cells were identified by expression of the ScxGFP 
transgene and whole mount in situ hybridization detected Scx mRNA 
expression in the Meox2 heterozygous controls and homozygous mutants 
during the key tendon developmental stages starting from induction at E11.5 




4.3 Results  
 
4.3.1 NORMAL TENDON CELL INDUCTION AT E11.5  
 
The induction of tendon progenitors in the axial and appendicular regions 
occurs at E11.5 (Schweitzer et al., 2001). To determine if there is a requirement 
for Meox2 at this stage we performed Scx whole-mount in situ hybridization at 
E11.5 (Fig. 4.3.1). We found normal tendon progenitor distribution in the 
syndetome that is present in intersomitic region of mutant embryos (Fig. 4.3.1A-
D, yellow arrows). When analysed at higher magnification, the proximal 
sclerotome showed orderly strips of Scx expressing cells in both controls and 
mutants (Fig. 4.3.1C-D, yellow arrows). The Scx positive committed tendon 
progenitors were also normally induced in the mesodermal cells residing in the 
limb bud (Fig. 4.3.1A-B, red arrows).  
 
Therefore, we conclude that the induction of tendon precursors in trunk and 
limbs at embryonic stage 11.5 does not depend on Meox2 gene activity.   
 
 
4.3.2 FAILURE OF INITIAL ALIGNMENT OF TENDON 
CELLS IN FORELIMB AT E12.0 
 
The expression analysis of Scx at E12.0 shows that tendon cells are aligned 
and distributed evenly on the proximomedial axis and beneath surface 
ectoderm of growing limb bud (Schweitzer et al., 2001). We observed a 
significant loss of Scx expression using whole mount in situ hybridisation on the 
dorsal and ventral sides of the forelimb at E12.0 (Fig 4.3.2A-D). These included 
a reduction in the anterior and posterior domains in the presumptive autopod 
and zeugopod. The substantial loss of a chevron-shaped Scx domain was 
observed in the medial region of zeugopod (Fig 4.3.2A,B, yellow arrows). 
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Moreover, the ventral side of the limb showed severely reduced Scx expressing 
tendon progenitor cells indicating defective positioning of induced tendon 
progenitor cells at their functional site in the limbs (Fig. 4.2C, D).  
Furthermore, the control and mutant hindlimbs showed a similar expression of 
Scx transcripts that were present as a small patch of tendon progenitors on the 
dorsal side (Fig 4.3.2E-H). However, there was a small reduction of Scx mRNA 
on the ventral aspects of the hindlimb (Fig 4.3.2E-H, yellow arrows).  
 
Together, our results indicate that the first tendon phenotype is at E12.0 in the 
forelimb of Meox2-/- embryos, and suggests Meox2 is necessary for the normal 
resolution of the initial alignment of tendon progenitors in the limbs. The 
hindlimbs are developmentally delayed by half a day, and this may reflect the 
absence of severe phenotype in the hindlimbs at this stage. 
 
4.3.3 LOSS OF FORELIMB LIMB TENDONS AT E12.5 
 
Having established a failure of tendon cell alignment at E12.5 in the absence of 
Meox2, we asked does the phenotype persist in the forelimb after half a day. To 
answer this, we next examined Scx expression at E12.5, the stage when tendon 
progenitors undergo expansion and reorganisation between the skeletal 
elements i.e. muscle and cartilage (Murchison et al., 2007; Pryce et al., 2009). 
To determine whether Meox2 is involved in these events, whole mount in situ 
hybridisation of Scx was performed in the control and Meox2-/- mutant limbs. 
The results showed a sequential loss of tendon precursors at E12.5 (Fig. 
4.3.3A-C’).  
 
The degree of disruption for Scx expression domains varied in the presumptive 
zeugopod and autopod. For instance, the Scx expression was obvious in the 
autopod segment that gives rise to the distal digit tendons in heterozygous 
controls (Fig 4.3.3A, C, yellow arrowheads). In the mutants, a profound loss of 
Scx mRNA transcripts in the autopod tendon cells was noticeable (Fig 4.3.3B, 




Furthermore, despite the presence of Scx positive cells near the presumptive 
wrist of Meox2-/- forelimbs, overall levels of Scx expression were much reduced 
compared to the control limbs. Moreover, the arrangement of Scx positive 
domains in the zeugopod showed striking differences between the control and 
mutant limbs. The chevron-shaped Scx domain first observed to be completely 
missing at E12.0 was also absent at E12.5 in the absence of Meox2 
(Fig.4.3.3A, B and B’, red arrowheads). There was also an overall reduction of 
Scx expression throughout the zeugopod in the dorsal and ventral aspects of 
the forelimbs (Fig.4.3.3A-D’, yellow arrows).   
 
Collectively, these observations indicate that in Meox2-/- mutants at E12.5 the 
tendon precursors failed to position correctly between the developing muscles 
and cartilage. Moreover, due to the loss of Meox2 derived cues, the alignment, 
and integration of the functional musculoskeletal tendon tissue was defective at 
this stage.  
 
4.3.4 LOSS OF HINDLIMB TENDON PROGENITOR 
CELLS AT E12.5 
 
As hindlimbs are developmentally delayed by half a day with respect to 
forelimbs, and showed no abnormality at E12.0, we decided to analyse the Scx 
expression in the tendon progenitors of the hindlimb at E12.5. In Meox2-/-, we 
found a more dramatic loss in the arrangement of tendon cells within 
presumptive zeugopod displayed on the dorsal and ventral aspects of the 
hindlimb (Fig. 4.3.4A-D, black arrows). There was also a decrease in Scx 
transcripts in the developing autopod of Meox2-/- mutant hindlimbs (Fig. 4.3.4A-
D, black arrowheads).  
 
Hence, the loss of tendon progenitors from the hindlimbs at E12.5 indicated a 
catastrophic outcome of an earlier breakdown during the stages in the 




4.3.5 AXIAL TENDON PROGENITORS ARE DISRUPTED 
IN MEOX2-/- AT E12.5  
 
Our initial analysis of Scx mRNA expression in the trunk could not detect any 
significant changes at E12.0 and thus we analysed any axial tendon phenotype 
begin to emerge at E12.5. For this purpose, we took advantage of the ScxGFP 
transgene to analyse the distribution of tendon precursors in the control and 
mutant embryos (Fig. 4.3.5A, B). Using this tool, we found the GFP reporter 
expression in the dorsoventral regions of two adjacent somites in control 
embryos (Fig. 4.3.5A, white arrow). Additionally, control embryos also showed 
the expression of ScxGFP in the condensing mesenchyme (Fig. 4.3.5A, white 
arrowhead). In contrast, a profound reduction of GFP fluorescence from the 
condensing mesenchyme was evident in the Meox2-/- embryos (Fig. 4.3.5B, 
white arrowhead). There was also a widespread reduction of ScxGFP in the 
syndetome of the mutants (Fig. 4.3.5B, white arrow).  
 
At E12.5, ScxGFP expression is comparable to the endogenous Scx expression 
only for axial tendon cells (Pryce et al., 2007). The reduction of the ScxGFP in 
the proximal sclerotome prompted us to evaluate this region using Scx gene 
expression by whole mount in situ hybridisation (Fig. 4.3.5C-H). In controls, Scx 
mRNA was detected in the vertebral bodies (Fig 4.3.5C, black arrowhead) and 
stripes of transcripts were found in the condensing mesenchyme of the proximal 
ribs that form from the posterior sclerotome (Fig. 4.3.5C, black arrowhead). The 
cartilaginous rib primordia are shown to express Scx and Sox9 at high levels 
and hence are denoted as multipotent cells (Sugimoto et al., 2013a; Sugimoto 
et al., 2013b). The domains of Scx expression were markedly reduced in the 
somites of Meox2-/- embryos (Fig 4.3.5D, F, and H). The most dramatic 
reduction of Scx was seen in the regions of condensing mesenchyme in the 
posterior sclerotome that gives rise to the ribs and (Fig. 4.3.5H, black arrows). 
In addition, the Scx expression was lost in proximal regions of somites of the 




Therefore, a tendon defects were first manifest in axial tissues, similar to that of 
hindlimbs, at E12.5, in contrast to the forelimbs where abnormalities in Scx 
expression were first detected at E12.0.  
 
4.3.6 MODULARITY IN THE TENDON PHENOTYPE DUE 
TO THE MEOX2 MUTATION  
 
The classification of various tendon groups begins to emerge at E13.5. In 
Meox2-/- embryos, the examination of a cross section from autopod using 
ScxGFP transgene showed normal GFP expression and cellular arrangement 
when compared with a wild type section (Fig. 4.3.6A, B). Additionally, the two 
distinct condensed layers that form FDP tendon (Murchison et al., 2007) were 
found normal in Meox2-/- autopod at this stage (Fig. 4.3.6A, B, yellow 
arrowheads). This could explain the residual FDP found in the post-natal 
autopod of Meox2-/- animals (Result section 3.3.1). Moreover, the EDC tendon 
precursors also showed normal ScxGFP fluorescence and the alignment of 
cells on top of the digits (Fig. 4.3.6A, B, white arrows).  
 
Furthermore, our observations of transverse sections from the proximal 
zeugopod segments at E13.5 showed significant differences in contrast to the 
normal ScxGFP expression from the proximal regions. The ScxGFP 
fluorescence from the identified tendons groups at this stage in zeugopod 
showed reduced signal in the mutants suggesting the presence of fewer tendon 
cells in these groups (Fig. 4.3.6C, D). Meox2-/- embryos showed fewer flexor 
digitorum profundus (FDP) tendon cells near the cartilage (T1 in Fig. 4.3.6C, D). 
Conversely, EDC tendon precursors were found normal (T3 in Fig. 4.3.6C, D). 
Additionally, a reduction in the condensation of tendon cell numbers for digiti 
quinti/quarti and pollicis were observed that could explain the abnormality of 
these tendon groups in postnatal mutant mice (T5, T9a and T9b in Fig. 4.3.6).  
 
These results overall demonstrate that the autopod tendon individuation was 
not affected and normal FDP tendon cells anlagen were present at E13.5 even 
in the absence of Meox2. In addition, Meox2 gene regulates some aspects of 
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zeugopod tendon condensation and maintenance. Therefore, we conclude the 
autopod and zeugopod modularity of the tendon phenotype begins to emerge at 
E13.5 in Meox2-/- mutant embryos.  
 
4.3.7 DEFECTS IN TENDON CELL DIFFERENTIATION IN 
MEOX2-/- EMBRYOS  
 
As ScxGFP analysis showed the beginning of modularity in tendon phenotype 
in autopod and zeugopod at E13.5, here we performed whole mount analysis of 
Scx mRNA along the proximal-distal axis of the developing limb. The Scx 
expression from the distal segments of the digit tendon cells was severely 
reduced in both dorsal and ventral sides of the limb in the Meox2-/- embryos 
(Fig. 4.3.7A-D, black arrows). Furthermore, in the hand plate of a heterozygous 
control limbs showed the wider expression of Scx in both dorsal and ventral 
aspects (Fig. 4.3.7A-D). The examination of the wrist region in a homozygous 
limb showed extended and disorganised domains of Scx expressing tendon 
cells (Fig. 4.3.7B, D, red arrowhead).  
 
We conclude that the initial stages of the tendon cell condensation and 
differentiation were perturbed in the absence of Meox2. Thus the defective 
formation of load bearing tendons cells already existed at E13.5 in the Meox2-/- 
and there was an early irregularity of the tendon individualisation in the autopod 
and zeugopod of the Meox2-/- limbs resulting in defective long tendon formation.  
 
4.3.8 LOSS OF SCXGFP EXPRESSION IN SOMITES AT 
E13.5  
 
We evaluated ScxGFP expression in longitudinal sections obtained from the 
trunk of heterozygous controls and homozygous mutant embryos at E13.5 (Fig. 
4.3.8A, B). In the somites of heterozygous control, strong ScxGFP expression 
was present at the junction between adjacent myotomes (Fig 4.3.8A). However, 
a considerable loss of ScxGFP expression from mutant somites was evident 
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(Fig 4.3.8B). Therefore, the failure of axial tendon cell condensation at E13.5 in 
the absence of Meox2 could serve as plausible explanation for the post-natal 
tendon phenotype where all ScxGFP expression was disrupted.  
 
4.3.9 FAILURE OF FORELIMB FLEXOR TENDON 
DIFFERENTIATION IN MEOX2-/- EMBRYO AT E14.5  
 
By E14.5, the majority of the tendons in the limb have achieved their 
developmental maturity except FDS and FDB tendons. Tendon tissues from this 
stage onwards, while preserving their mature arrangement, only undergo 
growth and differentiation. In mouse, tendons that are associated with muscles 
are identifiable at this stage and can be considered as a miniature of the tendon 
of an adult animal. Therefore, we decided to evaluate the limb autopod tendons 
using the ScxGFP transgene to identify tendon cells. Myosin-heavy chain 
antibody was used to detect terminally differentiated muscles on the same 
sections. The deletion of Meox2 led to the disruption of FDP tendons at the 
metacarpal level, which were severely disorganised, in contrast to the controls, 
which showed a tight compact arrangement of ScxGFP+ tendon fibres in the 
FDP (T1 in Fig. 4.3.9A-F).  
 
The failure of the cell condensation process in the presumptive wrist region at 
E13.5 could explain a profound ScxGFP loss at E14.5 (Fig. 4.3.9, white 
arrowhead). Although examination at lower magnification of EDC tendons 
showed slight differences in GFP levels between controls and mutants; higher 
magnification levels revealed the normal cell condensation for this tendon group 
in the autopod and therefore this explains the presence of normal EDC tendon 
morphology in the digits after birth (T3 in Fig. 4.3.9G-H; see chapter 3).      
 
Furthermore, the staining for muscle fibres revealed mispatterend and loosely 
organised interosseous and lumbrical muscles in the palm (Fig. 4.3.9C and D, 
red arrowhead and red arrows). Cartilage formation in the mouse limbs is 
considered complete at E14.5 in all individual digits (Martin, 1990). When 
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analysed in Meox2-/-, the individuation for cartilage formation in each digits was 
found normal at this stage (Fig. 4.3.9A-F).   
 
Therefore, we conclude that there is continuous requirement of Meox2 gene 
during embryonic tendon morphogenesis through to E14.5. The tendon defects 
seen at this stage are the outcome of earlier breakdown of tendon cell 
condensation. 
 
4.3.10 DEFECTIVE ZEUGOPOD TENDON CELL 
DIFFERENTIATION IN MEOX2-/- EMBRYOS 
 
Although rudimentary flexor tendons in the autopod were formed in the mutants 
when analysed using ScxGFP expression, these flexor tendons along with 
extensors in zeugopod were severely reduced in the mutants. Analysis of 
transverse sections through the zeugopod showed strong ScxGFP expression 
in the FDP tendons of the control limb (Fig. 4.3.10A). However, in distal 
sections of mutant zeugopod, ScxGFP expression was completely absent from 
the FDP tendon bundles (T1 in Fig. 4.3.10B). Interestingly, an even more 
striking phenotype was evident in a proximal zeugopod section where 
mispatterning of FDP tendon cells occurred in this segment of Meox2-/- embryos 
(Fig. 4.3.10C, D). 
 
In contrast to the autopod, EDC tendon cells were loosely organised and 
muscle fibres replaced tendon cells, which could potentially explain the similar 
phenotype found at P0 (T3 in Fig. 4.3.10C, D; T3 in Fig. 3.3.6A, A’). At this level 
of section, the loss of other extensor tendons namely, carpi radialis brevis and 
carpi radialis longus was observed in Meox2-/- embryos (T7, T8 in Fig 4.3.10C, 
and D). Furthermore, a severe reduction in the size of extensor carpi ulnaris 
was noticeable that was lost completely at P0 (T6 in Fig 4.3.10C, D). 
Additionally, muscle patterning defects and splitting of muscle cells was also 
observed in the mutant zeugopod. The chondrification of the proximal limb 
elements was normal and resulted in the orderly formation of radius and ulna 




Together, these results demonstrate that Meox2 regulates the tendons of the 
zeugopod segment and coordinates in muscle patterning at E14.5. Additionally, 
the differential outcome of Meox2 mutation in the autopod and zeugopod was 
fully manifested by E14.5 since zeugopod tendons were profoundly affected 
then autopod tendons. It supports the notion of modularity in limb tendon 
development described by Huang et al., 2015.  
 
 
4.3.11 DISRUPTED INTERCOSTAL MUSCLE/TENDON 
UNIT AT E14.5   
 
The defects in the neonatal axial tendons prompted us to examine the 
organisation of trunk tendons at E14.5. The analysis of ScxGFP fluorescence 
from sagittal section of the trunk represented clear differences in the 
heterozygous and homozygous embryos. Consistent with the limb data, trunk 
tendon cells of control embryos showed strong ScxGFP+ cells near the cartilage 
in the ribs and thereby assisting in the joining of the intercostal muscles to the 
ribs (Fig. 4.3.11A). Conversely, ScxGFP expression was completely lost from 
intercostal tendons in a homozygous mutant embryo (Fig. 4.3.11B). This 
observation explains with the loss of GFP+ cells from intercostal tendons in the 
Meox2-/- neonates (see chapter 3). 
 
The intercostal muscles of control embryos appeared as highly organized in a 
meshwork of parallel muscle fibers divided in layers and formed muscle mass 
boundaries in between adjacent cartilages of the trunk (Fig. 4.3.11C, yellow 
arrows). However, in the Meox2-/- embryos, a sharp disruption of these muscles 
were observed (Fig. 4.3.11D, yellow arrows). Strikingly, the internal intercostal 
muscle that connect the two adjacent cartilages in the rib cage was completely 
missing in the mutants, whereas, other intercostal muscles layers showed 
loosely organised muscle fibres (Fig. 4.3.11D). Collectively, these observations 
indicate an exclusive role of Meox2 expression in the development of intercostal 
muscle-tendon units at embryonic stages.  
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4.3.12 LOSS OF SKELETAL MUSCLE PROGENITORS 
REFLECTS THE ZEUGOPOD TENDON DEFECT AT 
E12.5  
 
In previous findings, Meox2-/- embryos show a down regulation Pax3, which is 
expressed in somitic myogenic precursors that eventually populate the limb 
mesenchyme (Mankoo et al., 1999). The Pax3 transcription factor is required for 
the myogenic progenitor cells to migrate into the limb bud mesenchyme 
(Goulding et al., 1994; Williams et al., 1994). Meox2 is expressed by these 
muscle precursors when migrating from somite to limbs between E9.5-E10.5; 
however, it is down regulated soon after entering into limb territory (Mankoo et 
al., 1999). In addition, Meox2 is also known to be upstream of Pax3 in the 
genetic hierarchy and thereby to regulate limb skeletal muscle development 
(Bismuth and Relaix, 2010).  
 
All this led us to investigate whether the limb tendon phenotype could be an 
indirect consequence of the Meox2 activity due to defective migration of muscle 
cells. For this purpose, we utilized a Spd muscle-less embryo that has a 
mutation in the Pax3 gene locus to examine Scx expression at E12.5. 
Consistent with a recent study, we found normal distribution of Scx transcripts in 
the presumptive autopod of both control and mutant forelimbs (Fig. 4.3.12A-D) 
(Huang et al., 2015b). However, in the zeugopod, the tendon progenitor cells 
that differentiate and form a chevron-shaped domains were severely reduced 
(Fig. 4.3.12A,B, yellow arrowhead) This specific tendon phenotype of the 
zeugopod was found to be similar to Meox2-/- forelimbs at E12.5 (Fig. 4.3.8). 
Although in absence of Meox2, this chevron-shaped domain remained invisible 
whereas loss of Pax3 results in remnants of this Scx expressing domain in the 
zeugopod. Once again, our data showed the spatial relationship that exists 
between the diverse musculoskeletal tissues in these early stages. 
Hence, we conclude that Meox2 expressing cells could be acting indirectly via 
developing muscles to regulate the zeugopod tendon development during 
embryonic stages.  
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4.3.13 NORMAL CHONDROGENESIS IN MEOX2-/- AT 
E12.5  
 
A recent study revealed the necessity of cartilage derived cues for autopod 
tendon development (Huang et al., 2015b). The authors showed that in the 
absence of Sox9, the autopod tendon cells were failed to form at E12.5, 
whereas, zeugopod tendon cells were properly aligned at their functional 
positions. Thereby, it was concluded that the cartilage cells are necessary and 
sufficient for autopod tendon induction. Moreover, it has been shown that during 
musculoskeletal development, at E12.5, a subpopulation of tendon progenitor 
cells express Scx and Sox9 in axial and appendicular regions (Sugimoto et al., 
2013a; Sugimoto et al., 2013b). Specifically, in ScxCre-H;Ai14;ScxGFP at 
E12.5, the endogenous Scx and Sox9 expression was located in the 
cartilaginous rib primordia and intervertebral regions (Sugimoto et al., 2013a). 
Further analysis in this genetic model revealed overlapping expression domains 
of Scx and Sox9 also in the limb region.  
 
We found that due to Meox2 mutation, there was complete loss of forelimb 
autopod tendons at E12.5, highly reduced Scx expression from the syndetome 
(Scx+/Sox9-) and diminished Scx regions in the proximal sclerotome 
(Scx+/Sox9+). Therefore, we aimed to evaluate the consequences of Meox2 
alteration on the cartilage cells labelled by Sox9, which could provide better 
explanation of tendon phenotype in Meox2-/- mutant embryos at E12.5. We 
performed Sox9 whole mount in situ hybridisation on Meox2+/- heterozygous 
controls and Meox2-/- homozygous mutant embryos at E12.5. The patterns of 
Sox9 expression were found indistinguishable between control and mutant 
embryos (Fig. 4.3.13A-D). In the limb buds at this stage, the Sox9 transcripts 
were found normal in the cartilage primordia of the digits. Therefore, it seems 
that Meox2 dependent autopod tendon development is independent but parallel 
to the skeletal derived regulation for the tendon cells in this segment of the limb.  
 
Furthermore, in axial regions, we found similar expression pattern in the 
vertebrae, ribs, cranial cartilage and tail tip vertebrae suggesting normal 
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progression of cartilage condensation even in the absence of Meox2. This could 
explain the presence of normal skeleton in the Meox2-/- newborn littermates 
(Mankoo et al., 1999). In conclusion, the data indicate that the process of 
chondrogenesis in the axial and appendicular tissues remained unaffected in 
the Meox2-/- embryos at E12.5 when there was a profound loss of Scx+ tendon 





In this study, we showed that the defects seen in Meox2-/- neonates are 
preceded by a dramatic loss of tendon progenitor cells during embryonic 
stages. In Meox2-/- mutant embryos, Scleraxis expressing tendon cells were 
induced normally at E11.5. However, the proliferative phase of tendon 
precursors was impaired. The earliest limb tendon phenotype was found in the 
forelimb at E12.0, the stage when committed tendon cells initiate to align 
between muscle and cartilage cells and at E12.5 for hindlimb and axial tendon 
tissues. Moreover, we found differential outcome of Meox2 mutation on tendon 
development whereby a profound defect of all zeugopod tendons occurred in 
contrast to the autopod tendons. This observation is in agreement with the 
developmental modularity established for limb tendon morphogenesis. Further 
analysis of Meox2-/- mutant embryos revealed a sustained role of Meox2 in 
alignment and organisation (E12.5), maturation (E13.5), integration, and 
differentiation (E14.5) of tendon progenitor cells to form the musculoskeletal 
system. In somites, disruption of Scx expression occurred both in sclerotome 
(Scx+/Sox9+) and in the syndetome (Scx+/Sox9-). The intercostal muscle-tendon 
unit was severely affected where tendon layer connecting adjacent ribs were 







Meox2 promotes organisation and alignment of tendon 
progenitor cells  
 
Whole mount Scx expression analysis in Meox2-/- embryos indicates that tendon 
precursor cells are induced normally in the limb mesoderm and syndetome, and 
that Meox2 plays an essential role in the maintenance of committed tendon 
precursors after the induction. In the absence of Meox2, a significant loss of Scx 
expression in the forelimbs of Meox2-/- embryos occurred from E12.0 onwards. 
The experimental data in this study using Scx labelled tendon precursors 
strongly indicate that Meox2 is also required for the proper organisation and 
alignment of tendon cells. Interestingly, these tendon defects precede the 
tendon phenotype found in Scx-/- embryos where the tendon disruption was first 
apparent at E13.5 (Murchison et al., 2007).  
 
Moreover, in TGFβ2-/-;TGFβ3-/- and TGFβRII embryos, the first indication of a 
tendon loss was seen at E12.5 and thereby demonstrated an absolute 
necessity of TGFβ signalling for the alignment of tendon primordia between the 
differentiating muscles and cartilage. Our observations suggest a dynamic role 
of Meox2 in tendon genesis, which is upstream of Scx and presumably parallel 
or downstream to TGFβ signalling. Furthermore, TGFβ2 signalling 
encompasses a second wave of tendon cell recruitment at E12.5 (Pryce et al., 
2009). In line with this report, our data provide substantial evidence that 
supports the notion that along with TGFβ signalling, Meox2 could also actively 
participate in maintaining the tenoblastic identity and recruitment of a second 
wave of committed progenitors. This alignment then begins to resolve into the 
tendon-like elements from E13.5 under the influence of Scx gene and the 
appropriate trajectories of all tendon groups found by E14.5. However, it is 
unclear at this point that whether Meox2 and TGFβ signals act in a reciprocal 
fashion whereby Meox2 synergies with TGFβ signals or Meox2 stimulates 
TGFβ signals to produce a similar outcome on tendon development by 





Murchison and colleagues (2007) reported an important role of Scx function 
during tendon development. In Scx-/- mutant embryos the majority of the 
progenitors were lost by E13.5 and the rudimentary tendon cells that were, still 
present exposed their loosely organised mesenchyme identity as opposed to 
tight compaction of tendon cell mass found in control embryos. Meox2 ablation 
led to very similar outcome in forelimb tendon differentiation with severe loss of 
autopod flexor tendon and a significant disruption of zeugopod tendons. The 
defective flexor tendons at metacarpal level show similar phenotype in Meox2-/- 
and Scx-/- embryos at E13.5. However, unlike Scx-/- mutant embryos, the 
extensor tendons in the forelimbs were normal in Meox2-/- mutant embryos. This 
demonstrates a divergent role of Meox2 in the extensor and flexor tendon 
formation. Notably, we found an overall complex phenotype at E13.5 along the 
proximodistal axis of the limb in three ways: first, the significant loss of all 
zeugopod tendons revealed by gross reduction in ScxGFP expression. Second, 
an unaffected autopod EDC tendon cell segment demonstrated by normal 
condensation of ScxGFP+ cells. Third, reduction in the digit FDP tendons 
defined by reduced endogenous Scx in the distal autopod segment.  
 
To gain a better understanding of Meox2 gene function, we also performed 
analysis on the hindlimbs of mutant embryos that are developmentally delayed 
by half a day. The hindlimb shares similar developmental sequences to that of 
the forelimb. The observations in a Meox2-/- mutant hindlimb found a reduction 
in Scx expression emphasising an overall failure of tendon development 
machinery that was visible at E12.5. In favour of limb tendon modularity during 
development (Huang et al., 2015b), our hindlimb data showed an apparent 
reduction in zeugopod than the autopod similar to autopod. This suggests that 
the tendon alignment disruption that was appeared in the forelimb at E12.5 
could be a consequence of an even earlier defect during the transition from 
induction to the alignment stage of tendon progenitors, which is at E12.0.  
Furthermore, the data presented here on axial tissues lends to support the 
hypothesis that Meox2 is necessary for both axial and appendicular tendon 
development, at different anatomical locations. The syndetome is a sub 
compartment of sclerotome in which the Scx-expressing axial tendon 
progenitors are concentrated; in contrast to the appendicular tendon cells that 
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are induced from undifferentiated limb mesenchyme (Brent et al., 2003; 
Schweitzer et al., 2001). The reduction of axial tendon tissue marked by 
endogenous Scx expression and ScxGFP transgene due to Meox2 loss-of-
function from E12.5 onwards provided a conclusive evidence for the substantial 
role of Meox2 in overall tendon genesis. Moreover, a similar phenotype of 
tendon cells in axial musculature was also observed in Scx-/- embryos 
(Murchison et al., 2007). Similar to Meox2-/- embryos, Scx-/- embryos also 
displayed reduction in tendon cells at E13.5. Therefore, we can extrapolate that 
in addition to Scx, Meox2 play a decisive role in axial tendon morphogenesis. 
 
The multipotent progenitors for tendons and cartilage are initially intermixed in 
the somites and limbs (Brent et al., 2005; Sugimoto et al., 2013a; Sugimoto et 
al., 2013b). Interestingly, in somites, a mutual repression of cartilage forming 
sclerotome cells labelled by Sox9 and promoting the tendon-forming Scx cells 
present in the syndetome is due to FGF signalling from adjacent myotome 
(Brent et al., 2005; Brent et al., 2003; Tozer and Duprez, 2005). Further 
evidence has shown an implication of TGFβ signalling during tendon induction, 
which promotes Scx+ cells to differentiate (Pryce et al., 2009). Sugimoto and co-
workers (2013 a,b) more recently showed that the sclerotome is comprised of 
Scx+/Sox9+ cells whereas the syndetome has Scx+/Sox9- cell population.  
 
We found that in Meox2-/- mutant embryos, the severe loss of Scx expression in 
the sclerotome that could be from the loss of Scx+ in Scx+/Sox9+ multipotent 
cells. However, Scx expression was slightly reduced in the syndetome 
suggesting a milder effect of the Meox2 mutation on Scx+/Sox9- cell population. 
Our data of ScxGFP expression in somites demonstrate complete loss of GFP 
signals from the proximal sclerotome that reinforced our observation of 
complete loss of Scx+ only in Scx+/Sox9+ cell population. Normally, Scx 
expression can be found in the anterior and posterior somite borders (Brent et 
al., 2003). Previously, it was shown that Meox2 expression is restricted to 
dermomyotome and sclerotome at stage 16 chick embryos (Reijntjes et al., 
2007) and therefore, it might be possible that Meox2 loss-of function targeted 
the Scx+ cells in the sclerotome. The syndetome expression though present 
was found to be severely reduced. Nevertheless, the extensive loss of Scx 
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transcripts in the somites represented a gross embryonic tendon defect due to 
Meox2 ablation at E12.5. 
 
The residual expression of Scx at E12.5 in Meox2-/- embryos suggests that 
Meox2 is could be directly or indirectly regulating Scx expression and thereby 
commencing the tendon phenotype. The analysis to understand the expression 
domains of Meox2 and Scx during the formation of a mature tendon segments 
in the autopod and zeugopod are investigated in the next chapter.  
 
Meox2 specifies condensation and differentiation of tendon 
cells 
 
By E14.5, the tendons and muscles appear as a miniature of mature 
musculoskeletal system (Pryce et al., 2009). Although some features e.g. FDS 
and FDB tendon units are incomplete and the final development of these 
tissues are achieved by E16.5 (Huang et al., 2013). Our results suggest the 
disorganised tendon cell-condensation and differentiation due to Meox2 
mutation at E14.5 in the forelimbs. This could be a most likely explanation of the 
tendon phenotype in the Meox2-/- mutant new-borns. It emphasizes the 
continuous requirement of Meox2 gene in the later stages of tendon 
development. In the autopod segment, ScxGFP expression showed that despite 
defect in both tendon categories, flexor tendons were more affected than 
extensor tendons. An essential function of Meox2 was also evident for the 
zeugopod tendons since we found a severe reduction of ScxGFP expression in 
all tendon cells. Consequently, we propose that a unique cue from Meox2+ cells 
is necessary alongside the muscle cells for normal zeugopod tendon 
development (Huang et al., 2015b). Additionally, loose fibers of interosseous 
and lumbrical muscles in the palm was evident, highlighting, a pivotal role of 
Meox2 in muscle and tendon development during embryonic stage.  
 
Similar to the limb tendons, we also found defects in the axial tendons at E14.5, 
despite anatomical differences between both tendon categories. In the absence 
of Meox2 derived clues, the intercostal muscle-tendon unit were severely 
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affected. The absence of tendon layer from this unit during embryogenesis 
explains the complete loss in neonates (chapter 3). Intercostal tendons are 
grouped in anchoring tendon tissues that mediate connection between 
associated muscle and ribs. While the Scx loss of function did not affected 
intercostal tendons, all force-transmitting and inter-muscular tendons showed 
phenotype (Murchison et al., 2007). Notably, our findings suggest an identical 
role of Meox2 for the development of all tendon categories. On the other hand, 
it also suggests a significant role of Meox2 in the development of anchoring 
tendons.   
 
It has been shown that intercostal muscles were lost in Myf5-/- embryos at E12.5 
(Tajbakhsh and Buckingham, 1994). While the Myf5-/- mutant embryos show 
delay in hypaxial myogenesis (Braun et al., 1994); still these embryos displayed 
lung hypoplasia due to complete lack of intercostal muscles and rib cage 
(Inanlou and Kablar, 2005a, b). Similar abnormality due to defect of these 
muscles was also found in myogenin null mice (Tseng et al., 2000). 
Interestingly, Meox2 mutation targeted the down regulation of Myf5 (Mankoo et 
al., 1999) and a subsequent study showed that the concerted role of Meox 
transcription factors is necessary to maintain Myf5 and myogenin expression 
(Mankoo et al., 2003). While this study showed non-redundant roles of Meox 
genes in skeletal musculature, the Meox1; Meox2 double homozygous mutant 
foetuses at E16.5 lacked both epaxial (back) and hypaxial (intercostal) muscles. 
Therefore, the disruption of intercostal muscles in Meox2-/- embryo in our report 
indicates an essential requirement of Meox2 gene activity in hypaxial 
myogenesis.      
 
Collectively, these data are an important contribution to the evidence for the role 
of Meox2 in modular limb tendon formation. In general, it emphasizes the 
distinctive role of Meox2 in segmental and complex dense connective tissue 
such as tendons. Furthermore, a transgenic approach would be required to 
generate conditional inactivation of Meox2 gene. Prx1-Cre mediated loss-of-
function (Logan et al., 2002) of Meox2 allele would result in the ubiquitous loss 
of Meox2 protein from limb bud mesenchyme that gives rise to connective 




Furthermore, to evaluate the outcome of defective migration of Meox2+ muscle 
cells on the limb tendon development, mating Meox2 heterozygous animals with 
Splotch animals that has defective Pax3 gene restricting the migration of 
myogenic cells from somites in to the limb territory could be achieved. The 
observations from this approach would be useful to gain a better understanding 
of Meox2 gene function in modular tendon development along the proximodistal 
axis of the limbs.  
 
Orderly cartilage condensation in the absence of Meox2 
 
In the primitive mesenchyme, Sox9 gene labels the cells undergoing cartilage 
condensation (Wright et al., 1995). Due to the shared progenitors for tendons 
and cartilage cells in the limb mesenchyme at E10.5 and subsequently the 
overlapping expression of Sox9 labelled cartilage cells and Scx positive tendon 
cells in the axial and appendicular tissue at E12.5 was reported (Blitz et al., 
2013; Sugimoto et al., 2013a). Previously, it has been shown that the expansion 
of tendon progenitors occured in the absence of cartilage differentiation in Sox5-
/-; Sox6-/- double mutants in sclerotome (Brent et al., 2005). However, a recent 
study from the embryos of Sox9Prx1Cre mutants revealed complete failure of 
autopod tendon formation in the absence of cartilage and authors concluded 
that cartilage is necessary and sufficient for the induction of autopod tendon 
progenitors (Huang et al., 2015b). In our study, we found that Meox2 ablation 
does not affected Sox9 expressing cartilage cells at E12.5, in fact, we found 
normal chondrogenesis throughout the embryonic stages and at neo-natal 
stage (see chapter 3). Despite normal cartilage cells in the autopod of Meox2-/- 
mutant embryos, we found gross tendon defects in the digits and metacarpal 
segment of the limb.  
 
Moreover, Sugimoto and coworkers found that all tendons are derived from 
early precursor cells that are either Scx+/Sox9+ near the joints or Scx+/Sox9- in 
all other regions due to presence of bipotent cells in the limb mesenchyme and 
sclerotome. Using loss-of-function assays, they further showed that the tendon 
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cells closer to the cartilage primordia were originated from Scx+/Sox9+ 
(Sugimoto et al., 2013a; Sugimoto et al., 2013b). The normal Sox9 expression 
in the limbs and axial cartilage tissue of Meox2-/- mutant embryos at E12.5, 
suggest the substantial effects of Meox2 derived clues are restricted to 
Scx+/Sox9- cell population.  
 
Furthermore, in autopod segment of the forelimb, reports have shown that Wnt 
signalling from the ectoderm can induce Scx expression (Yamamoto-Shiraishi 
and Kuroiwa, 2013) and TGFβ signalling secreted from the condensing autopod 
cartilage can also potently induce Scx expression (Pryce et al., 2009). 
Therefore, we could anticipate that these signalling pathways might affect the 
spatial and temporal expression of Meox2+ cells during regulation of autopod 
tendon genesis. However, current study is limited to address this issue, as it 
would require in vitro analysis using mesenchymal cell line and in vivo analysis 
using bead soaked in the recombinant protein solution and implanted in to the 
chick or mouse limb to monitor the effect on Meox2 transcripts. From these 
experiments, we aimed to understand the Meox2 expression in response to 
TGFb and Wnt signalling that can help in elucidating the mechanism behind the 
autopod tendon defects in Meox2-/- mutants.  
 
Together, the tendon and muscle phenotype in our mutant model, demonstrate 
that these defects are not secondary to the skeletal perturbations but represent 
an independent role of Meox2 gene on the tendon cells either intrinsic or 
extrinsic during the tendon morphogenesis. 
 
 
An indirect role of Meox2 in the zeugopod tendon 
development 
 
Various comprehensive studies had identified diversity in the segmental 
development limb tendons along the proximodistal axis (Bonnin et al., 2005; 
Huang et al., 2015b; Kardon, 1998; Swinehart et al., 2013). The data from the 
chick experiments showed that muscle and tendon induce autonomously in the 
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limb (Chevallier et al., 1977). However, for continuous growth and 
differentiation, both tissues are highly dependent on each other. This 
interdependence in the generation of functional musculoskeletal system has 
revealed an increased complexity during the limb tendon development. In 
addition, the distinct and independent developmental cues of the autopod 
tendons from skeletal cells and zeugopod tendons from muscle cells are 
established by Huang and co-worker (2015).  
 
Previous work has shown that in the earliest stages of limb development, 
Meox2 plays an important role in limb myogenesis and positively regulate the 
onset of Pax3 and Myf5 expression. During the subsequent stages, Meox2 is 
necessary to restrict uncontrolled MyoD-dependent terminal muscle 
differentiation at the time of patterning and splitting of muscle masses during 
limb development (Bismuth and Relaix, 2010; Mankoo et al., 1999). 
Furthermore, role of muscles in tendon development was revealed using Spd 
mutants in which Pax3 point mutation resulted in loss of all muscle cells (Huang 
et al., 2015b; Vogan et al., 1993). The tendon progenitors of presumptive 
autopod and zeugopod are induced normally in the absence of muscles but the 
differentiation and maintenance of zeugopod tendon progenitors were lost at 
E13.5 (Bonnin et al., 2005; Huang et al., 2015b; Kardon, 1998).  
 
Our analysis of Scx expression in Spd embryos at E12.5 showed severe 
reduction of chevron-shaped tendon domain in the medial region of the 
presumptive zeugopod that was lost in the Meox2-/- embryos. This indicates a 
secondary defect of Meox2 mutation on Scx+ tendon cells in zeugopod. It could 
provide us to hypothesis an indirect role of Meox2 gene activity from the muscle 
connective tissue on the zeugopod tendon development and muscle patterning. 
Cohort studies have shown a pivotal role of muscle connective tissue on limb 
muscle patterning and tendon formation (Hasson et al., 2010; Kardon et al., 
2003; Mathew et al., 2011; Swinehart et al., 2013). The evidence showed 
ectopic splitting of the dorsal and ventral limb muscle masses in the absence of 
Tbx5 gene from muscle connective tissue (Hasson et al., 2010). The limb 
tendon organisation was also affected due to loss of Tbx5 function in the 
muscle connective tissue. In another report, authors showed that an over 
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expression of Tcf4 gene in muscle connective tissue, resulted in ectopic muscle 
formation (Kardon et al., 2003). There is also demonstration that Hox11 gene 
coordinates in the maintenance and differentiation of zeugopod tendon and 
muscle formation (Swinehart et al., 2013). It therefore follows that the 
retrospective analysis of Meox2 function in zeugopod requires the generation of 
conditional knockout mice by removing the limb specific expression of Meox2 by 
mating with prx1Cre animal (Logan et al., 2002) and thereby examining 




In summary, we found that induction of axial and appendicular tendon 
progenitor cells does not required Meox2 function. Forelimb tendon phenotype 
was first manifested at E12.0, whereas, the hindlimb and axial tendon 
phenotype emerged at E12.5. The limb tendon phenotype was more profound 
in autopod than in zeugopod segments. In our mutant model, the proximal 
sclerotome (Scx+/Sox9+) and the syndetome (Scx+/Sox9-) showed reduction in 
Scx expressing tendon progenitor cells. At E14.5, in Meox2-/- mutant embryos, 
flexor digitorium profundus (FDP) was severely affected whereas extensor 
digitorium communis (EDC) remained normal in the autopod. An overall 
disruption of all tendons including extensors and flexors in zeugopod segment 
occurred. There was a complete loss of intercostal tendon layer and disrupted 
intercostal muscle in Meox2-/- mutant embryos. Lastly, our data indicate the fact 
that Meox2 is crucial for the normal limb muscle patterning and tendon 
formation. In conclusion, the embryonic tendon defect in the Meox2-/- embryos 
has uncovered various previously unexplored role of Meox2 in the tendon 
development. The following chapter investigates the possible mechanism by 
determining whether Meox2 acts intrinsically or extrinsically from tendon during 




Fig 4.3.1 Normal tendon induction in the absence of Meox2 at 
embryonic day (E) 11.5  
Whole-mount in situ analysis for Scx at E11.5 in a wild-type embryo (A and C) 
and in Meox2-/- embryo (B and D). Red arrows represent normal induction of 
Scx positive tendon progenitors in the limb buds. Yellow arrows indicate normal 
Scx transcripts in the interlimb somites. C and D is a higher magnification of 



















Fig.4.3.2 Aberrant Scleraxis expression restricted for only 
forelimb tendon precursor cells at E12.0 
Whole-mount in situ analysis for Scx at E12.0 in a wild-type forelimb dorsal and 
ventral (A and C) and in the Meox2-/- embryo dorsal and ventral forelimb (B and 
D) was performed. Yellow arrowhead indicates a missing chevron-shaped Scx 
expression domain and yellow arrows on the ventral side showed overall 
considerable reduction of Scx levels in the absence of Meox2. In addition, Scx 
whole-mount in situ analysis on the hindlimb dorsal and ventral (E and G) and in 
Meox2-/- embryo dorsal and ventral (F and H) was performed. Yellow arrows in 
ventral side represent reduced Scx expression domain in the presumptive 

























Fig 4.3.3 Disordered organization of tendon progenitors in the 
absence of Meox2 at E12.5  
Whole-mount in situ analysis for Scx at E12.5 in a wild-type forelimb dorsal and 
ventral (A and C) and in the two separate Meox2-/- embryos 1 and 2 dorsal 
forelimbs (B, B’) and ventral forelimbs (D, D’). Red arrows indicate a missing 
chevron-shaped Scx expression domain in the Meox2 mutants. Yellow arrow 
heads indicate considerable reduction of Scx levels in the presumptive autopod; 



















Fig 4.3.4 Depleted Scleraxis levels in the hindlimbs of Meox2-/-  
at E 12.5  
Whole-mount in situ analysis for Scx at E12.5 in a wild-type hindlimb dorsal and 
ventral (A and C) and in Meox2-/- embryo dorsal and ventral (B and D) was 
performed. Black arrows represent reduced Scx expression domain in the 
presumptive zeugopod of hindlimb whereas black arrowhead showed 


















Fig 4.3.5 Disordered axial tendon progenitors in the absence of 
Meox2 at embryonic day (E) 12.5 
 
Analysis of ScxGFP on longitudinal sections of the trunk at E12.5 in a 
heterozygous embryo (A) and in homozygous mutant embryo (B) revealed 
important differences for axial tendon progenitors. White arrowheads represent 
complete loss of ScxGFP expression domains in the proximal sclerotome in the 
mutants; white arrows indicate reduction in GFP expression from syndetome. 
Endogenous Scx expression was observed by whole mount in situ hybridisation 
in a Meox2+/- heterozygous control (C,E and G) and in Meox2-/- homozygous 
mutant embryo (D, F and H). Black arrowheads represent severe loss of Scx 
mRNA expression domains in the somite whereas black arrows indicate 














Fig 4.3.6 ScxGFP expression at E13.5 remained unaffected in 
autopod but reduced in zeugopod of Meox2 mutant mice 
 
The heterozygous and homozygous alleles for Meox2 were maintained on a 
ScxGFP transgenic background. The cross sections of autopod in the 
heterozygous embryo (A) and homozygous embryo (B) were observed for 
ScxGFP expression domains. The GFP signals from extensor and flexor 
tendons were found normal. T1, flexor digitorium profundus indicated by yellow 
arrowheads; T3, extensor digitorium communis tendon progenitors showed by 
white arrows. Additionally, the cross sections of zeugopod in the heterozygous 
(C) and homozygous (D) at E13.5 showed reduction in ScxGFP tendon cells, 


















Fig 4.3.7 Endogenous Scx expression at E13.5 showed 
disrupted expression patterns in both autopod and zeugopod  
Whole-mount in situ analysis was performed using Scx antisense cRNA probe 
on a heterozygous control forelimbs (A and C) and in homozygous Meox2-/- 
mutant embryo (B and D). The dorsal aspect of the limb is shown as A and C 
whereas the ventral aspects is shown in B and D. Red arrowhead indicate an 
expansion of Scx mRNA domain in the Meox2 mutants. Black arrows show 














Fig 4.3.8 Decreased ScxGFP expression in tendon precursors 
of somite at E13.5  
Frontal sections of the trunk from Meox2+/-;ScxGFP (A) and Meox2-/-;ScxGFP 
(B) embryos observed under fluorescence microscope for ScxGFP signal 























Fig 4.3.9 Disruption of autopod tendons at E14.5 in Meox2 
mutant mice 
The heterozygous and homozygous alleles for Meox2 were maintained on a 
ScxGFP transgenic background. The cross sections of autopod in the 
heterozygous embryo (A,C,E and G) and homozygous embryo (B,D,F and H) 
were stained for myosine heavy chain (C and D) red immunofluorescence and 
ScxGFP tendon cells are in green (A and B). Merged image shown in E and F. 
The EDC tendon (T3) was found normal at higher magnification in G and H. 
Tendon nomenclature are tabulated in Table 2. Yellow arrowhead indicates 














Fig 4.3.10  Loss of zeugopod tendons at E14.5 in  Meox2-/-
;ScxGFP 
The heterozygous and homozygous alleles for Meox2 are maintained on a 
ScxGFP transgenic background. The cross sections of zeugopod in the 
heterozygous embryo (A) and homozygous embryo (B) at E14.5 stained for 
muscles using myosin heavy chain antibody and ScxGFP tendon cells are in 
green. White arrow indicates flexor digitorium profundus (FDP) tendon (T1).  


















Fig 4.3.11 Disrupted intercostal muscle-tendon unit at E14.5  
Frontal sections of the trunk from Meox2+/-;ScxGFP (A,C and E) and Meox2-/-
;ScxGFP (B,D and F) embryos stained with myosin heavy chain (MHC;red) 
which detected intercostal muscles to the ribs. ScxGFP signal (green) from the 
intercostal tendons were completely lost (A and B, white arrows) in the mutants. 
Yellow arrowhead represents intercostal muscle in controls (C and E) but 













Fig 4.3.12 Disrupted zeugopod tendon progenitor cells in Spd 
embryos at E12.5  
 
Whole-mount in situ analysis for Scx at E12.5 in a Pax3+/Sp heterozygous 
forelimb dorsal and ventral (A and C) and in the Pax3Sp/Sp homozygous mutant 
embryo (B and D) was performed. Yellow arrowheads indicate a reduced 

















Fig 4.3.13 Normal cartilage development in the absence of 
Meox2 at embryonic day (E) 12.5  
 
Whole-mount in situ analysis for Sox9 at E12.5 in a Meox2+/- heterozygous 
embryo (A,C) and in Meox2-/- homozygous mutant embryo (B,D). The left and 
right sides of the embryos showed normal Sox9 expression in the somites and 
limbs in controls and mutants. The heads were removed in the Meox2-/- 














Cellular and molecular 
mechanisms of Meox2 function 

















5.1 Introduction  
 
Several studies have shown the chain of events ongoing during tendon 
development. Despite this progress, we still lack a fundamental understanding 
of many aspects of tendon development, such as the molecular regulators that 
control all tendon categories in a similar fashion. In previous chapters, we 
showed that in the absence of Meox2, all tendon categories are affected. We 
also show that the tendon defect is embryonic in origin. In addition, the 
expression of the Scx transcription factor is down regulated in Meox2-/- mutant 
embryos. In the previous chapter, we concluded that the first manifestation of 
the embryonic tendon phenotype in the Meox2-/- mutant embryos occurred at 
E12.5 in axial tissue.  
 
Tendon fate commitment and induction (E10.5-11.5), alignment and 
organisation (E12.0-12.5), condensation and aggregation (E13.5) and lastly, 
tendon differentiation, growth and maturation (E14.5 onwards continuing after 
birth) are well-coordinated events. The early specification and induction of 
committed axial tendon progenitors occurs inside the syndetome and are 
dependent on FGF signalling emanated from the adjacent myotome(Brent and 
Tabin, 2004; Edom-Vovard et al., 2002). This extrinsic signal is necessary and 
sufficient to promote Scx expressing tendon precursors thereby expanding them 
in the sclerotome. The tendon precursors are induced at the expense of Sox5/6 
expressing chondrogenic progenitors that also share common origins in the 
sclerotome (Brent et al., 2003). Interestingly, a recent study showed that the 
sclerotome acts as host for multipotent chondrotendo progenitors expressing 
both Scx and Sox9 (Sugimoto et al., 2013). Under the influence of extrinsic 
cues, the relative proportions of Scx+/Sox9+ inside the sclerotome are 
maintained and as the development proceeds, they diverge into a Scx-/Sox9+ 
cell population that is retained inside the sclerotome, whereas Scx+/Sox9- 




Moreover, the TGFβ signalling pathway is also shown to coordinate cartilage 
and tendon differentiation (Lorda-Diez et al., 2009). It favours tendon formation 
by leading to the robust induction of Scx and tenomodulin, a type II 
transmembrane protein (Furumatsu et al., 2010; Lorda-Diez et al., 2009; Pryce 
et al., 2009). In addition, unlike in somites, the initial Scx induction for limb 
tendons is independent of the requirement of myogenic factors and is achieved 
by mutual repression between BMP and FGF signalling. Thus, FGF and TGFβ 
signalling pathways modulate the Scx+/Sox9- cell population at the 
myotendinous junction and repress Sox9+ cartilage cells in the limb. 
Conversely, BMP signalling pathways favour cartilage progenitors and repress 
tendon precursors at the site of skeletal condensations (Edom-Vovard and 
Duprez, 2004; Edom-Vovard et al., 2002; Schweitzer et al., 2001).   
 
TGFβ signalling is crucial for the orderly alignment and organisation of limb 
tendon progenitors to maintain the integrity of the musculoskeletal system at 
E12.5 (Pryce et al., 2009). The same study also showed that the ectopic 
expression of the TGFβ2 protein could induce Scx in both vivo and in vitro 
systems. Moreover, the TGFβ signals are also required for maintaining the 
tenoblastic identity of the committed precursor, thereby restricting them from 
adopting alternative cell fates, such as cartilage formation. Evidence also 
suggests that TGFβ signals recruit a second wave of tendon progenitor cells at 
E12.5 (Pryce et al., 2009).  
 
From E13.5, Scx is required for the tendon progenitor cells to undergo 
condensation and differentiation(Murchison et al., 2007). Additionally, another 
transcription factor, Mohawk (Mkx) is also expressed in tendon cells at E13.5 
(Anderson et al., 2006); yet, it has no functional role at this stage of tendon 
development (Anderson et al., 2006; Ito et al., 2010; Liu et al., 2010).  
 
Our earlier chapters showed that in the Meox2 null mice, almost all diverse 
groups of tendon tissue, i.e. short tendons (intercostal tendons), long tendons 
(limb and tail tendons) and fascia were profoundly affected. The first 
manifestation of the tendon phenotype in the forelimbs occurs at E12.0 and thus 
precedes the tendon defects found in TGFβ2/3 knockouts (E12.5)(Pryce et al., 
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2009), TGFβRII mutants (E12.5)(Pryce et al., 2009), and Scx null mutants 
(E13.5)(Murchison et al., 2007). Conversely, in axial tissues, the failure of 
tendon machinery in the absence of Meox2 was first detectable at E12.5, 
coinciding with the TGFβ2/3 mutant axial tendon phenotype (Pryce et al., 2009).  
Moreover, Scx expression domains were overall reduced in both mutant mice 
models at E12.5. Therefore, with an aim to unravel the molecular mechanisms 
involving Meox2 in tendon genesis, at this point, we hypothesized that Meox2 
and TGFβ signalling pathways act in a complementary manner to modulate Scx 
expression in tendon development. And that Meox2 and TGFβ signals are 
coordinated for the proper alignment, organisation, and recruitment of additional 
tendon progenitor cells during the assembly of the musculoskeletal system.  
 
 
5.2 Aims  
 
First, we aimed to account for the considerable loss of Scx expression in 
Meox2-/- mutant embryos at E12.5. For this, we analysed changes in cell 
proliferation and cell death using anti-Ki-67 and anti-Caspase 3 antibodies. 
Second, we aimed to characterise the expression domains of Meox2 and Scx 
during embryonic stages. This would be the key to understanding whether 
Meox2 acts intrinsically or extrinsically on Scx+ tendon progenitor cells. We 
utilised the ScxGFP transgene to identify tendon cells on cross sections 
obtained from E12.5 (only in axial tissue), E13.5, and 14.5 embryos. We used 
Scx in situ hybridization for the limbs at E12.5. Third, using Meox2-nLacZ tool, 
we observed the derivatives of Meox2 expressing cells in Meox2 heterozygous 
embryos and therefore lineage tracing analysis was performed using salmon-
gal staining to detect β-galactosidase activity at embryonic stages. 
Subsequently, we also performed X-gal staining on Meox2nLacZ/+ heterozygous 
control and Meox2nLacZ/nLacZ homozygous foetuses at E16.5. At this point, we 
also hypothesised that Meox2 and TGFβ signals are coordinated for the proper 
alignment, organisation, and recruitment of additional tendon progenitor cells 
during the assembly of the musculoskeletal system. For this, we investigated 
the interaction between Meox2 and TGFβ2 signalling by analysing endogenous 
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Tgfβ2 expression in Meox2-/- embryos at E12.5 and by in vitro assays, which 
included the evaluation of ectopic expression of TGFβ2 protein on Meox2 




5.3.1 IMPAIRMENT OF CELLULAR PROLIFERATION IN 
MEOX2-/- MUTANT EMBRYOS AT E12.5 
 
Here we tested the hypothesis that failure of cell proliferation could be 
responsible for the reduction in Scx expression in Meox2-/- embryos at E12.5. 
For this purpose, we performed immunostaining for anti-Ki67 (cell proliferation 
marker) on longitudinal trunk sections obtained from Meox2+/-; ScxGFP 
heterozygous and Meox2-/-; ScxGFP homozygous mutant embryos at E12.5 
(Fig. 5.3.1A-D). We were able to detect the active proliferation of cells by bright 
red fluorescence for Ki67 staining (Fig. 5.3.1A and B). Conversely, a severe 
loss of proliferating cells was observed in the absence of Meox2 (Fig. 5.3.1C 
and D). An overall failure of cell proliferation was found evenly throughout the 
section. ScxGFP expression was used to locate the tendon progenitors in the 
syndetome (Fig. 5.3.1B and D). This suggests a necessary role of the Meox2 
transcription factor during cell proliferation of all tissue types that label various 
regions within somites.  
Furthermore, we also evaluated the expression of Meox2 on an equivalent 
longitudinal section by antibody staining of the Meox2+/- embryo heterozygous 
control at E12.5 (Fig. 5.3.1E and F). We found a strong Meox2+ signal in cells 
situated at distinct region away from the syndetome (Fig. 5.3.1E, white arrow).  
 
Taken together, these findings reveal that the failure of cell proliferation indeed 
accounted for the defective tendon genesis and therefore reduced Scx 
expression at E12.5 in Meox2-/- embryos.  
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5.3.2 NORMAL LEVELS OF APOPTOSIS IN MEOX2-/- 
EMBRYOS AT E12.5 
 
We also suspected that the loss of Scx levels in the somites could be due to 
apoptotic cell death. To test the attribution of Meox2 role in this pathway, we 
examined the expression of active caspase3 on longitudinal sections obtained 
from Meox2+/-; ScxGFP heterozygous controls and Meox2-/-; ScxGFP 
homozygous mutant embryos (Fig. 5.3.2). The cells of neural tube progenitors 
showed cell death in a pattern indistinguishable between controls and mutants 
serving as an internal positive control for the experiment (Fig. 5.3.2A and D, 
white arrowheads). Moreover, the expression of caspase3 remained unchanged 
in the somites of Meox2-/- mutant embryos (Fig. 5.3.2B and E, white 
arrowheads). Therefore, these data suggest that Meox2 dependent signals play 
no role in the normal cell death machinery, which is an important cellular event 
during embryonic development of musculoskeletal development. 
 
 
5.3.3 MEOX2 EXPRESSION IN NON-TENOGENIC CELLS 
AT E12.5 
 
The ScxGFP transgenic reporter labels all tendon cells in axial tissue (Pryce et 
al., 2007). To compare the expression domains of Meox2+ cells in detail, we 
performed antibody staining for Meox2 and GFP on frozen sections obtained 
from Meox2+/-;ScxGFP embryos at E12.5. The syndetome exhibited overlapping 
expression patterns for Meox2+ and ScxGFP+ cells when observed under a 
fluorescence microscope (Fig. 5.3A and B, white arrowheads). To investigate if 
Meox2 expression was expressed within tendon progenitor cells, we performed 
confocal analysis. Importantly, we found that ScxGFP+ cells were 
predominantly found in the syndetome (Fig. 5.3B and E, yellow arrows). In 
contrast, the majority of Meox2+ cells were found in the regions of the 
sclerotome (Fig. 5.3A and D, white arrows). However, there were few double 
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positive cells (Meox2+/ScxGFP+) identified at the interface of the two exclusive 
domains (Fig. 5.3C and F, yellow arrowheads).  
 
Therefore, these data indicate that Meox2 is widely expressed in the sclerotome 
that hosts the chondro-tenogenic progenitors (Scx+/Sox9+). It also shows the 
absence of Meox2 expression from ScxGFP+ tendon progenitors at E12.5 in the 
axial tissue.  
 
 
5.3.4 NON-OVERLAPPING EXPRESSION OF MEOX2+ 
AND SCX+ CELLS IN THE LIMB TENDON CELLS AT 
E12.5 
 
Since the ScxGFP reporter only corresponds faithfully to endogenous Scx 
expression for limb progenitors from E13.5 onwards(Pryce et al., 2007), we 
decided to evaluate the expression of Scx and Meox2 at E12.5 limbs by in situ 
hybridisation for Scx combined with immunostaining for Meox2. Due to lack of 
Scx antibody, we used this feasible approach of combination of in situ 
hybridisation and immunofluroscence and thereby demonstrating the 
expression domains of Meox2+ and Scx+ tendon cells. We observed that 
location of Meox2+ cells adjacent to the Scx+ cells and surrounding the cartilage 
primordia (Fig. 5.3.4A, white arrows). Moreover, Scx expression was found in 
dorsal and ventral patches in the mesenchyme of developing limb bud (Fig. 
5.3.4B, white arrows) (Schweitzer et al., 2001). In order to achieve the 
comparison of both cell populations on same section, a false colour image for 
Scx expression was produced using photoshop and merged with the fluorescent 
image of Meox2 antibody staining. Similar to axial tendon cells at E12.5, limb 
tendon progenitors also showed non-overlapping expression domains for Scx+ 




Hence, we can infer that the Meox2 gene is specifically expressed in the 
regions that are closely associated with tendon precursors in the limbs at E12.5 
but never co-expressed with Scx. 
 
5.3.5 EXPRESSION PATTERN OF MEOX2 IN THE 
FORELIMB AT E13.5 
 
The severe loss of autopod tendons and the expanded domain of Scx 
transcripts in the metacarpal region at E13.5 (Fig. 4.3.6 in chapter 4), prompted 
us to examine endogenous Meox2 expression during tendon cell condensation. 
The comparison of Meox2 and Scx transcripts in the digit tendons showed 
partially overlapping expression domains (Fig. 5.3.5A-D, red arrowheads). This 
could be a plausible explanation for the reduced Scx expression in the digit 
tendons of Meox2-/- embryos at E13.5.  
 
Furthermore, Scx labelled tendon cells in the zeugopod showed overlapping 
and non-overlapping expression domains with Meox2 throughout the 
proximodistal axis. Specifically, Meox2 transcripts were detected in the cells 
immediately beneath the ectoderm and overlaid the broader Scx+ domains (Fig. 
5.3.5, A-D, black arrows). Although tendon progenitor cells in the prospective 
metacarpal region were clearly identified as a broad patch of Scx expression, 
this cell group does not express Meox2 transcripts (Fig. 5.3.5, yellow arrows). 
Interestingly, despite the absence of Meox2 expression in the prospective 
metacarpal tendon progenitors, a patterning defect in these tendon cells was 
found in Meox2-/- embryos (see Fig.4.3.6 in chapter 4, red arrowheads).  
 
In summary, the partially overlapping expression patterns of Meox2 and Scx in 
the distal digit tendons could explain the failure in the formation of these 
tendons cells and therefore an intrinsic role of Meox2 in autopod tendon cells. 
On the contrary, wrist tendon cells and zeugopod tendons do not express 




5.3.6 CHARACTERISATION OF MEOX2 EXPRESSION IN 
THE AUTOPOD AT E13.5  
	  
Previously, it was reported that Meox2+ cells showed non-overlapping 
expression patterns with MyoD+ muscle cells in the chick embryos at stage 25 
(Reijntjes et al., 2007). Similarly, in the mouse embryos at E13.5, it was 
observed that the Meox2-nLacZ+ signal could not be detected in muscle cells 
(B. Mankoo, unpublished observation). Therefore, here we investigated the 
expression pattern of Meox2 using antibody staining on forearm autopod cross 
sections at E13.5. The results showed strong antibody staining inside the cells 
surrounding flexor digitorium profundus tendons (Fig. 5.3.6A-D, white arrows). 
Closer examination revealed that Meox2 expression was also observed in the 
regions nearby tendons and cartilage (Fig. 5.3.6C, D white arrowheads). This 
expression is likely to be from the muscle connective tissue that contributes to 
maintain a functional musculoskeletal system.  
 
Collectively, Meox2 is strongly expressed in the cell group located at the 
circumference of the flexor digitorium profundus tendons. These cells could be 
tendon sheath, which are an elastic connective tissue that surrounds tendons. 
Meox2 expression is also in the muscle connective tissue at E13.5.  
 
5.3.7 DISTINCT EXPRESSION PROFILES FOR MEOX2+ 
AND SCXGFP+ IN THE ZEUGOPOD AND STYLOPOD AT 
E13.5  
 
Examination of transverse sections through the zeugopod and stylopod of a 
Meox2+/-; ScxGFP embryo at E13.5 revealed the distribution of Meox2+ cells 
along the proximodistal axis of the limb segment. Using the Meox2 antibody and 
the ScxGFP expression to label tendon cells, we found that Meox2+ cells were 
positioned adjacent to the surface ectoderm and at the circumference of the 
cartilage condensations (Fig. 5.3.7A, D and G, white arrows). ScxGFP 
expression was found strongest in the regions surrounding the radius and ulna 
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in the zeugopod and the humerus in the stylopod (Fig. 5.3.7A, D and G, yellow 
arrows). The exclusive domains of Meox2+ and ScxGFP+ cells were obvious 
and paralleled our observation recorded for both cell populations at E12.5.  
 
Hence, Meox2+ cells exhibit non-overlapping expression territories when 
compared with the ScxGFP+ tendon cells. 
 
5.3.8 MEOX2 IS EXPRESSED IN THE DIGIT TENDONS 
AT E14.5  
 
By E14.5, tendon differentiation and individualisation was clearly observed in 
the forelimb by performing whole mount in situ hybridisation for Scx in a 
Meox2+/- control embryos (Fig. 5.3.8A). The profound loss of ScxGFP 
expression in the mutants led us to investigate the Meox2 expression in the 
forelimb autopod at E14.5. Once again we performed immunostaining using the 
Meox2 antibody on cross section obtained from Meox2+/-;ScxGFP control 
embryos (Fig. 5.3.8B-H). The observation was performed for the digit tendons 
and tendon anlagen at the metacarpal level. In the distal autopod segment, the 
Meox2 protein was strongly confined to the FDP (T1) and EDC (T3) tendon 
bundles (Fig. 5.3.8B-E, white arrows, white arrowheads). Noticeably, a cell 
population near the tendon tissue also expressed Meox2; however, these were 
restricted near the tendon periphery (Fig. 5.3.8B-E, pink arrowheads).  
 
Furthermore, at the metacarpal level, the expression patterns of both genes 
showed striking differences compared to the distal region. A robust expression 
of Meox2 was found in the cell population that was present near the cartilage 
condensation and found in between the cartilage and ScxGFP+ EDC tendon 
cells (T3 in Fig. 5.3.8H, white arrowheads). The FDP tendon was found at the 
wrist region as an expanded ScxGFP+ domain and few Meox2+ cells were 
interspersed in this region (T1 in Fig. 5 5.3.8H, white arrow).  
 
Together, the molecular diversity among the tendon cells was exhibited by the 
distinct expression of Meox2 in the distal and proximal autopod segments.  
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5.3.9 MEOX2 EXPRESSION IN THE ZEUGOPOD AND 
STYLOPOD AT E14.5  
 
We analysed Meox2 expression and tendon cells by the ScxGFP transgene in 
the zeugopod and stylopod at E14.5. On the cross sections obtained from 
Meox2+/-;ScxGFP control embryos, we observed exclusive domains of Meox2 
and ScxGFP expression along the proximodistal axis of the forearm (Fig. 5.3.9). 
We found a close proximity of both cell populations in the zeugopod segment 
(Fig. 5.3.9C and F, white and yellow arrowheads). Conversely, in the stylopod 
both of these cell groups are positioned as two distinct cell population that were 
situated far apart on the section, i.e. ScxGFP+ cells were found adjacent to the 
cartilage whereas Meox2+ cells were located beneath the ectoderm (Fig. 
5.3.9G-I, white and yellow arrowheads).  
 
Collectively, these data demonstrate that in the zeugopod and stylopod, Meox2+ 
cells represent non-ScxGFP tendon cells, however, a close proximity with 
ScxGFP labelled tendon cells only in the zeugopod. It also strongly implies the 
important role of Meox2 in the modular development of tendons in autopod and 
zeugopod. 
 
5.3.10 MEOX2 DERIVED CELLS CONTRIBUTE TO 
TENDONS AND MUSCLE CONNECTIVE TISSUE  
 
To facilitate a temporal-spatial characterisation of Meox2 derived cells during 
key stages of tendon morphogenesis, we utilised mice carrying insertion of a 
LacZ cassette into the Meox2 locus. The Meox2-nLacZ transgene created a null 
allele of Meox2 by nuclear localised expression of lacZ gene under the control 
of Meox2 regulatory elements. Expression of the Meox2-nLacZ transgene 
faithfully outlines Meox2 expression in the progeny cell populations inside axial 
and appendicular tissues throughout developmental stages. As previously 
shown that Meox2 proteins were recruited in the autopod tendons by E14.5, 
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using genetic fate mapping approach we hypothesized an intrinsic role of 
Meox2 in tendon precursors during development.  
 
Therefore, in order to address the mechanisms that account for the tendon 
phenotype in the absence of Meox2, we used Salmon-gal staining for 
visualising β-galactosidase activity in the cells that were expressing Meox2-
nLacZ gene. We obtained transverse sections of the forelimb from Meox2nLacZ/+ 
embryos at two developmental stages i.e. at E13.5, the phase when tendon cell 
condensation is ongoing, and at E15.5, when all mature tendon bundles are 
formed.  
 
Our results show that at both stages, S-gal positive cells were found in EDC 
(T3) and FDP (T1) tendons in the distal autopod sections (Fig. 5.3.10A and E). 
FDS tendon development is considered almost complete by E15.5 and it 
surrounds the FDP tendon tissue in the autopod segment (Watson et al., 2009). 
S-gal staining was also present in FDS tendon cells (T2 in Fig. 5.3.10E, F, G 
and J). Furthermore, we found a broader staining of S-gal positive cells in the 
proximal autopod at both embryonic stages (Fig 5.3.10 B, G and J). This cell 
group must be classified as loose connective tissue cells due to following 
reasons: (i) Meox2-nLacZ cells are never present in muscle cells as revealed by 
non-overlapping expression of LacZ+ cells and MyHC expression at E13.5, and 
(ii) Meox2 derived cells never contribute to cartilage cells of the digits (Fig. 
5.3.10A). 
  
In the proximal zeugopod segment, Meox2-nLacZ labelling was observed in all 
tendon groups and in a broader zone closer to the cartilage condensation that 
appears to be the muscle connective tissue (Fig. 5.3.10C, D, H, and I). Notably, 
S-gal staining was not observed in radius and ulna at both developmental 
stages. This observation is consistent with our line of reasoning that Meox2 
progeny do not contribute to the cartilage. 
 
Taken together, these data confirm that β-galactosidase reporter at the Meox2 
locus labelled both dense (tendon) and loose (muscle connective tissue) 
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connective tissue in the forelimb at E13.5 and E15.5 during embryonic 
development.  
 
5.3.11 DISRUPTED MUSCLE CONNECTIVE TISSUE IN 
MEOX2nLacZ/nLacZ FOETUS AT E16.5  
 
Our data showed that tendons and muscle connective tissue express the 
Meox2-nLacZ. Next, we investigated the impact of a Meox2 mutation on muscle 
connective tissue. Therefore, in Meox2nLacZ/+ heterozygous control and 
Meox2nLacZ/nLacZ homozygous foetus, we investigated expression of β-
galactosidase gene. We obtained forelimb cross-sections at E16.5 and 
performed X-gal staining to perform LacZ staining. Strong blue cells were 
observed in all zeugopod tendons of heterozygous controls (Fig. 5.3.11A, B, 
black arrow). Meox2-nLacZ+ cells were also detected in the cell population 
surrounding stained tendons and unstained cartilage cells, which are grouped 
as muscle connective tissue (Fig. 5.3.11A, B, red arrows). In addition, all the 
cells surrounding the individual muscle groups in the proximal zeugopod were 
stained for strong β-galactosidase activity (Fig. 5.3.11D). Noticeably, X-gal 
staining was never found in muscle fibres (Fig. 5.3.11D, red asterisks). 
Collectively, these analyses served to demonstrate the contribution of Meox2 to 
muscle connective tissue. 
 
Furthermore, examination of the cross sections obtained from Meox2nLacZ/nLacZ 
embryos demonstrated disruption of blue staining in mature tendon bundles in 
the zeugopod (Fig. 5.3.11C and E). It is noteworthy that, despite the absence of 
tendons, the same sections showed lacZ (Meox2) positive cells from the muscle 
connective tissue. However, finding fields of Meox2-nLacZ positive cells in this 
tissue group showed severe abnormality in patterning around the muscles that 
resulted in the fusion of individual loosely organised muscle compartments.  
 
Corroborating our genetic fate mapping data clearly indicated that Meox2 
derived cells are recruited to the individuated tendon cells and muscle 
connective tissue. The absence of lacZ expression from muscle fibres 
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confirmed the down regulation of the Meox2 gene in the myoblasts when they 
have migrated and are positioned as differentiated muscle groups inside the 
limb territory(Mankoo et al., 1999).   
 
5.3.12 INTERLIMB SOMITES DISPLAY ATYPICAL 
EXPRESSION OF TGFβ2 IN MEOX2-/- EMBRYOS AT 
E12.5 
 
TGFβ2 plays a pivotal role in axial tendon development (Pryce et al., 2009). 
Therefore, we examined the effect of Meox2 mutation on TGFβ2 expression by 
whole mount in situ hybridization in Meox2+/- heterozygous controls and Meox2-
/- homozygous mutants at E12.5 (Fig. 5.3.12). The expression pattern was 
similar in most regions of the trunk for both mutants and controls (Fig. 5.3.12A 
and B, yellow arrowheads). Surprisingly, we found an elevated TGFβ2 
expression in interlimb somites that extended towards the distal sclerotome, 
whereas, in controls, it was restricted only in the medial regions of sclerotome 
(Fig. 5.3.12A-F, black arrowheads).  
 
Together, our data here represent an unexpected increase in the level of 
TGFβ2 expression only in somites present at interlimb level in Meox2-/- mutant 
embryos.  
 
5.3.13 INCREASED TGFβ2 EXPRESSION IN THE 
ZEUGOPOD IN MEOX2-/- MUTANTS AT E12.5 
 
Given the critical tendon inducing activity of TGFβ2 signalling in limb tendon 
development, we analysed TGFβ2 expression in the dorsal and ventral aspects 
of Meox2+/- heterozygous controls and Meox2-/- homozygous mutant forelimbs 
and hindlimbs (Fig. 5.3.13). While, the evidence showed a decrease in Scx 
expression in TGFb2-/- mutants (Pryce et al., 2009), the Meox2-/- mutants 
showed similar down regulation of Scx domains at E12.5. We predicted this 
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down regulation of Scx could be accompanied by decrease in TGFb2 
expression. Surprisingly, we found an increase in the TGFβ2 within the 
zeugopod in Meox2-/- mutant embryos. Importantly, there was a wider 
expression domain towards the proximal axis of the forelimb segment on dorsal 
and ventral aspects (Fig. 5.3.13A-D, red arrowheads). Conversely, we observed 
similar expression patterns in forelimb autopod segments of control and mutant 
(Fig. 5.3.13A-D, yellow arrows).  
 
Furthermore, in hindlimbs, we found a similar phenotype with the broader 
expression pattern of TGFβ2 in the prospective zeugopod (Fig. 5.3.13E-H, red 
arrows). However, no evident differences were observed in the autopod of 
hindlimb (Fig. 5.3.13E-H, yellow arrows). In summary, absence of Meox2 
results in an increase in levels and domains of TGFβ2 expression in zeugopod 
segments of the forelimb and hindlimb. This observation does not support our 
proposed model of Meox2 coordinates with TGFβ signalling that up regulates 
Scx expression in target cells.  
 
5.3.14 MEOX2 EXHIBITS VARIABLE LEVELS IN 
RESPONSE TO TGFβ2 SIGNALLING  
 
After our investigation of TGFb2 up regulation in the absence of Meox2, at this 
point, we proposed an alternative model that TGFb signalling acts upstream on 
both Scx and Meox2. Therefore, we decided to use an in vitro assay to 
investigate if Meox2 is regulated by TGFb signalling as previously described for 
Scx in C3H10T1/2 cell line by Pryce et al., (2009). We stimulated these cells by 
adding recombinant TGFβ2 protein and performed semi-quantitative PCR 
analysis of Scx and Meox2 mRNA at various time points up to 24 hours (Fig. 
5.3.14). TGFβ2 protein induced robust expression of Scx at 8 hours (Fig. 
5.3.14A) (Pryce et al., 2009). We found that Meox2 levels were initially down 
regulated after addition of TGFβ2 protein; however, the level sharply increased 
at 24 hours (Fig. 5.3.14B). We found repeatedly this biphasic response of 
Meox2 in response to TGFβ2 protein.  
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5.4 Discussion  
 
Our evidence indicates that the Meox2 protein is not expressed by Scx+ tendon 
progenitors at E12.5-13.5 and E14.5 in the zeugopod of the forearm. However, 
Meox2+ cells are present in forelimb autopod tendons at E14.5 revealing a 
pivotal function of Meox2 in modular limb tendon development. The aim of our 
study was to identify whether Meox2 acts extrinsically or intrinsically in tendon 
progenitor cells during embryonic tendon development. We employed the co-
expression analysis for Meox2 and ScxGFP at E12.5, the stage when profound 
loss of Scx transcripts is evident. For this purpose, first we optimised the IHC 
protocol using the Meox2 antibody as described in methods section. Moreover, 
using a lineage-tracing method, an integrative description for Meox2 
contribution during tendon formation and muscle connective tissue is described. 
Interestingly, in the absence of Meox2, severe loss of cell proliferation resulted, 
which could account for the reduction in the number of cells being recruited to 
express Scx. 
 
Various signalling molecules have been demonstrated to influence tendon cell 
commitment, organisation, and differentiation at all stages of tendon 
development (Brent et al., 2004; Edom-Vovard et al., 2002; Pryce et al., 2009; 
Lords-Diez et al., 2009; Mendias et al., 2008; Clark et al., 2001; Eloy-Trinquet et 
al., 2009). Using Scx as a marker for tendon cells, in Tgfβ2-/-; Tgfβ3-/- double 
knock out mouse embryos, a complete loss of all tendons was reported. In 
addition, Tgfβ2-/- mutant embryos exhibit severe disruption in tendon progenitor 
cells at E12.5 but no change of Scx expression observed in Tgfβ3-/- mutant 
embryos (Pryce et al., 2009). However, deletion of TGFβRII, which is single 
type II receptor utilised by all the members TGFβ superfamily, affected overall 
tendon development suggesting a wider role of the signalling pathway in tendon 
morphogenesis.  
 
Likewise, Meox2-/- mutant embryos also show first manifestation of axial tendon 
phenotype at E12.5 whereas limb phenotype was apparent at E12.0 (see 
chapter 4). All these facts point to the existence of a reciprocal interaction 
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between Meox2 and TGFβ2 signals in regulating Scx expression and thereby 
suggest their significant contributions in maintaining tendon architecture. For 
this study, we employed analysis of two experimental approaches: (i) TGFβ2 
expression in Meox2-/- mutant embryos (ii) response of Meox2 by over 
expressing TGFβ2 proteins under in vitro conditions.  
 
Characterization of Meox2 expression during tendon 
development  
 
Given the satisfactory results of Meox2 expression in limb buds during 
optimization protocols, we next characterised the expression of Meox2 from 
E12.5-14.5 that are the key developmental phases to form load bearing 
functional tendons. We then compared these expression patterns with ScxGFP 
fluorescence to identify tendon progenitor cells. Thereby, we proposed two 
alternative hypotheses: (i) Meox2 is co-expressed in ScxGFP+ cells and thereby 
causing an intrinsic defect in tendon cells at E12.5 in the knockouts. (ii) 
Alternatively, Meox2 is never co-expressed with ScxGFP+ tendon cells and is 
part of extrinsic cues necessary for normal tendon morphogenesis. Therefore, 
we used confocal analysis to identify co-expression of both genes in the tendon 
cells at E12.5. Our analysis in the syndetome demonstrated that the majority of 
the Meox2+ cells are located in the sclerotome and very few cells show co-
expression with ScxGFP+ cells in syndetome.  
 
Furthermore, the study that generated the ScxGFP reporter mouse has shown 
an expanded GFP expression in the early limbs bud (E10.5-12.5) (Pryce et al., 
2009). Therefore, for our limb tendon analysis at this stage, we combined Scx in 
situ hybridization with Meox2 antibody staining on limb cross sections. The non-
overlapping domains for both genes are evident (Fig. 5.3.2). However, we 
speculate that our observations for double positive cells from this method could 
be challenging. This is because the dense colour precipitates from the whole 
mount in situ hybridisation protocol in a cell could potentially mask the GFP 
signals that are localised in the cytoplasm. To ascertain our current observation 
for limbs at E12.5, in future we will perform double whole mount in situ 
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hybridization for both genes using fluorescent probe to compare the expression 
domains using a confocal microscope. Alternatively, the limb tissue specimens 
can be doubly labelled with Scx and Meox2 antibodies, which will provide a 
robust conclusion for the limbs. Due to the lack of a Scx antibody, the later 
approach is not possible at present.  
 
In order to gain a better understanding of Meox2 expression during further 
developmental stages of the tendons, we compared whole mount in situ 
hybridizations for Meox2 and Scx in forelimbs of Meox2+/- control embryos at 
E13.5. The analysis of these results suggests a distinct role of Meox2 in 
modularity during tendon development. Both transcription factors showed 
partially overlapping expression domains in the distal autopod tendon cells, 
which suggest an intrinsic requirement of Meox2 by digit tendon precursors. 
Likewise, the subectodermal mesenchyme region showed overlapping 
expression patterns in the presumptive zeugopod segment.  
 
Although overlapping within the proximal limb, Scx mRNA was expressed in a 
considerable wider region than Meox2. Additionally, the Scx+ wrist tendon 
progenitors never expressed Meox2 (Fig. 5.3.3, yellow arrows). These wrist 
tendon cells connect the autopod tendons to their corresponding muscle 
counterparts in the proximal limb region (Huang et al., 2015b). Similar to 
autopod tendon precursors, the induction of wrist tendon cells is independent of 
the cues from the muscle cells, however, the maintenance and elongation 
towards the proximal zeugopod is dependent on the signals derived from 
muscle cells (Huang et al., 2015b; Huang et al., 2013). Despite the absence of 
Meox2 in this unique tendon population, we found severe irregularity in the 
organisation of wrist tendon anlagen in Meox2-/- mutant embryos at E13.5 (see 
Fig. 4.3.6, red arrowheads). This suggests an extrinsic role of Meox2 in tendon 
development whereby Meox2+ non-tenogenic cells are essential for continuous 
maintenance of the wrist tendon cells.   
 
The presence of Meox2+ in non-tenogenic cells is apparent throughout the 
proximodistal axis that includes zeugopod and stylopod of the developing limb 
at E13.5 (Fig. 5.3.4 and 5.3.5). Whilst the specific identity of these Meox2+ cells 
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was not determined at this point, the fact they are present at the circumference 
of condensed tendons e.g. in the digits and nearby periphery of tendons 
suggest that they could be muscle connective tissue cells. Moreover, in the 
zeugopod and stylopod, cells that populate the regions adjacent to the surface 
ectoderm express Meox2 whereas tendon cells (ScxGFP+) are present near the 
cartilage condensations. This analysis once again exposed an inevitable 
involvement of Meox2 in modular limb tendon development due to its distinct 
expression patterns in autopod, zeugopod and stylopod.  
 
By E14.5, the majority of the Meox2+ cells are integrated into the autopod 
tendon cells in the distal digit segment (Fig. 5.3.6). Conversely, the tendon cells 
at the metacarpal level do not express Meox2 and this expression pattern 
persisted in the zeugopod and stylopod regions even at this stage (Fig. 5.3.7).  
 
Altogether, on one hand, Meox2 plays an intrinsic role for the digit tendon 
development. On the other hand, for normal wrist tendons and zeugopod 
tendons, Meox2 provides extrinsic cues for their maintenance and growth. 
Similar differential regulations of tendon development is also observed in 
various mouse models. For instance, Sox5 and Sox6 transcription factors are 
shown to be essential for autopod tendon development only. In Sox5-/-;Sox6-/- 
double mutant embryos at E12.5, due to a failure in cartilage formation, all 
autopod tendons are lost, on the contrary, zeugopod tendons remained 
unaffected (Huang et al., 2015b). This study has shown for the first time a 
positive cooperative action of cartilage on normal autopod tendon induction. 
The authors concluded that cartilage is not only necessary but also sufficient for 
the autopod tendon formation. In the same line of reasoning, it would be worth 
identifying the mechanisms by which Meox2 coordinates with Sox5 and Sox6 
genes for normal digit tendon formation and therefore could be the topic of 




 The Meox2+ cell lineage contributes to normal tendon 
development and muscle connective tissue 
 
The proper insight into the consequences of Meox2 loss-of-function on muscle-
tendon interactions and muscle connective tissue was revealed by inserting the 
LacZ gene into the Meox2 locus (see methods section). The analysis of Meox2-
nLacZ at embryonic stages revealed that the lacZ+ (Meox2+) cells contribute to 
the establishment of tendons and muscle connective tissue at E13.5 (Fig. 
5.3.8). In general, the connective tissue can be defined as cells rich in 
proteoglycan and collagen fibers. Categorically using this definition, they can be 
divided into two subgroups: (i) dense fibrous connective tissues i.e. tendons and 
ligaments, which aid in joining muscle to the bone and bone to bone, 
respectively, (ii) loose fibrous connective tissue i.e. muscle connective tissue 
and fascia which encompass muscle fibers and individual muscle groups (Gray 
et al., 2005).  
 
Several studies have shown that the limb mesenchyme contains pools of 
multipotent progenitor cells that give rise to both categories of connective 
tissues and are present adjacent to the muscle and cartilage progenitors 
(Kardon, 1998; Oliver et al., 1995; Suzuki and Kuroiwa, 2002). These lateral 
plate mesoderm derived connective tissue are shown to regulate various 
aspects of limb muscle development and patterning (Chevallier and Kieny, 
1982) (Chevallier and Kieny, 1982; Grim and Wachtler, 1991; Hasson et al., 
2010; Kardon et al., 2003; Mathew et al., 2011; Swinehart et al., 2013). 
 
Furthermore, muscle connective tissue actively coordinates muscle-tendon 
interactions during embryonic morphogenesis (Hasson et al., 2010; Kardon et 
al., 2003; Swinehart et al., 2013). All tendons and ligaments express Scx that is 
widely acknowledged as a faithful marker for distinguishing events in dense 
connective tissue (Schweitzer et al., 2001). Likewise, the Tcf4 transcription 
factor, a member of the Tcf/Lef family was identified as a marker for muscle 
connective tissue (Kardon et al., 2003). A critical role for the muscle connective 
tissue during myogenesis was demonstrated using TCF4, which is a 
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downstream regulator of the canonical Wnt-β-catenin pathway (Mathew et al., 
2011). The TCF4-dependent signal from the MCT was shown to regulate the 
muscle fibre differentiation from embryonic to fetal myofibers. In another study, 
Hasson et al. (2010) reported the forelimb muscle patterning defects including 
muscle splitting in the absence of Tbx5 gene. They further reported that Tbx5 is 
expressed in the muscle connective tissue and regulates muscle development 
in a cell non-autonomous manner.  
 
Our lineage tracing data suggest that Meox2 is expressed by both categories of 
connective tissues. In the autopod segment, all prominent tendon groups e.g. 
FDP, FDS and EDC tendons show strong staining for Meox2-nLacZ at 
embryonic stages beginning from E13.5. Moreover, β-galactosidase activity is 
widely detected in the proximal tendon cells of the zeugopod. Therefore, in 
dense connective tissue i.e. tendons, Meox2 seems to play an essential role in 
the specification of the committed tendon progenitors cells. Interestingly, the 
close proximity of Meox2+ cells near the autopod tendons at E13.5 (Figure 
5.3.4) and the strong Meox2-nLacZ+ (Figure 5.3.8) in these tendon groups 
strongly suggests that Meox2 expressing cells are later on recruited for autopod 
tendon formation. Indeed, by E14.5, Meox2+ cells are detected in digit tendons 
(Figure 5.3.6).  
 
Additionally, we demonstrated that the differentiated cartilage cell population 
are not a derivative of the Meox2 progeny. Despite sharing common origins with 
tendon progenitor cells in limb mesenchyme, chondrocytes never show β-
galactosidase activity at any embryonic stages and hence specify the role of 
Meox2 as restricted to tendons and muscle connective tissue only.   
 
By E15.5, defined regions of Meox2-nLacZ expression corresponded to the 
FDS tendon cup formed around FDP tendon cells. In this scenario, Meox2 
performs an intrinsic role in tendon genesis whereby it is involved in 
commitment and specification of tendon progenitor cells. In addition, the loss of 
this early Meox2 dependent tendon precursor specification caused both 
embryonic and post-natal tendon defects (see chapter 3 and 4). On the 
contrary, continuous expression of Meox2 is required for the proper 
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establishment and functioning of muscle connective tissue. Hence, an 
indispensable requirement of Meox2 in muscle connective tissue during muscle 
patterning and tendon formation in the limbs are concluded.  
 
The possibility of Meox2 playing a central in tendon cell morphogenesis was 
further established by carrying out analysis in Meox2nLacZ/+ heterozygous 
controls and a Meox2nLacZ/nLacZ homozygous mutant fetus at E16.5 that provided 
two key informations. First, all tendon groups show strong β-galactosidase 
activity. The majority of tendons were lost in Meox2nLacZ/nLacZ  embryos, the 
stage when morphogenesis of all tendon groups are achieved and the muscle-
tendon units are well-established. Some tendon tissue that was present showed 
reduction in tissue mass and fusion of tendon bundles (Fig. 5.3.9).  
 
Second, the loose connective tissue (fascia and muscle connective tissue) was 
present despite the insertion of the LacZ gene at both allelic loci disrupting 
Meox2 gene function. However, severe patterning defects of this tissue are 
evident in the mutants. Strikingly, the Meox2 mutation in the muscle connective 
tissue caused intermixing and disruption of individual muscle compartments. 
Evidently, it demonstrates an important intrinsic function of Meox2 from muscle 
connective tissue to regulate muscle patterning and organisation.  
 
Altogether, our data provide strong evidence that the muscle phenotype in 
Meox2 mutants is due an abnormality in the muscle connective tissue (see 
chapter 3 and (Mankoo et al., 1999). It also indicates both intrinsic and extrinsic 
actions of Meox2 during tendon development and muscle connective tissue 




Meox2 is essential for normal cellular proliferation but 
not cell death during tendon morphogenesis  
 
The down regulation of ScxGFP+ tendon cells at E12.0 suggests that the Meox2 
gene act as an even earlier regulatory factor to dictate tendon cell commitment 
compared to TGFβ signalling and the Scx transcription factor. Once specified, 
these cells no longer need Meox2 in zeugopod tendons but exhibit a continuous 
wave of recruitment in autopod tendon formation. During development of a 
tissue, it is worth considering cell proliferation and cell death that occur in 
synchronisation to achieve a final functional form of that tissue. Therefore, this 
fact along with our data on the failure of muscle connective tissue organisation 
and tendon progenitor specification led us to perform analysis for both important 
cellular events in Meox2-/- mutant embryos. We concluded severe loss of 
cellular proliferation at E12.5, which occurred due to loss of Meox2 function. 
 
This strongly implies that Meox2 regulates tendon genesis by promoting cell 
proliferation and thereby assists in additional recruitment of tendon progenitor 
cells at the site of condensation. However, there was an overall reduction in cell 
proliferation among all cell types across the entire compartment in somites 
suggesting a significant role of Meox2 in cell cycle progression during 
embryogenesis. Nonetheless, functional roles of Meox2 in promoting cell cycle 
events need a rigorous examination during embryonic development. 
 
Moreover, in the absence of Meox2, reduction in ScxGFP+ cells in somites is 
not due to activation of the cell death machinery at E12.5 (see Fig. 4.3.11 and 
5.3.11). We found no change in apoptotic pathways in the mutants at this 
embryonic stage. Taken together, one of the aspects by which Meox2 is 
required for tendon development is through regulating mitotic proteins in the cell 
cycle of tendon cell proliferation. It also implies that early Meox2 expression 
represents a commitment to tendon lineage at E12.5 by regulating only cell 




Increase of TGFβ2 in interlimb somites in Meox2-/- 
embryos at E12.5  
 
To gain insight into the cooperative molecular functions of Meox2 and TGFβ2 
signals, it was important for us to demonstrate that both molecules are 
regulating Scx expression in a complementary manner. Therefore, to begin 
with, we sought to validate the expression patterns of TGFβ2 in the absence of 
Meox2 at E12.5. Surprisingly, our results demonstrated an increase in TGFβ2 
levels in the interlimb somites of Meox2-/- mutant embryos. TGFβ2 expression 
pattern were similar in cervical (contribute towards tongue, neck and shoulder 
muscles) and lumbar (opposite the hindlimbs) somites.  
 
Various studies have shown that along the rostrocaudal body axis, somites at 
each levels exhibit some variation in morphological characteristics (Franz et al., 
1993; Smith et al., 1994; Tajbakhsh et al., 1996). Interlimb somites differ from 
the somites located opposite to the limbs that express Pax3, c-met, Meox2 and 
Lbx1 and thereby leave the lateral dermomyotome and migrate into the 
developing limb bud (Bober et al., 1991; Mankoo et al., 1999). As a result, the 
lateral dermomyotome of somites at the limb level is reduced compare to the 
somites present at the interlimb levels. The migratory behaviour of somite cells 
opposite to the limb was accompanied by apoptosis in the lateral 
dermomyotome during later developmental stages of forelimb level somites 
(Tosney, 1994). From these evidence, we can attempt to interpret the 
differences found in TGFβ2 expression only in interlimb somites of Meox2-/- 
mutant embryos. 
 
However, this contradicts our initial hypothesis, as our assumptions were that at 
E12.5, the expression pattern of TGFβ2 in Meox2-/- embryos and Meox2 in 
TGFβ2-/- mutant embryos would be normal in somites and limbs. Thereby, we 
predicted a concerted action of Meox2 and TGFβ2 in providing means of 
guiding the developing tendons from the site of induction to their appropriate 
insertions. Furthermore, evidence suggests a complex interaction between 
Meox2 and TGFβ signals in epithelial cell biology (Valcourt et al., 2007). Tgfβ1 
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derived signals synergised with ectopic Meox2 to arrest proliferation of epithelial 
cells and, conversely, Meox2 partially caused blockage of TGFβ-1 derived 
epithelial-to-mesenchymal transition (EMT) in cultured keratinocytes (Valcourt 
et al., 2007). Therefore, our results should be considered novel in the course of 
development, but are unexpected.   
 
Moreover, during development, TGFβ2 expression is localised in the medial 
domains of the sclerotome that act as primitive sites of cartilage condensation 
(Pryce et al., 2009). It was shown that this compartment contains a multipotent 
cell population that expresses both Scx and Sox9 (Sugimoto et al., 2013). 
Conversely, TGFβ2 expression was never located in the syndetome, which 
hosts only Scx+/Sox9- tendon precursors (Pryce et al., 2009; Sugimoto et al., 
2013a; Sugimoto et al., 2013b). Moreover, TGFβ2 levels are upregulated in the 
presumptive zeugopod and stylopod of Meox2-/- mutant limbs at E12.5 (Fig. 
5.3.12). On the contrary, the Meox2 mutation does not affect TGFβ2 expression 
in the autopod segment. Finally, unlike in epithelial cells, we could not detect 
any down regulation of TGFβ2 in the absence of Meox2.  
 
Previously, Pryce and co-worker (2009) indicated that the prechondrogenic 
mesenchymal condensation along the proximodistal axis of the limb bud shows 
robust expression of TGFβ2. In the same work, the authors described a partial 
but not complete overlap of TGFβ2 with differentiating muscles and tendon 
progenitor cells in the limbs. Evidence suggests that the distal tendon progenitor 
cells of the limb never express TGFβ2 at E12.5. In the same way, we found 
non-overlapping expression of Meox2 and Scx in the dorsal and ventral 
domains of the limb. Collectively, we can deduce two possible ways of 
interaction between Meox2 and TGFβ2 during embryonic development: (i) in a 
growing limb bud, Meox2+ muscle connective tissue and TGFβ2+ cartilage cells 
work in conjunction to guide the Scx+ tendon precursors for their organisation 
and proper insertions to establish a functional musculoskeletal system (Pryce et 
al., 2009). (ii) During proximodistal differentiation of limb bud and in somites, 
Meox2+ cells in turn also restrict TGFβ2+ cells to achieve an integrated 
musculoskeletal system by limiting TGFβ2+ domains. 
183	  
	  
In the same line of reasoning, we could propose the involvement of Meox2 
along with TGFβ2 for the active recruitment of a second stream of induced 
tendon progenitor cells. This is because all tendon groups and muscle 
connective tissue at later embryonic tendon development stages are derived 
from the Meox2 progeny (see Fig. 5.3.8 and 5.3.9). Nonetheless, in future it 
would be useful to analyse Meox2 expression in TGFβ2-/- mutant embryos at 
E12.5. This will help us to conclude if Meox2 functions upstream of TGFβ2 for 
regulating Scx expression during tendon development.  
 
Transient expression of Meox2 in response to TGFβ 
signalling  
 
In this study, effect TGFβ signalling on Meox2 expression was evaluated using 
C3H10T1/2 fibroblast cells. We found ambiguous patterns of Meox2 expression 
at various time points of the experiment. Initially, upon stimulation of cultured 
cells, Meox2 levels were downregulated until 8 hour after which its expression 
was elevated. We found this behaviour analogous to observations performed in 
cultured epithelial cells (Valcourt et al., 2007). The authors described that the 
cytostatic response of TGFβ1 caused an initial suppression of Meox2 
expression but at later time points, a sharp elevation of Meox2 levels occurred. 
Furthermore, the functional experiments in keratinocytes suggested Meox2 
forms a complex with Smad proteins and thereby acts as a downstream effector 
of TGFβ1 induced cell growth arrest.  
 
Collectively, evidence so far suggest a biphasic interaction between Meox2 and 
TGFβ signals, however, our next step will be to analyse the expression pattern 
of known downstream effectors of the TGFβ pathway in Meox2-/- mutant 
embryos e.g. Smad proteins. Thereby, for future studies, we hypothesised that 
Meox2 is involved in restricting TGFβ signalling pathways and thereby promotes 





5.5 Conclusions  
 
In summary, Meox2 plays an intrinsic role for the distal autopod tendon 
development, whereas, it exhibits a key extrinsic role for the zeugopod tendons. 
Meox2 is also necessary for normal cell proliferation. Additionally, using lineage 
tracing, we concluded that Meox2 derived cells are incorporated in both tendons 
and muscle connective tissue. Moreover, our data here represent an 
unexpected increase in the level of TGFβ2 expression only in the somites 
present at interlimb level in Meox2-/- mutant embryos. Also, an increase in levels 
and domains of TGFβ2 expression in zeugopod segments of the forelimb and 
hindlimb. There is a biphasic interaction between TGFβ2 and Meox2 under in 





Fig 5.3.1 Failure of cell proliferation in Meox2-/- embryos at 
E12.5   
Sagittal sections were obtained from trunk of a Meox2+/-;ScxGFP (A and C); 
Meox2-/-;ScxGFP (B and D) and Meox2+/- (E and F) at E12.5. (A-D) 
Immunostaining was performed to identify actively proliferating cells by Ki67 
antibody. ScxGFP fluorescence marked tendon progenitor cells in the 
syndetome. The profound loss of proliferating cells occurred due to Meox2 
mutation. (E and F) An equivalent sagittal section from Meox2+/- embryo was 
stained using Meox2 antibody. White arrows indicate the Meox2+ expression 
























Fig 5.3.2 Normal apoptosis in Meox2-/- embryos at E12.5   
Sagittal sections were obtained from trunk of a Meox2+/-;ScxGFP (A, B and C); 
Meox2-/-;ScxGFP (D, E and F) at E12.5. Immunostaining was performed for 
activated caspase 3 by antibody as marker for apoptotic cell death. ScxGFP 
fluorescence marked tendon progenitor cells in the syndetome. (A and D) high 
level of apoptosis is observed near neural tube in control and mutant embryos. 
(B and E) Expression of Caspase 3 staining is found normal in the somite of 
heterozygous controls and homozygous mutants. (C and F) The caspase 3 
staining is merged with ScxGFP expression to detect tendon cells. White 
arrowheads indicate the expression of Caspase 3 from the cells undergoing 



















Fig 5.3.3 Majority of Meox2+ cells are distributed in the 
sclerotome 
Longitudinally sections from a Meox2+/-;ScxGFP embryo at E12.5 was obtained 
(A-I). Immunostaining was performed using specific antibodies for Meox2 and 
GFP while nuclei were stained with DAPI. (A-C) show overlapping expression 
domains of Meox2+ and ScxGFP+ under fluorescence microscope. The boxes I 
and II in C show the two regions of the section analysed under confocal 
microscope. (D-I) show the higher magnification of the same section observed 
in confocal microscope. ScxGFP+ cells mark syndetome region in the somite. 
Meox2+ cells were mostly located in the sclerotome. White arrowheads in A-C 
indicate overlapping Meox2+  and GFP+ cells; white arrows in D,F and G 
indicate Meox2+ cells; yellow arrows in E,F and H show ScxGFP+ cells; yellow 
arrowheads show few Meox2+;ScxGFP+ double positive cells. NT, neural tube; 



















Fig 5.3.4 Meox2+ is not expressed in Scx+ domains in the limbs 
at E12.5   
The transverse section of limbs from an E12.5 Meox2+/- embryo was obtained 
(A-C). In situ hybridisation for Scx was performed to identify tendon progenitor 
cells in the limb (B) and immunofluorescence for Meox2 using an antibody was 
performed (A). The non-overlapping expression domains of Meox2 and Scx 
were evident on merged image (C). White arrowhead indicates Meox2+ cells 
surrounding cartilage primordia; white arrows indicate dorsal and ventral 










Fig 5.3.5 Expression analysis of Meox2 and Scx in the forelimbs 
at E13.5  
(A-D) Whole mount in situ hybridization of the forelimbs using antisense probe 
for Meox2 and Scx at E13.5. (A and B) show the dorsal aspect of limbs while (C 
and D) show the ventral aspects of limbs. Black arrows show similar region of 
expression in the zeugopod. Red arrows in the autopod show expression of 
Meox2 transcripts in the digit tendon cells. Yellow arrows represent Scx 
















Fig 5.3.6 Meox2 expressing cells surround the condensed 
tendon bundles in the autopod at E13.5 
(A-D) Transverse sections of limbs from an E13.5 Meox2+/- embryo were 
stained for Meox2 expression using an antibody. FDP tendons cells were visibly 
condensed (T1). The higher magnification of a tendon tissue in C and D is from 
the boxed regions in A and B. Meox2+ cells were confined at the circumference 
of tendon tissue and were found in muscle connective tissue. White arrowheads 
indicate Meox2+ cells surrounding cartilage primordial and connective tissue; 
white arrows indicate Meox2+ cells surrounding tendon condensation; white 
arrowheads show Meox2+ cells in muscle connective tissue; C, cartilage; T1, 












Fig 5.3.7 Non-overlapping expression of Meox2+ and ScxGFP+ 
in the zeugopod and stylopod at E13.5 
The transverse section of limbs from an E13.5 Meox2+/-;ScxGFP embryo was 
obtained (A-D). Immunofluorescence for Meox2 using an antibody was 
performed (red) and tendons cells were identified using ScxGFP expression. 
The higher magnification of a tendon tissue in C and D is from tagged panel in 
A and B. The Meox2+ was confined in outer layer of tendon tissue and was 
found in soft connective tissue. White arrowhead indicates Meox2+ cells 
surrounding cartilage primordial and connective tissue; white arrows indicate 
Meox2+ cells surrounding tendons; yellow arrowhead show tendons; C, 












Fig 5.3.8 Distinct expression of Meox2 in distal and proximal 
autopod tendon compartment at E14.5  
(A) Whole mount in situ hybridisation for Scx in a Meox2+/- embryo showing 
individuated tendon groups in the forelimb. (B-E) Immunostaining with antibody 
for Meox2 (red) and nuclei stained with DAPI (blue) on a transverse section 
from the digit of a Meox2+/- embryo. The level of section (1) obtained is 
indicated in panel (1 in A). The boxed areas in B and C is shown in higher 
magnification in D and E. (F-H) Transverse section through the limb of Meox2+/-
;ScxGFP was obtained at the metacarpal level indicated in figure (2 in A). 
Meox2+ cells in red identified by using antibody staining and ScxGFP 
expression for tendon cells. White arrowheads in B and C indicate EDC tendons 
(T3); white arrows in B and C show FDP tendons (T1); pink arrowheads in B-E 
show Meox2 expression in muscle connective tissues; white arrowheads in F 
and H Meox2+ cells adjacent to EDC tendon (T3) and white arrowheads in F 






















Fig 5.3.9 Meox2+ cells are not expressed in ScxGFP+ tendon 
cells of zeugopod at E14.5  
(A-I) Transverse section was obtained from a forearm zeugopod and stylopod of 
Meox2+/-;ScxGFP at E14.5. Immunostaining was carried out using Meox2 
antibody (red) and ScxGFP expression located tendon cells (green). (A-F) 
represents a cross section from zeugopod segment in which Meox2+ cells 
marked a non-ScxGP+ regions. The boxed regions in A-C were analysed at 
higher magnification as shown in D-F. The Meox2+ cells were never found in 
the regions of ScxGFP+ expression domains. (G-H) represent a stylopod 
segment following the similar pattern of non-overlapping expression domain of 
Meox2 (red) and ScxGFP tendon cells (green). White arrows show Meox2+ 


















Fig 5.3.10 Fate-mapping of Meox2+ cells during embryonic 
stages:  
β-galactosidase activity was identified from Meox2 locus on transverse sections 
obtained from the forelimbs of Meox2nLacZ/+ embryos at E13.5 (A-D) and E15.5 
(E-J). Descendants of Meox2+ cells were visualised by S-gal staining. (A-D) At 
E13.5, Meox2 derived S-gal+ cells are present in the FDP (T1) and EDC (T3) 
digit tendons. The proximal sections show wider expression from the muscle 
connective tissue in C and D. (E-J) At E15.5, all digit tendon show S-gal 
staining. The boxed region in E is shown at higher magnification in F and the 
boxed region of G is magnified in J. Tendon nomenclature is tabulated in Table 
2. Notice, by E15.5, all tendon groups and surrounding cells are showing a 
strong β-galactosidase activity. The cartilage cells are not S-gal+ at both 













Fig 5.3.11 Meox2+ derived cells are present in tendons and 
muscle connective tissue at E16.5  
Transverse sections of forearm zeugopod were obtained from Meox2nLacZ/+ (A, 
B and D) and Meox2nLacZ/nLacZ (C and E). X-gal staining was performed to 
identify b-galactosidase activity from Meox2 locus. The boxed region in B is 
magnified in A to show blue tendon cells and muscle connective tissue in 
heterozygous controls. (C and E) In homozygous mutant, all tendons were lost, 
however, the muscle connective tissue showed strong X-gal staining. Black 
arrow in (A) show tendon; red arrows represent muscle connective tissue; 
asterisks in (D) show muscle fibres; R, radius; U, ulna. Notice, absence of blue 














Fig 5.3.12 Interlimb somites showed increase in TGFb2 
transcripts in Meox2-/- at E 12.5 
 
Whole-mount in situ analysis for TGFb2 at E12.5 on a Meox2+/- control embryo 
(A, C and E) and in homozygous Meox2-/- mutant embryo (B, D and F) was 
performed. Black arrows represent increased TGFb2 expression domain in the 
interlimb somites whereas yellow arrowhead showed normal expression levels 

































Fig 5.3.13 Increased TGFb2 expression restricted for only 
zeugopod and not autopod in Meox2-/- at E 12.5 
 
Whole-mount in situ analysis for TGFb2 at E12.5 in a Meox2+/- forelimb dorsal 
and ventral (A and C) and in the Meox2-/- embryo dorsal and ventral forelimb (B 
and D) was performed. Yellow arrows indicates normal TGFb2 expression 
domain whereas red arrows showed overall considerable increase of TGFb2 
expression levels in the absence of Meox2. In addition, TGFb2 whole-mount in 
situ analysis on the Meox2+/- control hindlimb dorsal and ventral (E and G) and 












Fig 5.3.14 Biphasic interaction between Meox2 and TGFβ2 
signalling in cell culture 
 
Overexpression of TGFβ2 protein was performed in C3H10T1/2 cells. Scx and 
Meox2 cDNA was monitored by semi-quantitative PCR after 1h, 2h, 6h and 8h 
of the incubation followed by harvesting cells. Scx was upregulated from 6h 
onwards whereas Meox2 levels showed biphasic response to the TGFβ2 
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6.1 General discussion 
 
During embryonic tendon genesis, the specified tendon cells are positioned 
between the muscle fibres and bone to form a functional musculoskeletal 
system. However, the mechanisms underlying precise alignment of tendon cells 
at their functional sites have just started to be elucidated. Currently, there are 
only few molecular regulators present to study the development of tendon. 
Using Meox2-/- mutant mice, we show an essential role for the Meox2 gene in  
tendon formation. The mutant neonates displayed much thinner and extremely 
fragile tendons; and  these defects were found to be a failure in embryonic 
tendon development and demonstrated a sustained role for Meox2 in the 
alignment and organisation (E12.5), maturation (E13.5), integration, and 
differentiation (E14.5 onwards) of tendon progenitor cells.. However, the 
induction of tendon progenitor cells at E11.5 remained unaffected in the mutant 
embryos, and there was no discernible defect in cartilage cells and ligaments of 
Meox2-/- embryos. Deciphering the tendon phenotype in the Meox2 mutants, we 
show that Meox2 is expressed by the Scleraxis+ autopod tendons but not in the 
zeugopod tendon indicating a position specific roles of Meox2 in the  autopod 
and zeugopod. Furthermore, Meox2 ablation affected cell proliferation but not 
cell death. In mice, TGFβ2 signalling is crucial for the embryonic tendon 
development where it maintains tendon cell identity and recruits additional 
specified tendon progenitor cells. We found a biphasic interaction between 
Meox2 and TGFβ2 signalling in vitro whereby, initially Meox2 levels were up 
regulated and then weakly repressed at later time points. Therefore, it raises the 
possibility of direct interaction between Meox2 and TGFβ2 signalling during 
embryonic tendon development. Interestingly, in Meox2 mutant embryos we 







Meox2-/- mutant animals have profound limb tendon 
defects  
 
Broadly, connective tissues are categorized into two groups: (i) dense 
connective tissue (tendons and ligaments) and (ii) loose connective tissue 
(fascia and muscle connective tissue). Using the ScxGFP transgene as a 
tendon marker, we showed that mutant neonates lack axial tendons of the 
trunk, tail tendons and the limbs displayed only thin trails of tendon fibres. In 
Meox2-/- neonates, apart from the substantial defects in all appendicular and 
axial tendons, there was severe impairment of fascia formation that led to 
intermixing of muscle groups in the forelimbs and hindlimbs. 
 
An essential requirement of the Scx gene has been proposed for FDS tendon 
development in the forelimb autopod but not in the zeugopod (Huang et al., 
2013; Murchison et al., 2007). Our observations in Meox2-/- neonates indicated 
a complete loss of FDS in the autopod and zeugopod. This suggests that 
Meox2 also plays a decisive role in the autopod and zeugopod FDS tendon 
development, Scx expressing FDS tendon progenitors in the autopod rely on 
the cues from meta-carpophalageal joints (MCP) joints for the development 
(Huang et al., 2015b). This observation was supported by the loss of the 
autopod FDS tendon unit in Sox5-/-; Sox6-/- double mutant embryos which show 
complete failure in the cartilage differentiation; and in the Indian hedgehog null 
embryos (Ihh-/-) embryos that exhibit skeletal defects (Huang et al., 2015b). 
Conversely, zeugopod FDS tendon segment does not rely on the cartilage and 
therefore, it suggests that Scx mediates the signals from the cartilage in the 
FDS tendon progenitors of the autopod. 
 
It is noteworthy that Meox2-/- mutant neonates displayed a regular bilateral 
symmetry of MCP joints in the digits. So why then does a loss of FDS tendon in 
the digit occur in the mutants despite the presence of normal skeletal elements? 
We propose the Meox2 gene is required intrinsically for the normal development 
of the autopod tendons. The finding that the Meox2 protein is expressed in digit 
tendons during tendon maturation stage supports this view. Our data showed 
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similar expression domains of Meox2 transcripts with Scx in the distal autopod 
tendon cells of the forelimb at E13.5 and Meox2 proteins in the forelimb 
autopod tendons by E14.5. In this scenario, we propose an intrinsic role of 
Meox2 to drive the normal expression of Scx gene function inside digits of the 
forelimb. Interestingly, we have observed the loss of Scx mRNA expression in 
Meox2-/- mutant embryos at E13.5. Therefore, we conclude that a Meox2 
function genetically upstream of Scx in the autopod tendon progenitors and that 
Meox2 is a member of the intrinsic regulatory mechanisms to control maturation 
and differentiation of digit tendon progenitors. Therefore, skeletal cues are 
unable to compensate for the loss of Meox2 gene function in the autopod.  
As development proceeds, FDS tendons residing in the zeugopod (Huang et al., 
2015b; Huang et al., 2013) control contraction of differentiated FDS muscle 
from the autopod towards zeugopod. The muscle inactivity in paralysed mdg 
embryos or absence of muscles in Spd embryos shows loss of FDS tendon in 
zeugopod but not in autopod (Huang et al., 2015b) suggesting that the cues 
from the muscles are necessary for the development of FDS tendon inside 
zeugopod. Likewise, our data revealed a reduction in the FDS tendon in the 
zeugopod due to Meox2 loss-of-function. We propose that unlike the autopod, 
an extrinsic regulation of Meox2 gene function for the zeugopod tendon 
development. This is supported by the observation that expression of Meox2 is 
not localised to Scx+ cells throughout zeugopod tendon development.  
 
The morphological characterisation in Meox2-/- neonates revealed an overall 
disruption of flexor and extensor tendons. Other major tendons that were 
affected throughout the proximodistal axis included other flexor and extensor 
tendons i.e. FDP and EDC tendons. Lineage tracing analysis has shown that 
induction and progression of these tendons originates from two separate pools 
of progenitor cells in the autopod (Six2+/Scx+) and zeugopod segments (Scx+) 
(Huang et al., 2015b). The same study also showed that extrinsic cues from the 
muscle cells are required for the tendon development in the metacarpal and 
zeugopod segments. The subtle changes in FDP tendon morphology and fusion 
of individuated EDC tendon bundles in the zeugopod of the forelimb in Meox2-/- 
neonates indicate deleterious effects on both of these cell populations in the 
autopod (Six2+/Scx+) and zeugopod (Scx+). We demonstrate the EDC tendon 
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phenotype in Meox2-/- was similar to that reported for Spd and mdg mutant 
embryos (Huang et al., 2015b). This suggests an indirect role of Meox2 during 
zeugopod tendon formation and we conclude that the zeugopod tendon defects 
are secondary to an initial failure of the normal muscle formation. Significantly, 
Meox2 is expressed in limb myoblasts only as they migrate into the limb at 
E10.5, and is quickly down regulated prior to the expression of myogenic 
regulators such a MyoD (Mankoo et al., 1999). Furthermore, the same study 
also showed that in Meox2 mutants, limb myoblast migration and differentiation 
are observed to be normal (Mankoo et al., 1999). Therefore, we conclude the 
tendon defects, although similar to those seen in Sp and mdg mutants, are 
unlikely to be a consequence of a loss of Meox2 in myogenic precursors. 
Instead, we propose that Meox2 functions in muscle connective tissues (MCT), 
affecting muscle development that secondarily impacts on zeugopod tendon 
development, as previously shown (Hasson, 2011; Kardon et al., 2003; Mathew 
et al., 2011). Of course, this does exclude the possibility that Meox2 functions 
extrinsically to Scx+ cells in progenitors that are subsequently recruited to 
tendons. Additionally, we cannot exclude the possibility that a pool of mesoderm 
cells that are bipotential and can be directed to a MCT or tendon fate; in a 
mechanism similar to that seen with Sox9+; Scx+ cells which can contribute to 
cartilage or tendon(Lorda-Diez et al., 2014; Lorda-Diez et al., 2009)  
 
Our lineage analysis with the Meox2-nLacZ transgene further revealed the 
muscle connective tissue retains a history of Meox2 expression. Interestingly, 
unlike the complete loss of tendons in Meox2nLacZ/nLacZ foetus at E16.5, loose 
connective tissue (fascia and muscle connective tissue) was still present in the 
mutants. However, development defects of these tissues were evident in the 
mutants that showed severe mispatterning and reduction in the tissue mass. 
Importantly, this correlated with the intermixing and disruption of individual 
muscle compartments at E16.5 and neonatal stage (Mankoo et al., 1999). This 
demonstrates an important intrinsic function of Meox2 from muscle connective 
tissue to regulate muscle patterning and organisation. Muscle connective tissue 
actively coordinates muscle-tendon interactions and muscle patterning during 
embryonic morphogenesis (Hasson et al., 2010; Kardon et al., 2003; Swinehart 
et al., 2013). A critical role for the muscle connective tissue (MCT) during 
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myogenesis was demonstrated using classic chick-quail experiment and single-
cell lineage tracing of myogenic progenitor cells that lacked the capacity to form 
a particular anatomical muscle (Chevallier et al., 1977; Christ et al., 1977; 
Kardon et al., 2002). Therefore, the pivotal role of the cells that are derived from 
limb mesoderm emerged as an extrinsic cue for muscle pattern. In recent years, 
the TCF4 transcription factor, a downstream regulator of the canonical Wnt-β-
catenin pathway is recognised as a marker for MCT (Kardon et al., 2003; 
Mathew et al., 2011). The TCF4-dependent signal from the MCT was shown 
extrinsically regulating the muscle fibre differentiation as genetic deletion of 
fibroblast specific Tcf4 expression led to severe reduction in muscle mass at 
P0. Same study also showed that Tcf4-dependent signals are necessary for the 
switching of embryonic myofibres to multinucleated foetal muscle fibres. 
Intriguingly, the authors showed that Tcf4 positively regulates embryonic and 
foetal myogenic cells by directly binding to the MyHCI and MyHCIIb enhancers 
via Wnt/β-catenin signalling pathway and therefore, an intrinsic regulatory Tcf4 
dependent machinery controls muscle fibre switch.  
 
In addition, Hasson et al. (2010) reported that Tbx genes are also required for 
the development of MCT. Tbx5 knockout mice have forelimb muscle patterning 
defects including the muscle splitting in the forelimb. The data in the same 
report also showed that Tbx5 regulates muscle connective tissue development 
via N-Cadherin and β-catenin pathway and thereby controls the intrinsic 
pathway in maintaining integrity of this tissue. The profound disruption in the 
embryonic development of zeugopod muscle and tendon was also occurred due 
to the loss of Hox11 genes in the muscle connective tissue (Swinehart et al., 
2013). Using Hoxa11eGFP reporter, the study showed that Hoxa11 gene is 
expressed in the muscle connective tissue, however, in Hox11 knock out 
embryos, tendons and muscle precursors failed to differentiate and thereby an 
extrinsic role of Hox genes from MCT was suggested during tendon 
morphogenesis.  
 
Evidence for a direct contribution of Meox2+ cells to developing tendons was 
obtained from the analysis of Meox2nLacZ/+ mice limbs which showed that all 
prominent tendon groups of the autopod e.g. FDP, FDS and EDC tendon 
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bundles showed strong LacZ staining from E13.5 onwards. Similarly, the 
zeugopod tendons showed β-galactosidase activity indicating that the 
Scx+/Meox2- tendon cells at these stages are derivatives of Meox2 progenitor 
cells. Interestingly, the close proximity of Meox2+ cells near the autopod 
tendons and strong Meox2-nLacZ+ in these tendon groups at E13.5 strongly 
suggests that Meox2 expressing cells are recruited in the autopod tendon 
formation. Indeed, by E14.5, Meox2+ cells are detected in the digit tendons. 
Therefore, in dense connective tissue i.e. tendons, Meox2 seems to play 
essential role in organisation and recruitment of the committed tendon 
progenitors cells.  
 
Therefore, on the basis of published data  and observations  in the present 
study, we hypothesize that, during tendon development, Meox2 regulates 
autopod tendon progenitors intrinsically whilst there is an external cues 
delivered by Meox2 for proper zeugopod tendon formation. Our RNA and 
protein expression data confirmed Meox2 expression is excluded from domains 
of Scx+ tendon progenitors at E12.5-13.5 and by E14.5 in the zeugopod of the 
forearm, although, significantly, the Meox2+ positive areas are adjacent o Scx+ 
domains. These observations indicate an indirect role of Meox2 and this 
interpretation is further supported by similarities in the phenotype of Scx 
expression in Meox2-/- and Spd embryos at E12.5. Whilst Meox2 loss-of-function 
resulted in complete loss of chevron-shaped Scx domain in the medial 
zeugopod; there was a significant reduction of the same expression domain due 
to the absence of muscles in Pax3 mutants. The presence of Meox2-nLacZ+ 
cells in both MCT and tendons can suggest that a pool of uncommitted 


















Figure6.1: Diagrammatic summary of research findings in limb tendon 
development. (A) Induction of initial Scx/Sox9/Meox2 multipotent limb mesenchyme 
cells is specified to form tendons under the influence of Wnt and Fgf signalling. (B) 
Organisation of tendon progenitors requires signals that are derived from Meox2+ 
muscle connective tissue, muscle cells and adjacent cartilage condensation in the 
zeugopod. However, the extrinsic signals from the cartilage and Meox2 derived cues 
within the tendon cells are necessary for the autopod tendon formation. (C) Scx favours 
aggregation and differentiation of tendon progenitors to form mature distinct tendon 
along the proximo-distal axis occurs by E13.5. Additional Meox2+ cells are recruited to 
form the autopod tendons. While in the zeugopod, Meox2+ cells continue to regulate 
tendon development extrinsically from the muscle connective tissue.  
 
 
An extrinsic and intrinsic influence of the transcription factors to regulate the 
development of neuron, blood cell and retinal tissue development has been 
described before (Cepko, 1999; Nguyen et al., 2014; Tosney et al., 1994). For 
instance, the extrinsic regulation of Meox1 from the somite on the endothelial 
cell derivatives was revealed when the genetic deletion of Meox1 in the 
zebrafish embryos resulted in the expansion of haematopoietic stem cells that 
are derived from endothelial cells (Nguyen et al., 2014). Moreover, during the 
vertebrate eye development, various cell types (rod and cone photoreceptor 
cells, bipolar cells and glial cells) though derived from common pool of 
progenitors, the morphogenesis all cells are affected by extrinsic and intrinsic 
activities of bHLH transcription factors (Brown et al., 2001; Furukawa et al., 
2000; Hatakeyama et al., 2001). For example, bHLH genes Mash1, Mash3 and 
Chx10 play an intrinsic role for the bipolar cell morphogenesis. While, Mash1 
and Mash3 indirectly promoted the formation of rod cell genesis, Chx10 
extrinsically favoured glial cell formation (Cepko, 1999). Such findings support 
the notion of both intrinsic and extrinsic roles of Meox2 that governs the 
molecular mechanisms for the normal differentiation and morphogenesis of 
tendon tissue.  
 
Furthermore, several line of evidence have demonstrated the modular 
development of FDS, FDP and EDC tendon groups by two separate groups of 
208	  
	  
progenitor cells in the autopod and zeugopod; we propose a crucial role of 
Meox2 function that controls the regulatory mechanisms in both progenitor 
populations of the tendons along the proximodistal axis of the forelimb.  
 
A particularly striking finding of our data is the conserved role of Meox2 along 
the proximo-distal axis of the limb. Specifically, it indicate that Meox2 plays an 
evolutionary conserved function in the genetic regulatory mechanisms that are 
responsible for the functional and morphological shifts from fish fins to the 
tetrapod limbs. Using comparative morphology and functional genomics 
methods, previous studies have shown that the tetrapod limbs develop due to 
dual phases of HoxD and HoxA expression. These phases modulate the 
development of the autopod including wrist and digits that are controlled by cis-
acting enhancers (Zakany and Duboule, 2007). A recent study has shown that 
two topological domains at Hox loci are conserved both in the zebrafish and in 
tetrapods (Woltering et al., 2014). However, functional genomics studies show 
that the late phase enhancers isolated from teleosts (zebrafish, tetraodon) are 
able to drive the expression of Hox genes only in the proximal structure of the 
limb but not in the autopod (Spitz et al., 2003). This suggests that the extrinsic 
roles of Meox2 in the zeugopod are conserved in the ancestors during early 
evolution. On the other hand, it also suggests that the intrinsic role of Meox2 in 
the autopod is acquired during the late evolution of autopods in the tetrapods.  
 
Therefore- and hindlimb share similar genetic regulations and are evolutionary 
conserved (Wagner, 1989; Young et al., 2009), so it was not surprising that the 
FDB in the hindlimb, an analogue of the FDS in the forelimb, was completely 
missing in Meox2-/- neonate. To date, there is no other genetic model described 
that investigated FDB tendon development. Therefore, our data can be 
considered as the first report of a conserved genetic mechanism necessary for 
both FDS (forelimb) and FDB (hindlimb) tendon development.  
 
Meox2-/- neonates showed a significant loss of Achilles tendon mass suggesting 
a role in both the prenatal and postnatal development and regulation of 
tendons. The hallmark of postnatal tendon development is the continuous 
deposition of collagenous matrix. Interestingly, the majority of the molecular 
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regulators that are important for post-natal tendon formation do not exhibit 
embryonic tendon defects in the respective mutants. Abnormalities in the 
collagen fibril organisation of Achilles tendon have been reported in COMP 
mutants, which display muscle myopathy, bone dysplasia, and reduce tendon 
thickness (Pirog et al., 2010). The defects in the collagen composition from this 
tendon group was also observed in Gdf5-/- that showed impaired properties of 
mechanical loading along with delayed in healing properties when observed in 
injury model. Therefore, it is interesting for us to speculate that the 
biomechanical properties of individual collagen fibrils in the Achilles tendon of 
Meox2-/- could be altered.  
 
Meox2-/- mutant animals show gross axial tendon 
defects  
 
Our analysis of the trunk and tail tendons in addition to the limbs indicated that 
Meox2 plays an essential role in the tendons that assist in the passive transfer 
of the force from both epaxial and hypaxial muscles. Whilst epaxial muscles 
support the back and neck muscles, the hypaxial muscles controls the limb, 
tongue, diaphragm, intercostal, tail and the entire body wall (Kablar et al., 
1997).The somite expression of Meox1 in the demomyotome and Meox2 in the 
sclerotome suggests they regulate epaxial and hypaxial muscle development 
(Candia et al., 1992; Mankoo et al., 2003).  
 
Using ScxGFP transgene expression, we showed the disrupted tendon fibres of 
the dorsal back skeleton in the mutant neonates. However, Meox2 exhibits a 
crucial role for the maintenance of intercostal at E14.5 and tail tendons that are 
required by hypaxial muscles of the trunk. Interestingly, the annulus fibrosus 
ligament in the tail, that also expresses ScxGFP, remained unaffected in our 
mutant model. A similar tail tendon phenotype was also reported in the ScxGFP-
/- animals (Murchison et al., 2007). Previously, the data showed that Meox2-/- 
animals are born with expected Mendelian frequency and no embryonic lethality 
observed due to Meox2 mutation (Mankoo et al., 1999). Such normal survival 
ratio despite loss of ScxGFP from the intercostal tendons could be explained by 
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the observation of normal tissue morphology and size of the hypaxial muscles in 
neonates i.e. intercostal and diaphragm muscles that are essential for the 
viability of all vertebrates.  
 
Our findings further demonstrated the tendon defects are embryonic and the 
earliest tendon phenotype was at E12.5 for axial tendon tissues, in contrats to 
E12.0 in the limbs. Between E12.0- E12.5, the committed axial tendon cells 
initiate to position between muscle and cartilage cells (Murchison et al., 2007; 
Schweitzer et al., 2001). It is well known that tenocytes that are positioned near 
a cartilage arise from Scx+/Sox9+ progenitor cells, whereas Scx-/Sox9+ cells 
contribute to the cartilage (Blitz et al., 2013; Sugimoto et al., 2013a; Sugimoto et 
al., 2013b). The lack of Meox2 has shown no effect on the cartilage cells that 
are marked by Sox9. 
 
The evidence here further showed that the expression of Meox2 was 
predominantly found in the sclerotome that hosts the multipotent Scx+/Sox9+ 
cell progenitors (Sugimoto et al., 2013a; Sugimoto et al., 2013b). However, we 
also found a narrow overlap between Meox2+ cells residing in the sclerotome 
and ScxGFP+ cells in the syndetome. The syndetome is a sub compartment of 
the anterior sclerotome (Brent et al., 2003; Schweitzer et al., 2001), which is 
comprised of Scx+/Sox9- tendon precursors (Sugimoto et al., 2013a). 
Collectively, we conclude that Meox2+ cells in the sclerotome selectively affects 
only Scx+/Sox9- progenitor and not Scx+/Sox9+- cells during tendon 
morphogenesis population although further analyses are needed to establish 
this point.  
 
Meox2 regulates cell proliferation but not cell death  
 
 We observed that at E12.5 there was an overall reduction in cell proliferation in 
mutant embryos across the entire compartment in somites suggesting a 
significant role of Meox2 in cell cycle progression. In contrast, we found no 
change in programmed cell death in mutants at embryonic stages. This is 
consistent with our finding that Meox2 is required for additional recruitment of 
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tendon progenitor cells at the site of condensation, and suggests the primary 
role of Meox2 is by regulating the proliferation of progenitors that will be 
recruited to the tendon pool.  Previous data has shown the overlapping 
expression regions of Meox homoeobox genes  in the early developing somites 
of chick and mouse emrbyos (Reijntjes et al., 2007). Moreover, the somites of 
Meox1 null embryos showed developmental alterations in cell proliferation 
(Mankoo et al, 2009). It was shown that in the absence of functional Meox1, 
increased cell proliferation rates were observed in the rostral somitic region at 
the expense of caudal region. However, ablation of Meox1 gene caused no 
significant changes in the cell death. The similarities of the role of Meox genes 
during the somite development highlight the concentrated action of Meox1 and 
Meox2 during the cell proliferation and cell death in developing embryos. 
Therefore, our data provide a line of evidence that Meox2 function is essential 
to maintain the cell densities during embryonic tendon development.  
 
Interaction between Meox2 and TGFβ signalling 
 
By E12.5, an overall decrease of Scx levels was observed in the absence of 
both TGFβ2 (Pryce et al., 2009) and Meox2. TGFβ signalling is essential for the 
organisation and recruitment of tendon progenitor cells. Using Scx as a marker 
for tendon cells, in Tgfβ2-/-; Tgfβ3-/- double knock out mouse embryos, a 
complete loss of all tendons was reported (Pryce et al., 2009). In addition, 
Tgfβ2-/- mutant embryos exhibit a severe disruption in tendon progenitor cells at 
E12.5 but no change of Scx expression was observed in Tgfβ3-/- mutant 
embryos (Pryce et al., 2009). However, deletion of the TGFβRII, which is the 
single type II receptor utilised by all the members of the TGFβ superfamily, 
affected overall tendon development suggesting a wider role of the signalling 
pathway in tendon morphogenesis. Therefore, we propose a series of possible 
models for the interaction of Meox2 and TGFβ2 in regulating Scx expression. 
First, Meox2 acts upstream of TGFβ2, and so a loss of Meox2 will lead to a 
deficit of TGfb2 signalling and impact in turn on Scx expression; second Tgfβ2 
functions upstream of Meox2, a loss of Meox2 will therefore impair the TGFb 
mediated signalling required for Scx expression; last, Meox2 and TGFβ2 acting 
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in parallel to regulate the Scx expression at E12.5. Consequently, we expected 
either, a down regulation (model 1) or normal (models 2 and 3) TGFβ2 
expression in Meox2 knock out embryos. Surprisingly, our results revealed an 
increase in Tgfβ2 transcripts in the interlimb somites and in the zeugopod of 
Meox2-/- mutant embryos. On the contrary, other regions e.g. cervical 
(contribute towards tongue, neck and shoulder muscles), lumbar (opposite the 
hindlimbs) somites and presumptive autopod showed similar Tgfβ2 expression 
pattern. At present we cannot resolve this paradox, and it is essential to 
investigate expression of TFGb2 protein levels in Meox2 mutants. We have 
attempted to investigate the expression of Meox2 in TGFBII2 mutants; however 
these experiments were unsuccessful, due to transport delays of embryos from 
Dr. Schweitzer’s laboratory. 
 
We also investigated the relationship between TGFb signalling and Meox2 
using the in vitro culture of C3H10T1/2 mesodermal stem cells. We observed a 
biphasic interaction of Meox2 expression due to ectopic TGFβ2 proteins at 
various time points in the cells. There was a decrease in Meox2 levels until 8 
hours; however, Meox2 expression was later on increased. Interestingly, it was 
shown that the Scx level was significantly up regulated when TGFβ2 was added 
in the medium (Pryce et al., 2009). Moreover, a previous study has shown the 
complex interaction between Meox2 and TGFβ signals in epithelial cell biology 
(Valcourt et al., 2007). Tgfβ1 derived signals synergised with ectopic Meox2 to 
arrest proliferation of epithelial cells and, conversely, Meox2 partially caused 
blockage of TGFβ-1 derived epithelial-to-mesenchymal transition (EMT) in 
cultured keratinocytes (Valcourt et al., 2007).  
 
We can suggest a possible mechanism by which Meox2 modulates restriction of 
TGFβ2 domains to maintain integrity of functional musculoskeletal system. 
Moreover, the TGFβ signalling pathway promotes programmed cell death 
during limb formation (Dunker et al., 2002), whereas, Meox2 stimulates cellular 
proliferation. Hence, we hypothesize a reciprocal interaction between Meox2 





6.2 Future perspectives 
 
ScxGFP expression and tissue histology in Meox2-/- neonates revealed gross 
tendon defects in appendicular and axial tissues. The specific loss of tendons, 
namely, FDS in forelimb and FDB in hindlimb suggest a unique role of Meox2 in 
these tendon groups. Further investigations are needed in Meox2 null 
embryonic and foetal stages to examine the FDS/FDB tendon induction, 
organisation, and differentiation as these events are delayed in mouse (starting 
only at E14.5 until E16.5) compare to all other limb tendons (from E10.5 until 
E14.5) (Huang et al., 2013; Schweitzer et al., 2001). Moreover, during this late 
developmental phase, FDS muscle differentiates in the autopod and then 
translocation occurs towards zeugopod. Substantial effects of this translocation 
are shown to be associated with FDS tendon development because this tendon 
elongates from the FDS muscle insertion sites within the autopod towards 
zeugopod (Huang et al., 2013). Therefore, developmental analysis of FDS 
muscle in Meox2 control embryos from E14.5 to E16.5 will provide a clue for the 
failure of FDS tendon formation.  
 
Tendon is composed largely of collagen-rich extracellular matrix and secreted 
by tendon fibroblasts and this has a pivotal role in the normal physiological 
homeostasis and regulation of the tendon matrix. Therefore, a manifestation of 
defective collagen fibril organization would be analysed by transmission 
electron microscopy to investigate collagen fibril diameter and arrangement in 
the mutant neonates. There are number of individual proteins present in tendon 
cells e.g. type I and type II collagen and tenomodulin, therefore, these proteins 
will be observed by immunohistochemistry in the mutant tendons. Collectively, 
all these analysis will help us to derive the focussed role of Meox2 in 
determining the post-natal integrity of tendons and regulating tendon 
homeostasis. 
 
In vitro assays in C3H10T1/2 cells can be validated to identify the levels of 
Meox2 in response to TGFβ signalling. It was also shown that in the C3H 10T/2 
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cells, Scleraxis expression increases in response to TGFβ addition over the 
period of 24 hours. Therefore, our assay will provide an opportunity to identify 
direct targets of Meox2 gene. Additionally, we can extrapolate this method to 
identify response of cell cycle proteins in the fibroblasts as we established that 
Meox2 positively regulates cellular proliferation during embryogenesis. For this, 
we could also able to employ the assay in primary fibroblast and monitor their 
active proliferation in response to ectopic expression of Meox2.  
 
Finally, it is necessary to unfold the interaction of Meox2 and TGFβ2 proteins. 
As we have already found a regionalised increase of Tgfβ2 transcripts in 
Meox2-/- embryos at E12.5, an in vivo analysis of Meox2 expression in TGFβ2-/- 
embryos would be important. In limb organ culture, ectopic expression of Scx is 
induced by TGFβ2 soaked beads. Therefore, an ex vivo approach using Scx as 
the positive control, TGFβ2 soaked bead would be implanted in the chick limbs 
of appropriate stages and Meox2 expression will be monitored. Our results from 
this methodology will also enable to describe the dynamic relationships of 
Meox2 and TGFβ2 throughout the proximo-distal axis of the limb.  
 
Meox2 mutants in some aspects resemble Scx knockouts, with defects 
associated with the later stages of limb tendon development. As our data from 
Meox2-nLacZ expression analysis provide an evidence that all tendon cells 
retains Meox2 expression history during the tendon development, therefore, 
from our proposed genetic model we aimed to study the Meox2 gene function in 
tendon-less model. To analyse the intrinsic regulation of tendon progenitor cells 
by Meox2, we plan to utilize Prx1-Cre transgenic mice (Logan et al., 2002) that 
will be obtained from Prof. Malcolm Logan in the Randall division. The 
conditional inactivation of Meox2 in limb mesoderm could then be achieved by 





6.3 Final conclusion 
 
In summary, our study reveals that Meox2 is an important regulator of axial and 
appendicular tendon development. Meox2 exhibit an intrinsic regulation of 
autopod tendons whereas it extrinsically regulates zeugopod tendon 
development. The muscle connective tissue is derivatives of Meox2 progenitor 
cells and therefore Meox2 extrinsically regulate muscle and tendon patterning 
during embryogenesis. Our study has contributed an additional transcription 
factor in tendon research that provides novel insights for the new therapeutic 
methods during tendon pathology and will benefit the tendon tissue healing 
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